ticker,rpa_date_utc,rpa_time_utc,rp_entity_id,entity_name,relevance,event_sentiment_score,group,sub_type,event_text,news_type,source_name,headline
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.8,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2023 revenue increased by 97%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2023 revenue increased by 39%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore has partnered with Ascensia Diabetes Care to,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-04-30,10:00:01,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update and Audited Results for 2023
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-06-03,12:00:02,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Update: Achieved profitability,PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE -- COMPANY ACHIEVES PROFITABILITY
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Corporate Update: Mid-Year Results,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-08-29,10:05:00,5A06E6,Avricore Health Inc.,99,0.76,revenues,up,"Avricore Health Inc.: In the six months ended June 30, 2024 revenues grew by 84%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability"
APH,2024-11-14,23:01:23,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host a conference call via Zoom on November 18th,PRESS-RELEASE,GlobeNewswire,Avricore Health Refocuses Strategy to Unlock Growth Potential
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.66,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2024, revenue increased by 58%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2024, revenue increased by 25%",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.61,earnings,positive,"Avricore Health Inc.: the Company recorded net profit of $43,494",PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2024-11-29,12:30:01,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Add new locations,PRESS-RELEASE,GlobeNewswire,"Avricore Health Corporate Update: Effective Plan, Resources Result in Success"
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.5 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-01-26,13:00:05,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.5 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Announces $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-04,01:05:17,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,"Avricore"") announces a non-brokered private placement of up to 7,000,000 units",PRESS-RELEASE,GlobeNewswire,Avricore Health Announces $1.54 Million Financing
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:01,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.0,equity-actions,,Avricore Health Completes $1.54 Million Financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-12,13:30:52,5A06E6,Avricore Health Inc.,100,0.4,equity-actions,completed,Avricore Health Inc.: Closing of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Avricore Health Completes $1.54 Million Financing and Grants Options
APH,2021-02-16,13:00:04,5A06E6,Avricore Health Inc.,99,0.49,equity-actions,,Avricore Health Inc.: Private Placement,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
APH,2021-05-31,12:00:01,5A06E6,Avricore Health Inc.,100,0.39,products-services,,Avricore Health's HealthTab(TM) Signs Distribution Agreement,PRESS-RELEASE,GlobeNewswire,Avricore Health's HealthTab(TM) Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
APH,2021-06-03,13:30:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Signs Master Agreement to,PRESS-RELEASE,GlobeNewswire,Avricore Health Signs Master Agreement to Pilot HealthTab(TM) Platform for Diabetes Management in Select Shoppers Drug Mart(R) Pharmacies
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,Avricore Health Inc.: The Company secured two rounds of financing,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.61,products-services,increase,Avricore Health Inc.: The Company sees strong demand,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-09,12:00:03,5A06E6,Avricore Health Inc.,99,0.0,products-services,,Avricore Health Inc.: The Company also has developed tools,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update Summer 2021
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Partnered with Abbott,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-06-22,12:35:00,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: Secured Master Agreement with,PRESS-RELEASE,GlobeNewswire,Avricore Health Inc (ACVRF) to Webcast Live at Life Sciences Investor Forum June 24th
APH,2021-07-28,13:55:54,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,Avricore Health Inc.: Working together with patients in this way reduces the cost and,PRESS-RELEASE,GlobeNewswire,Avricore Health Partners with Ellerca Health Inc to Offer Joint Diabetes Screening and Management Support
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2022-06-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Fiscal Discipline / Revenues Growing,PRESS-RELEASE,GlobeNewswire,Avricore Health Executing Growth Strategy - Summer 2022 Corporate Update
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Second-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $207,363",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $176,175",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-08-29,12:30:02,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Second-Quarter 2022 Results
APH,2022-10-21,13:00:03,5A06E6,Avricore Health Inc.,100,0.0,marketing,,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022",PRESS-RELEASE,GlobeNewswire,"Avricore to Present at Emerging Growth Conference on Oct. 26, 2022"
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,products-services,,Avricore Health Inc.: Developing new domestic pilot programs with,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE NINE MONTHS,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $791,139",PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.48,equity-actions,down,Avricore Health Inc.: Expenses decreased,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results
APH,2022-11-29,16:08:39,5A06E6,Avricore Health Inc.,100,0.0,earnings,,Avricore Health Reports Third-Quarter 2022 Results,PRESS-RELEASE,GlobeNewswire,Avricore Health Reports Third-Quarter 2022 Results -2-
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.64,earnings,up,Avricore Health Inc.: Record Earnings,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: the Company expects to see strong year,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.49,partnerships,,"Avricore Health Inc.: In collaboration with Abbott and Shoppers Drug Mart, the Company is",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-02-01,13:00:09,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Earnings Advisory 2022 and 2023 Objectives
APH,2023-03-23,14:46:36,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company will be deploying Abbott's ID Now(TM),PRESS-RELEASE,GlobeNewswire,"Avricore Health's HealthTab(TM) Passes 530 Locations, Adds Virus Detection"
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,investor-relations,,Avricore Health Inc.: The Company will host an investor update call on May 3rd,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: The Company achieved record revenues of over $1.75 million,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.34,products-services,,Avricore Health Inc.: the Company is deploying Abbott's ID Now,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,Avricore Health Inc.: ANNUAL FINANCIAL RESULTS,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,earnings,,"Avricore Health Inc.: RESULTS OF OPERATIONS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2022",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited Results for 2022
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,-0.65,earnings,negative,"Avricore Health Inc.: The Company incurred comprehensive loss of $818,228",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,"Avricore Health Inc.: Revenue increased to $1,768,374",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-05-02,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,equity-actions,,"Avricore Health Inc.: Expenses decreased to $1,274,738",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Updates on Audited -2-
APH,2023-06-21,22:38:30,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Record revenues in 2022,PRESS-RELEASE,GlobeNewswire,Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members
APH,2023-07-20,16:27:37,5A06E6,Avricore Health Inc.,96,0.39,products-services,,Avricore Health has entered into an agreement with Ascensia Diabetes Care to,PRESS-RELEASE,DJ Global Press Release Wire,Avricore Health announces company will add blood glucose meters to HealthTab Platform
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.9,earnings,up,Avricore Health Inc.: The company's gross profit grew 300%,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Revenues for the first half of 2023 reached $1,177,290",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.39,products-services,,Avricore Health Inc.: the Company announced its agreement with Ascensia Diabetes Care,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-08-30,12:00:02,5A06E6,Avricore Health Inc.,99,0.65,revenues,up,Avricore Health Inc.: Revenue growth,PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Mid-Year Review Demonstrates Company on Right Track
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.44,revenues,up,"Avricore Health Inc.: In the three months ended September 30, 2023 revenue increased by 27%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2023-11-30,17:58:26,5A06E6,Avricore Health Inc.,99,0.84,revenues,up,"Avricore Health Inc.: In the nine months ended September 30, 2023 revenue increased by 169%",PRESS-RELEASE,GlobeNewswire,Avricore Health Corporate Update -- Company Demonstrates Strong Growth
APH,2024-01-29,07:00:16,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Strong revenues on H2,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2024-01-29,07:00:16,A1C370,Alliance Pharma PLC,99,0.41,revenues,up,Alliance Pharma PLC: Nizoral revenues increased 3%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2024-01-29,07:00:16,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,Alliance Pharma PLC: Underlying profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2024-01-29,07:00:16,A1C370,Alliance Pharma PLC,99,0.65,revenues,up,Alliance Pharma PLC: our Consumer Healthcare revenues to continue to grow,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2024-01-29,07:00:16,A1C370,Alliance Pharma PLC,99,0.36,marketing,release,Alliance Pharma PLC: we launched new advertising,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2024-04-26,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results Publication Date
APH,2024-05-03,06:49:22,A1C370,Alliance Pharma PLC,100,0.95,analyst-ratings,positive,Alliance Pharma Started at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Alliance Pharma Started at Buy by Deutsche Bank
APH,2024-05-03,06:49:22,A1C370,Alliance Pharma PLC,100,0.0,price-targets,set,Alliance Pharma Target Started at 85.00p by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Alliance Pharma Target Started at 85.00p by Deutsche Bank
APH,2024-05-08,06:00:14,A1C370,Alliance Pharma PLC,99,0.47,labor-issues,,Peter joined the Board of Alliance,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Management Update
APH,2024-05-23,14:09:16,A1C370,Alliance Pharma PLC,100,-0.42,legal,,Alliance Pharma PLC Successful appeal of CMA decision,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Successful appeal of CMA decision
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Preliminary Results for the year ended 31 December 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Strong revenues on H2,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 105.0,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.44,credit,reduction,Alliance Pharma PLC: Net debt reduced to GBP91.2m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.53,legal,,"Competition and Markets Authority (""CMA"") decision clearing Alliance",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.0,investor-relations,,Alliance Pharma PLC: This year's AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.41,revenues,up,Alliance Pharma PLC: Statutory revenue increased 8% to GBP180.7m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: ScarAway sales reached GBP9.9m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.41,revenues,up,Alliance Pharma PLC: Nizoral revenues increased 3%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.54,revenues,up,Alliance Pharma PLC: H1 revenues grew 40%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.52,products-services,,"Alliance Pharma PLC: we launch new products, sales for FY 2024",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,-0.3,revenues,,Alliance Pharma PLC: Amberen revenues declined 25% CER to GBP11.2m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,-0.66,earnings,down,Alliance Pharma PLC: Reported operating loss increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,-0.65,earnings,down,Alliance Pharma PLC: Reported profit before tax decreased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Reported basic earnings per share was a loss of 6.13p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,-0.52,assets,down,Alliance Pharma PLC: Intangible assets decreased by GBP93.4m in the year to GBP300.0m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.52,products-services,,Alliance Pharma PLC: New products already launched in 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2024-06-19,06:00:17,A1C370,Alliance Pharma PLC,100,0.53,labor-issues,,Alliance Pharma PLC: Board and executive changes,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 105,019 - 105,019",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -5-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,-0.51,labor-issues,,"Alliance Pharma PLC: In February 2024, Jo LeCouilliard stepped down from the Board",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -5-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.52,products-services,,"Alliance Pharma PLC: we launch new products, Nizoral sales for FY 2024",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -5-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Operating expenses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -5-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.6,earnings,positive,Alliance Pharma PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -5-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -5-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,-0.65,earnings,negative,Alliance Pharma PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.57,equity-actions,listing,Alliance Pharma PLC: The Company is listed on the AIM stock exchange,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Underlying gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Operating expenses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,-0.65,earnings,negative,Alliance Pharma PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross Profit 82,727",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Nizoral statutory revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,-0.48,equity-actions,costs,Alliance Pharma PLC: restructuring costs,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,-0.62,earnings,negative,Alliance Pharma PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -11-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Basic EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -11-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -11-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying basic EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -11-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Cost At 1 January 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -11-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.38,equity-actions,,Alliance Pharma PLC: Onerous Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -11-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Adjusted profitability,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -12-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,-0.65,earnings,negative,Alliance Pharma PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -12-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Operating costs,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -12-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 105,019 - 105,019",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -13-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -13-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -13-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -13-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Underlying taxation charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -13-
APH,2024-06-19,06:00:18,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -14-
APH,2024-07-29,15:10:55,A1C370,Alliance Pharma PLC,99,0.0,investor-relations,,Alliance Pharma PLC: Result of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Result of AGM
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Results for the six months ended 30 June 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 50.7,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.08,revenues,,Alliance Pharma PLC: Consumer Healthcare revenues +5.6%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.41,revenues,up,Alliance Pharma PLC: Other consumer healthcare revenues increased 8.9%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.22,equity-actions,increase,Alliance Pharma PLC: we increase investment in marketing and innovation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.53,legal,,"Competition and Markets Authority (""CMA"") decision clearing Alliance",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.04,revenues,,Alliance Pharma PLC: Consumer Healthcare revenues of GBP61.4m were up 2.9%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.0,revenues,,"Alliance Pharma PLC: Consequently, Nizoral revenues",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.41,revenues,up,Alliance Pharma PLC: Other consumer healthcare revenues increased 8.9%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,-0.24,earnings,down,Alliance Pharma PLC: Reported operating profit declined 12.1% to GBP10.7m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.52,products-services,,Alliance Pharma PLC: We launched three significant new products during H1 24,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: We have also partnered with Walmart,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,94,0.47,equity-actions,,Alliance Pharma PLC: Significant restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -5-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,revenues,,Alliance Pharma PLC: Total Revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,revenues,,Alliance Pharma PLC: Nizoral revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,earnings,,Alliance Pharma PLC: Interest income,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,-0.48,equity-actions,costs,Alliance Pharma PLC: restructuring costs,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.62,earnings,up,Alliance Pharma PLC: Profit before taxation multiplied,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,-0.65,dividends,suspended,Alliance Pharma PLC: No dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,dividends,,Alliance Pharma PLC: No interim dividend for 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,dividends,,Alliance Pharma PLC: Interim dividend for the 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,earnings,,Alliance Pharma PLC: Underlying diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,equity-actions,,Alliance Pharma PLC: Cost At 1 January 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.59,earnings,positive,Alliance Pharma PLC: Underlying profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.0,equity-actions,,Alliance Pharma PLC: Total taxation charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2024-09-30,06:00:21,A1C370,Alliance Pharma PLC,90,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 50,662 - 50,662",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2021-01-20,07:00:07,A1C370,Alliance Pharma PLC,99,0.62,acquisitions-mergers,,Alliance Pharma PLC: Recent acquisition of Amberen(TM) set to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2021-01-20,07:00:07,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Underlying profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2021-01-20,07:00:07,A1C370,Alliance Pharma PLC,99,0.65,revenues,up,Alliance Pharma PLC: Whilst top line revenue growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2021-01-20,07:00:07,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Revenue for 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2021-01-20,08:56:12,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma Sees 2020 Profit,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Sees 2020 Profit Beat Despite Declining Revenue
APH,2021-02-18,07:00:23,A1C370,Alliance Pharma PLC,99,0.0,investor-relations,,Alliance Pharma PLC: Analyst Conference Call,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Notification of Preliminary Results
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Results for the year ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.16,revenues,,Alliance Pharma PLC: Prescription Medicine revenues down 14% to GBP44.5m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,-0.42,earnings,,Alliance Pharma PLC: Reported profit before tax down 58% to GBP13.0m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.62,acquisitions-mergers,,"Alliance Pharma PLC: Group leverage post acquisition of Biogix Inc at 2.43 times, up from",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,dividends,,Alliance Pharma PLC: Proposed final dividend payment of 1.074p per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 82.8,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Reported basic earnings per share 1.54p 4.80p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.65,revenues,up,Alliance Pharma PLC: Whilst top line revenue growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,investor-relations,,Alliance Pharma PLC: CONFERENCE CALL,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2020
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Sales of MacuShield (eye health supplement) for the first half of 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.52,products-services,,Alliance Pharma PLC: we launched a new formulation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.62,acquisitions-mergers,,Alliance Pharma PLC: The acquisition of Biogix has created scale in our business in,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,-0.46,partnerships,terminated,Alliance Pharma PLC: By the end of 2022 we will have concluded our partnership with Johnson & Johnson,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,-0.24,revenues,down,"Alliance Pharma PLC: our Consumer Healthcare portfolio was mixed, with revenues down 9% in 2020",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.72,revenues,up,Alliance Pharma PLC: We expect a recovery in sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.52,revenues,up,"Alliance Pharma PLC: However, the second half of 2020 saw a reversal of this trend, with sales up 38%",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Overall sales were,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,-0.51,products-services,decrease,Alliance Pharma PLC: we saw a reduction in demand,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.57,acquisitions-mergers,completed,"Alliance Pharma PLC: In December 2020, we successfully completed the acquisition of Biogix Inc and the Amberen brand, a highly",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.57,products-services,granted,Alliance Pharma PLC: Our new system allows for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.52,products-services,,Alliance Pharma PLC: our products continue to be available to consumers,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.22,acquisitions-mergers,,Alliance Pharma PLC: Continuing to invest in our,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.63,products-services,,Alliance Pharma PLC: Integrating Biogix and Amberen into the US-based Alliance business,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 82.8,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Reported basic earnings per share 1.54p 4.80p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,-0.66,earnings,down,Alliance Pharma PLC: Reported profit before tax decreased 58% in 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Group revenues were,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: The total tax charge for the year was GBP5.0m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,-0.64,earnings,down,Alliance Pharma PLC: Reported operating profit decreased 54% to GBP16.3m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.48,equity-actions,down,Alliance Pharma PLC: Finance costs were down,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Reported profit before,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Reported basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 82,816 - 82,816",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -5-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Operating expenses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -5-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -5-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Profit for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -6-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.57,equity-actions,listing,Alliance Pharma PLC: The Company is listed on the AIM stock exchange,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -6-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -7-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -7-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Nizoral revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -7-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross Profit 59,141",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -7-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Profit before,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: The taxation charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,dividends,,Alliance Pharma PLC: An interim dividend of 0.536p per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2018,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: For diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -9-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Basic EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -9-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -9-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying basic EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -9-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Cost At 1 January 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -9-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Cost At 1 January 2019,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -9-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -10-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -11-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,"Alliance Pharma PLC: The prior year expense included GBP1,152,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -11-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Profit for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -12-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -13-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.62,acquisitions-mergers,,Alliance Pharma PLC: Acquisition of Biogix Inc,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -13-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Adjusted profitability,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -13-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -14-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Underlying profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -14-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -14-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -14-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Total taxation charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -14-
APH,2021-03-23,07:00:22,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 82,816 - 82,816",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -14-
APH,2021-03-23,07:49:42,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma 2020 Pretax Profit,FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma 2020 Pretax Profit, Revenue Falls; Raises Dividend"
APH,2021-03-23,07:49:42,A1C370,Alliance Pharma PLC,100,-0.28,revenues,down,"Alliance said, with prescription medicine revenues falling 14%",FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma 2020 Pretax Profit, Revenue Falls; Raises Dividend"
APH,2021-03-23,07:49:42,A1C370,Alliance Pharma PLC,100,0.0,dividends,,Alliance Pharma declared a final dividend of 1.074 pence a share,FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma 2020 Pretax Profit, Revenue Falls; Raises Dividend"
APH,2021-03-29,07:13:19,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Reported diluted earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Annual Report and Preliminary Results correction
APH,2021-03-29,07:13:19,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Underlying basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Annual Report and Preliminary Results correction
APH,2021-04-15,13:45:08,A1C370,Alliance Pharma PLC,99,0.47,labor-issues,,Alliance Pharma PLC: Nigel was appointed to Alliance's Board,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Directorate Change
APH,2021-04-23,06:00:16,A1C370,Alliance Pharma PLC,99,0.0,investor-relations,,Alliance Pharma PLC: 2021 Annual General Meeting (AGM),PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Notice of AGM
APH,2021-05-19,12:56:38,A1C370,Alliance Pharma PLC,99,0.0,investor-relations,,Alliance Pharma PLC: Result of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Result of AGM
APH,2021-06-29,06:00:13,A1C370,Alliance Pharma PLC,100,0.47,labor-issues,,Alliance Pharma PLC Appointment of Non-Executive Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Appointment of Non-Executive Director
APH,2021-06-29,06:00:13,A1C370,Alliance Pharma PLC,100,0.53,labor-issues,,Alliance Pharma PLC: He joined WBA in 2015 as Vice-President,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Appointment of Non-Executive Director
APH,2021-07-20,06:00:16,A1C370,Alliance Pharma PLC,99,0.86,revenues,up,Alliance Pharma PLC: Strong revenue growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2021-07-20,06:00:16,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Nizoral(TM) revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2021-07-20,06:00:16,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Revenue for H1 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2021-07-20,08:16:08,A1C370,Alliance Pharma PLC,100,0.65,revenues,up,Alliance Pharma 1H Revenue Rose,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma 1H Revenue Rose; Sees FY Profit Meeting Market Views
APH,2021-07-20,08:16:08,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC said Tuesday that revenue for the first,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma 1H Revenue Rose; Sees FY Profit Meeting Market Views
APH,2021-07-20,08:16:41,A1C370,Alliance Pharma PLC,100,0.65,revenues,up,Alliance Pharma 1H Revenue Rose,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma 1H Revenue Rose; Sees FY Profit Meeting Market Views
APH,2021-07-20,08:16:41,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC said Tuesday that revenue for the first,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma 1H Revenue Rose; Sees FY Profit Meeting Market Views
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Interim results for the six months ended 30 June 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Full year outlook,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.42,revenues,up,Alliance Pharma PLC: LFL Consumer Healthcare revenue up 8%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,1.0,earnings,up,Alliance Pharma PLC: reported profit before tax GBP16.5m (H1 2020: GBP0.6m),PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,dividends,,Alliance Pharma PLC: Interim dividend payment of 0.563p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 51.6,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Underlying EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Underlying profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Reported profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Underlying basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,Alliance Pharma PLC: Reported basic earnings per share 1.54p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.5,earnings,up,Alliance Pharma PLC: Gross profit increased by 34% to GBP51.6m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Full year sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Nizoral see-through sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.65,revenues,up,Alliance Pharma PLC: The uplift in sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.52,products-services,,Alliance Pharma PLC: we rolled out a new hybrid,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 51.6,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,-0.49,equity-actions,up,Alliance Pharma PLC: Whilst operating expenses increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Underlying EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Underlying profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Reported profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Underlying basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,Alliance Pharma PLC: Reported basic earnings per share 1.54p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,dividends,,Alliance Pharma PLC: Interim dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.46,revenues,up,"Alliance Pharma PLC: On a constant currency basis, see-through revenue increased 28%",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.64,earnings,up,Alliance Pharma PLC: Gross profit increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Reported profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Underlying basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.64,earnings,up,Alliance Pharma PLC: Reported basic earnings per share increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 51,600 - 51,600",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.0,equity-actions,,Alliance Pharma PLC: Operating expenses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,99,0.6,earnings,positive,Alliance Pharma PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,94,0.39,products-services,,"Alliance Pharma PLC: Transactions with owners 24 319 720 - - - (8,605) (7,542",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,94,0.61,earnings,positive,Alliance Pharma PLC: Profit for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,90,0.0,revenues,,Alliance Pharma PLC: Total Revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,90,0.0,revenues,,Alliance Pharma PLC: Nizoral revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,90,0.0,earnings,,Alliance Pharma PLC: Interest income,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,90,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,90,0.0,dividends,,Alliance Pharma PLC: Interim dividend for the 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,90,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,90,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2019,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,90,0.0,earnings,,Alliance Pharma PLC: Underlying diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,90,0.0,equity-actions,,Alliance Pharma PLC: Cost At 1 January 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,94,0.61,earnings,positive,Alliance Pharma PLC: Adjusted profitability,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,94,0.59,earnings,positive,Alliance Pharma PLC: Profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,94,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2021-09-21,06:00:08,A1C370,Alliance Pharma PLC,92,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 51,600 - 51,600",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -10-
APH,2021-09-21,08:39:54,A1C370,Alliance Pharma PLC,100,0.62,earnings,up,Alliance Pharma 1H Pretax Profit Rose,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma 1H Pretax Profit Rose
APH,2021-11-09,16:36:55,A1C370,Alliance Pharma PLC,99,0.0,dividends,,"On 21 September 2021, Alliance stated that its 2021 interim dividend payment of 0.563p",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Update on Interim Dividend Timetable
APH,2021-11-18,13:00:05,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: is to build a trusted partnership with our,PRESS-RELEASE,PR Newswire,"Ampersand Invests in Alliance Pharma, Leading Bioanalytical CRO"
APH,2024-01-05,12:54:14,BB07E4,Amphenol Corp.,100,0.95,analyst-ratings,positive,Amphenol Initiated at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Initiated at Buy by Citigroup
APH,2024-01-05,12:54:14,BB07E4,Amphenol Corp.,100,0.0,price-targets,set,Amphenol Price Target Announced at $117.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Announced at $117.00/Share by Citigroup
APH,2024-01-24,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 1Q Sales $3.04B-$3.1B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q Sales $3.04B-$3.1B >APH
APH,2024-01-24,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 4Q Sales $3.33B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Sales $3.33B >APH
APH,2024-01-24,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 1Q Adj EPS 71c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q Adj EPS 71c-Adj EPS 73c >APH
APH,2024-01-24,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Adj EPS 82c,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Adj EPS 82c >APH
APH,2024-01-24,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 1Q EPS 69c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q EPS 69c-EPS 71c >APH
APH,2024-01-24,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,4Q EPS 83c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q EPS 83c >APH
APH,2024-01-24,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY Adj EPS 73c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Adj EPS 73c >APH
APH,2024-01-24,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Net $514.5M,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Net $514.5M >APH
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Fourth Quarter and Full Year 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Fourth Quarter and Full Year 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record Sales of $3.33 billion, up 3%",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.83, up",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.82,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: GAAP Operating Margin of 20.7%,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP Diluted EPS of $3.11,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Completed ten acquisitions,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,96,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2022",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,"Amphenol Corp.: During the fourth quarter, the Company purchased 1.3 million shares of its common stock for $115 million",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2024 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.04 billion to $3.10 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.71 to $0.73,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $3,327.5 $3,239.2",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -2-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,100.4",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -2-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -2-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -2-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,96,0.0,dividends,,Amphenol Corp.: Dividends declared per common share,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,96,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,96,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2022",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,96,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,96,0.0,assets,,"Amphenol Corp.: Total Assets $ 16,526.4 $ 15,326.2",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,96,0.61,earnings,positive,Amphenol Corp.: Net income $ 519.2 $ 511.0 $,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,98,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -4-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,98,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -4-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -5-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -6-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.71 - $0.73,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -6-
APH,2024-01-24,13:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.69 - $0.71,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -6-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Fourth Quarter and Full Year 2023 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Fourth Quarter and Full Year 2023 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record Sales of $3.33 billion, up 3%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.83, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.82,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: GAAP Operating Margin of 20.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP Diluted EPS of $3.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Completed ten acquisitions,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,"Amphenol Corp.: During the fourth quarter, the Company purchased 1.3 million shares of its common stock for $115 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2024 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.04 billion to $3.10 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.71 to $0.73,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2023 Results
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $3,327.5 $3,239.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -2-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,100.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -2-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -2-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -2-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,96,0.0,dividends,,Amphenol Corp.: Dividends declared per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,96,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,96,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,96,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,96,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,96,0.0,assets,,"Amphenol Corp.: Total Assets $ 16,526.4 $ 15,326.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,96,0.61,earnings,positive,Amphenol Corp.: Net income $ 519.2 $ 511.0 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,98,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -4-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,98,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -4-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -5-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -6-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.71 - $0.73,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -6-
APH,2024-01-24,13:01:20,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.69 - $0.71,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -6-
APH,2024-01-24,13:20:50,BB07E4,Amphenol Corp.,100,0.72,revenues,above-expectations,Amphenol 4Q Sales Beat Estimates,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 4Q Sales Beat Estimates, Boosted by Growth in Key Markets, Acquisitions"
APH,2024-01-24,13:20:50,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: The company closed four acquisitions during the quarter,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 4Q Sales Beat Estimates, Boosted by Growth in Key Markets, Acquisitions"
APH,2024-01-24,14:58:56,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: the Company's financial results for the quarter,RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Operations And Financial Condition >APH
APH,2024-01-25,14:11:22,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Goldman Sachs
APH,2024-01-25,14:11:22,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $119.00/Share From $107.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $119.00/Share From $107.00 by Goldman Sachs
APH,2024-01-25,14:55:02,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Hold by Stifel
APH,2024-01-25,14:55:02,BB07E4,Amphenol Corp.,100,0.7,price-targets,upgrade,Amphenol Price Target Raised to $95.00/Share From $88.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $95.00/Share From $88.00 by Stifel
APH,2024-01-25,19:33:33,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2024-01-25,19:33:33,BB07E4,Amphenol Corp.,100,0.62,price-targets,upgrade,Amphenol Price Target Raised to $106.00/Share From $100.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $106.00/Share From $100.00 by Baird
APH,2024-01-30,13:00:02,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corporation to Acquire CIT Business From Carlisle,PRESS-RELEASE,Business Wire,Amphenol Corporation to Acquire CIT Business From Carlisle
APH,2024-01-30,13:00:38,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corp to Acquire CIT Business From Carlisle for $2.025B,NEWS-FLASH,Dow Jones Newswires,Amphenol Corp to Acquire CIT Business From Carlisle for $2.025B
APH,2024-01-30,13:00:40,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corporation to Acquire CIT Business From Carlisle,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation to Acquire CIT Business From Carlisle
APH,2024-02-01,13:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2024 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces First Quarter 2024 Dividend
APH,2024-02-01,13:01:21,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2024 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces First Quarter 2024 Dividend
APH,2024-02-02,21:18:31,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 170,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 170,000 Of Amphenol Corp >APH"
APH,2024-02-05,15:18:51,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Doherty Sells 170,000 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"Officer Doherty Sells 170,000 Of Amphenol Corp >APH"
APH,2024-02-08,16:20:00,BB07E4,Amphenol Corp.,99,-0.42,assets,,Amphenol Corp.: The sale of the industrial products division,PRESS-RELEASE,Business Wire,Trexon Sells Industrial Products Group (IPG) to Amphenol Corporation
APH,2024-02-08,21:06:33,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Cfo Lampo Registers 100,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CFO Lampo Registers 100,000 Of Amphenol Corp >APH"
APH,2024-02-08,21:33:30,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 15,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 15,000 Of Amphenol Corp >APH"
APH,2024-02-08,22:42:10,BB07E4,Amphenol Corp.,100,0.0,insider-trading,,"Officer Walter Gifts 14,563 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Gifts 14,563 Of Amphenol Corp >APH"
APH,2024-02-09,18:27:35,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 15,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 15,000 Of Amphenol Corp >APH"
APH,2024-02-09,18:28:11,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Cfo Lampo Sells 100,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Lampo Sells 100,000 Of Amphenol Corp >APH"
APH,2024-02-15,17:10:56,BB07E4,Amphenol Corp.,100,0.49,partnerships,,Amphenol Partners with Melni Technologies to,PRESS-RELEASE,PR Newswire,Amphenol Partners with Melni Technologies to Further Expand Solar Splice Connector Series
APH,2024-02-15,17:15:18,BB07E4,Amphenol Corp.,100,0.49,partnerships,,Amphenol Partners with Melni Technologies to,PRESS-RELEASE,PR Newswire,Amphenol Partners with Melni Technologies to Further Expand Solar Splice Connector Series
APH,2024-03-06,21:06:48,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Straub Registers 20,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Straub Registers 20,000 Of Amphenol Corp >APH"
APH,2024-03-07,13:57:12,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Straub Sells 20,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Straub Sells 20,000 Of Amphenol Corp >APH"
APH,2024-03-22,21:29:48,BB07E4,Amphenol Corp.,99,0.38,credit,,"Amphenol Corp.: the ""Company"") entered into a third amended and restated credit agreement",RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Entry Into Definitive Agreement >APH
APH,2024-03-25,19:04:12,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Evercore ISI Group
APH,2024-03-25,19:04:12,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $125.00/Share From $110.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $125.00/Share From $110.00 by Evercore ISI Group
APH,2024-04-02,14:02:55,BB07E4,Amphenol Corp.,100,0.06,credit-ratings,set,S&PGR Rts Amphenol Corp.'s Proposed Sr Unsecured Notes 'BBB+,NEWS-FLASH,Dow Jones Newswires,S&PGR Rts Amphenol Corp.'s Proposed Sr Unsecured Notes 'BBB+'
APH,2024-04-02,14:02:55,BB07E4,Amphenol Corp.,100,0.06,credit-ratings,set,S&PGR Rts Amphenol Corp.'s Proposed Sr Unsecured Notes 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rts Amphenol Corp.'s Proposed Sr Unsecured Notes 'BBB+'
APH,2024-04-02,21:29:00,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corporation Announces Pricing of Senior Notes Offering,PRESS-RELEASE,Business Wire,Amphenol Corporation Announces Pricing of Senior Notes Offering
APH,2024-04-02,21:29:00,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corp.: the Company's pending acquisition of the Carlisle Interconnect Technologies business,PRESS-RELEASE,Business Wire,Amphenol Corporation Announces Pricing of Senior Notes Offering
APH,2024-04-02,21:29:01,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corporation Announces Pricing of Senior Notes Offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Announces Pricing of Senior Notes Offering
APH,2024-04-02,21:29:01,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corp.: the Company's pending acquisition of the Carlisle Interconnect Technologies business,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Announces Pricing of Senior Notes Offering
APH,2024-04-04,15:53:45,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2024-04-04,15:53:45,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $135.00/Share From $117.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $135.00/Share From $117.00 by Citigroup
APH,2024-04-05,20:22:13,BB07E4,Amphenol Corp.,99,0.55,acquisitions-mergers,,Amphenol Corp.: the Company's pending acquisition of the Carlisle Interconnect Technologies business,RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Entry Into Definitive Agreement >APH
APH,2024-04-09,11:18:16,BB07E4,Amphenol Corp.,100,0.01,analyst-ratings,neutral,Amphenol Initiated at Hold by Jefferies,NEWS-FLASH,Dow Jones Newswires,Amphenol Initiated at Hold by Jefferies
APH,2024-04-09,11:18:16,BB07E4,Amphenol Corp.,100,0.0,price-targets,set,Amphenol Price Target Announced at $125.00/Share by Jefferies,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Announced at $125.00/Share by Jefferies
APH,2024-04-11,12:07:33,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2024-04-11,12:07:33,BB07E4,Amphenol Corp.,100,0.62,price-targets,upgrade,Amphenol Price Target Raised to $125.00/Share From $118.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $125.00/Share From $118.00 by JP Morgan
APH,2024-04-16,12:53:01,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2024-04-16,12:53:01,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $135.00/Share From $118.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $135.00/Share From $118.00 by UBS
APH,2024-04-18,16:34:46,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by B of A Securities
APH,2024-04-18,16:34:46,BB07E4,Amphenol Corp.,100,0.48,price-targets,upgrade,Amphenol Price Target Raised to $121.00/Share From $117.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $121.00/Share From $117.00 by B of A Securities
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Sales of $3.26 billion, up 9%",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.87, up",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.80, up",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the quarter, the Company purchased 1.4 million shares of its common stock for $154 million",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2024 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.24 billion to $3.30 billion,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.79 to $0.81,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -2-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $ 3,256.3 $2,974.0",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -2-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,089.0",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -2-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -2-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -2-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended March 31, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -2-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -3-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $16,722.5 $ 16,526.4",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -3-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 552.0 $ 442.7,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -3-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: 5.2) Dividend,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -3-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -3-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -3-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -4-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -4-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: NET SALES,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -4-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -5-
APH,2024-04-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2024 Results and -5-
APH,2024-04-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 2Q Sales $3.24B-$3.3B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Sales $3.24B-$3.3B >APH
APH,2024-04-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 1Q Sales $3.26B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Sales $3.26B >APH
APH,2024-04-24,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Adj EPS 80c,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Adj EPS 80c >APH
APH,2024-04-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 2Q Adj EPS 79c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Adj EPS 79c-Adj EPS 81c >APH
APH,2024-04-24,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,1Q EPS 87c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q EPS 87c >APH
APH,2024-04-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2024 Results,NEWS-FLASH,Dow Jones Newswires,Amphenol Reports First Quarter 2024 Results And Announces New Stock Repurchase Program >APH
APH,2024-04-24,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Net $548.7M,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Net $548.7M >APH
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2024 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Sales of $3.26 billion, up 9%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.87, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.80, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the quarter, the Company purchased 1.4 million shares of its common stock for $154 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2024 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.24 billion to $3.30 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.79 to $0.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2024 Results and Announces New Stock Repurchase Program
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $ 3,256.3 $2,974.0",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,089.0",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended March 31, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,94,0.0,assets,,"Amphenol Corp.: Total Assets $16,722.5 $ 16,526.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,94,0.61,earnings,positive,Amphenol Corp.: Net income $ 552.0 $ 442.7,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,94,0.0,dividends,,Amphenol Corp.: 5.2) Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,94,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,94,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -4-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: NET SALES,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -4-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2024-04-24,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2024-04-24,12:20:37,BB07E4,Amphenol Corp.,100,0.65,revenues,up,"Amphenol 1Q Net, Sales Rise",FULL-ARTICLE,Dow Jones Newswires,"Amphenol 1Q Net, Sales Rise, Co. Sees More Growth in 2Q"
APH,2024-04-24,12:20:37,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol posted adjusted earnings of 80 cents a share,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 1Q Net, Sales Rise, Co. Sees More Growth in 2Q"
APH,2024-04-24,12:20:37,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol projected sales,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 1Q Net, Sales Rise, Co. Sees More Growth in 2Q"
APH,2024-04-24,12:20:37,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,Amphenol unveiled a $2 billion share buyback program,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 1Q Net, Sales Rise, Co. Sees More Growth in 2Q"
APH,2024-04-24,14:13:09,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: the Company's financial results for the quarter ended March 31, 2024.",RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Operations And Financial Condition >APH
APH,2024-04-24,14:13:09,BB07E4,Amphenol Corp.,99,0.59,equity-actions,,Amphenol Corp.: The Company's previously announced $2 billion stock repurchase,RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Other Events >APH
APH,2024-04-25,10:57:21,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2024-04-25,10:57:21,BB07E4,Amphenol Corp.,100,0.3,price-targets,upgrade,Amphenol Price Target Raised to $124.00/Share From $123.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $124.00/Share From $123.00 by Baird
APH,2024-04-25,14:09:41,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Evercore ISI Group
APH,2024-04-25,14:09:41,BB07E4,Amphenol Corp.,100,0.5,price-targets,upgrade,Amphenol Price Target Raised to $130.00/Share From $125.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $130.00/Share From $125.00 by Evercore ISI Group
APH,2024-04-25,14:59:11,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2024-04-25,14:59:11,BB07E4,Amphenol Corp.,100,0.4,price-targets,upgrade,Amphenol Price Target Raised to $138.00/Share From $135.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $138.00/Share From $135.00 by UBS
APH,2024-04-25,16:19:02,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2024-04-25,16:19:02,BB07E4,Amphenol Corp.,100,0.5,price-targets,upgrade,Amphenol Price Target Raised to $130.00/Share From $125.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $130.00/Share From $125.00 by JP Morgan
APH,2024-04-25,17:02:52,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by B of A Securities
APH,2024-04-25,17:02:52,BB07E4,Amphenol Corp.,100,0.42,price-targets,upgrade,Amphenol Price Target Raised to $124.00/Share From $121.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $124.00/Share From $121.00 by B of A Securities
APH,2024-04-25,17:51:42,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2024-04-25,17:51:42,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $136.00/Share From $121.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $136.00/Share From $121.00 by Truist Securities
APH,2024-05-02,12:00:01,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2024 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces Second Quarter 2024 Dividend
APH,2024-05-02,12:01:50,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2024 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Second Quarter 2024 Dividend
APH,2024-05-17,12:12:31,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by B of A Securities
APH,2024-05-17,12:12:31,BB07E4,Amphenol Corp.,100,0.58,price-targets,upgrade,Amphenol Price Target Raised to $144.00/Share From $137.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $144.00/Share From $137.00 by B of A Securities
APH,2024-05-20,13:43:57,BB07E4,Amphenol Corp.,100,0.95,analyst-ratings,positive,Amphenol Initiated at Buy by Seaport Global,NEWS-FLASH,Dow Jones Newswires,Amphenol Initiated at Buy by Seaport Global
APH,2024-05-20,13:43:57,BB07E4,Amphenol Corp.,100,0.0,price-targets,set,Amphenol Price Target Announced at $150.00/Share by Seaport Global,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Announced at $150.00/Share by Seaport Global
APH,2024-05-20,20:15:00,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corporation Announces Two-for-One Stock Split,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation Announces Two-for-One Stock Split >APH
APH,2024-05-20,20:15:01,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corporation Announces Two-for-One Stock Split,PRESS-RELEASE,Business Wire,Amphenol Corporation Announces Two-for-One Stock Split
APH,2024-05-20,20:15:01,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corporation Announces Two-for-One Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Announces Two-for-One Stock Split
APH,2024-05-20,21:01:26,BB07E4,Amphenol Corp.,96,0.0,equity-actions,,"Amphenol Corp.: the ""Company"") announced the approval of a two-for-one stock split of",RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Other Events >APH
APH,2024-05-21,20:15:01,BB07E4,Amphenol Corp.,100,0.5,acquisitions-mergers,completed,Amphenol Corporation Completes Acquisition of CIT Business From Carlisle,PRESS-RELEASE,Business Wire,Amphenol Corporation Completes Acquisition of CIT Business From Carlisle
APH,2024-05-21,20:15:01,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corp.: the Company's recently announced 2-for-1 stock split,PRESS-RELEASE,Business Wire,Amphenol Corporation Completes Acquisition of CIT Business From Carlisle
APH,2024-05-21,20:15:01,BB07E4,Amphenol Corp.,100,0.5,acquisitions-mergers,completed,Amphenol Corporation Completes Acquisition of CIT Business From Carlisle,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Completes Acquisition of CIT Business From Carlisle
APH,2024-05-21,20:15:01,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corp.: the Company's recently announced 2-for-1 stock split,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Completes Acquisition of CIT Business From Carlisle
APH,2024-05-22,20:28:29,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Walter Registers 115,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Walter Registers 115,000 Of Amphenol Corp >APH"
APH,2024-05-23,07:00:21,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,"Pctel Inc, Inst Holders, 1Q 2024 (PCTI)",RNS-SEC13F,Dow Jones Newswires,"PCTEL  Inc, Inst Holders, 1Q 2024 (PCTI)"
APH,2024-05-23,20:06:36,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Walter Registers 70,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Walter Registers 70,000 Of Amphenol Corp >APH"
APH,2024-05-24,13:29:46,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2024-05-24,13:29:46,BB07E4,Amphenol Corp.,100,0.76,price-targets,upgrade,Amphenol Price Target Raised to $149.00/Share From $136.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $149.00/Share From $136.00 by Truist Securities
APH,2024-05-24,14:45:29,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Walter Sells 185,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Sells 185,000 Of Amphenol Corp >APH"
APH,2024-05-28,12:13:44,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2024-05-28,12:13:44,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $160.00/Share From $135.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $160.00/Share From $135.00 by Citigroup
APH,2024-06-06,16:47:05,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Hold by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Hold by TD Cowen
APH,2024-06-06,16:47:05,BB07E4,Amphenol Corp.,100,0.8,price-targets,upgrade,Amphenol Price Target Raised to $115.00/Share From $90.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $115.00/Share From $90.00 by TD Cowen
APH,2024-06-12,12:50:02,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,Amphenol Corp.: the Company announced the approval of a two-for-one stock split of,RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Other Events >APH
APH,2024-06-13,17:13:00,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Evercore ISI Group
APH,2024-06-13,17:55:20,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Hold by Stifel
APH,2024-07-10,12:40:28,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by B of A Securities
APH,2024-07-10,12:40:28,BB07E4,Amphenol Corp.,100,0.5,price-targets,upgrade,Amphenol Price Target Raised to $75.00/Share From $72.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $75.00/Share From $72.00 by B of A Securities
APH,2024-07-10,13:28:48,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2024-07-10,13:28:48,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $80.00/Share From $69.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $80.00/Share From $69.00 by UBS
APH,2024-07-18,13:07:00,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corporation (NYSE: APH) today announced a definitive agreement to acquire CommScope's (NASDAQ: COMM) mobile networks businesses,PRESS-RELEASE,Business Wire,Amphenol Corporation to Acquire Mobile Networks Businesses From CommScope
APH,2024-07-18,13:07:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: the Company reports second quarter 2024 earnings on July 24, 2024",PRESS-RELEASE,Business Wire,Amphenol Corporation to Acquire Mobile Networks Businesses From CommScope
APH,2024-07-18,13:07:01,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corporation (NYSE: APH) today announced a definitive agreement to acquire CommScope's (NASDAQ: COMM) mobile networks businesses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation to Acquire Mobile Networks Businesses From CommScope
APH,2024-07-18,13:07:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: the Company reports second quarter 2024 earnings on July 24, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation to Acquire Mobile Networks Businesses From CommScope
APH,2024-07-18,13:07:14,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corp to Acquire Mobile Networks Businesses From CommScope,NEWS-FLASH,Dow Jones Newswires,Amphenol Corp to Acquire Mobile Networks Businesses From CommScope
APH,2024-07-18,13:07:32,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol to Acquire CommScope's Outdoor Wireless Networks and Distributed Antenna Systems Businesses for $2.1 B,NEWS-FLASH,Dow Jones Newswires,Amphenol to Acquire CommScope's Outdoor Wireless Networks and Distributed Antenna Systems Businesses for $2.1 B in Cash >APH
APH,2024-07-18,13:41:00,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol has agreed to buy CommScope's mobile networks businesses,FULL-ARTICLE,Dow Jones Newswires,Amphenol Inks $2.1B Deal to Buy CommScope's Mobile Networks Businesses
APH,2024-07-18,14:49:13,BB07E4,Amphenol Corp.,96,0.62,acquisitions-mergers,,Amphenol Corp. (APH) is buying CommScope's (COMM) outdoor wireless network business,FULL-ARTICLE,MarketWatch,MW CommScope rallies on deal to sell units to Amphenol for $2.1 billion
APH,2024-07-19,20:38:54,BB07E4,Amphenol Corp.,99,0.39,products-services,,Amphenol Corp.: We expect the transaction to close in the first half of 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: Amphenol Has Leverage Headroom For Acquisitions
APH,2024-07-23,15:22:32,BB07E4,Amphenol Corp.,100,0.01,analyst-ratings,neutral,Amphenol Initiated at Hold by Vertical Research,NEWS-FLASH,Dow Jones Newswires,Amphenol Initiated at Hold by Vertical Research
APH,2024-07-23,15:22:32,BB07E4,Amphenol Corp.,100,0.0,price-targets,set,Amphenol Price Target Announced at $65.00/Share by Vertical Research,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Announced at $65.00/Share by Vertical Research
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Second Quarter 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $3.61 billion, up 18%",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.41, up",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.44,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.62,dividends,up,Amphenol Corp.: Increases quarterly dividend by 50% to $0.165 per share,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the quarter, the Company purchased 3.1 million shares of its common stock for $190 million",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2024 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.70 billion to $3.80 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.43 to $0.45,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corp.: 2-for-1 Stock Split,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.57,equity-actions,listing,Amphenol Corp.: the Company's common stock began trading,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second Quarter 2024,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -2-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $3,609.7 $3,053.9",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -2-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,213.1",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -2-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -2-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -2-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second Quarter 2024,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -3-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -3-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -3-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -3-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -3-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $18,586.8 $ 16,526.4",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -3-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 528.7 $ 465.3 $,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -3-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second Quarter 2024,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -4-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -4-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -4-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second Quarter 2024,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -5-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -5-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second Quarter 2024,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -6-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.43 - $0.45,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -6-
APH,2024-07-24,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.40 - $0.42,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2024 -6-
APH,2024-07-24,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Adj EPS 44c,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Adj EPS 44c >APH
APH,2024-07-24,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 2Q Sales $3.61B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Sales $3.61B >APH
APH,2024-07-24,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,2Q EPS 41c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q EPS 41c >APH
APH,2024-07-24,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 3Q Sales $3.7B-$3.8B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Sales $3.7B-$3.8B >APH
APH,2024-07-24,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 3Q Adj EPS 43c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Adj EPS 43c-Adj EPS 45c >APH
APH,2024-07-24,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Net $524.8M,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Net $524.8M >APH
APH,2024-07-24,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Second Quarter 2024 Results,NEWS-FLASH,Dow Jones Newswires,Amphenol Reports Record Second Quarter 2024 Results And Announces Dividend Increase >APH
APH,2024-07-24,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY Adj EPS 45c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Adj EPS 45c >APH
APH,2024-07-24,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 3Q EPS 40c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q EPS 40c-EPS 42c >APH
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Second Quarter 2024 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $3.61 billion, up 18%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.41, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.44,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.62,dividends,up,Amphenol Corp.: Increases quarterly dividend by 50% to $0.165 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the quarter, the Company purchased 3.1 million shares of its common stock for $190 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2024 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.70 billion to $3.80 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.43 to $0.45,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corp.: 2-for-1 Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.57,equity-actions,listing,Amphenol Corp.: the Company's common stock began trading,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2024 Results and Announces Dividend Increase
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -2-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $3,609.7 $3,053.9",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -2-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,213.1",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -2-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -2-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -2-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $18,586.8 $ 16,526.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 528.7 $ 465.3 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -4-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -4-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -4-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -5-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -5-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Second,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -6-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.43 - $0.45,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -6-
APH,2024-07-24,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.40 - $0.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -6-
APH,2024-07-24,12:02:59,BB07E4,Amphenol Corp.,100,0.62,dividends,up,Raises Quarterly Dividend to 16.5c From 11c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Raises Quarterly Dividend to 16.5c From 11c >APH
APH,2024-07-24,12:19:47,BB07E4,Amphenol Corp.,100,0.62,dividends,up,Amphenol has lifted its quarterly dividend by 50% to 16.5 cents,FULL-ARTICLE,Dow Jones Newswires,Amphenol Raises Quarterly Dividend by 50%
APH,2024-07-24,12:19:47,BB07E4,Amphenol Corp.,100,0.62,dividends,up,Amphenol last raised its dividend in October,FULL-ARTICLE,Dow Jones Newswires,Amphenol Raises Quarterly Dividend by 50%
APH,2024-07-24,14:09:32,BB07E4,Amphenol Corp.,95,0.0,earnings,,Amphenol Corp.: the Company's financial results for the quarter,RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Operations And Financial Condition >APH
APH,2024-07-24,14:09:33,BB07E4,Amphenol Corp.,99,0.0,dividends,,"Amphenol Corp.: On July 24, 2024, the Company announced the approval of an increase to the Company's quarterly dividend",RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Other Events >APH
APH,2024-07-25,11:39:06,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2024-07-25,11:39:06,BB07E4,Amphenol Corp.,100,-0.44,price-targets,downgrade,Amphenol Price Target Cut to $70.00/Share From $72.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $70.00/Share From $72.00 by Baird
APH,2024-07-25,14:35:40,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2024-07-25,14:35:40,BB07E4,Amphenol Corp.,100,0.38,price-targets,upgrade,Amphenol Price Target Raised to $76.00/Share From $74.50 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $76.00/Share From $74.50 by Truist Securities
APH,2024-07-26,20:27:32,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 750,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 750,000 Of Amphenol Corp >APH"
APH,2024-07-26,20:36:27,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 90,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 90,000 Of Amphenol Corp >APH"
APH,2024-07-26,20:48:34,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Walter Registers 106,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Walter Registers 106,000 Of Amphenol Corp >APH"
APH,2024-07-29,20:27:41,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Walter Registers 170,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Walter Registers 170,000 Of Amphenol Corp >APH"
APH,2024-07-30,17:31:49,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 90,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 90,000 Of Amphenol Corp >APH"
APH,2024-07-30,17:33:47,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Walter Sells 276,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Sells 276,000 Of Amphenol Corp >APH"
APH,2024-07-30,17:40:18,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Ceo Norwitt Sells 750,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Norwitt Sells 750,000 Of Amphenol Corp >APH"
APH,2024-07-31,20:37:02,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 400,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 400,000 Of Amphenol Corp >APH"
APH,2024-08-01,20:02:03,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Ceo Norwitt Sells 400,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Norwitt Sells 400,000 Of Amphenol Corp >APH"
APH,2024-08-14,20:12:41,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Cfo Lampo Registers 250,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CFO Lampo Registers 250,000 Of Amphenol Corp >APH"
APH,2024-08-15,20:28:05,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 300,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 300,000 Of Amphenol Corp >APH"
APH,2024-08-15,20:39:31,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 100,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 100,000 Of Amphenol Corp >APH"
APH,2024-08-15,20:49:41,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Cfo Lampo Sells 250,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Lampo Sells 250,000 Of Amphenol Corp >APH"
APH,2024-08-16,21:24:13,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Doherty Sells 300,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Doherty Sells 300,000 Of Amphenol Corp >APH"
APH,2024-08-16,21:26:49,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 100,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 100,000 Of Amphenol Corp >APH"
APH,2024-09-04,10:31:38,BB07E4,Amphenol Corp.,100,-0.58,analyst-ratings,negative,Amphenol Cut to Neutral From Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Cut to Neutral From Buy by B of A Securities
APH,2024-09-04,10:31:38,BB07E4,Amphenol Corp.,100,-0.8,price-targets,downgrade,Amphenol Price Target Cut to $71.00/Share From $80.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $71.00/Share From $80.00 by B of A Securities
APH,2024-10-09,17:59:07,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Neutral by B of A Securities
APH,2024-10-09,17:59:07,BB07E4,Amphenol Corp.,100,-0.28,price-targets,downgrade,Amphenol Price Target Cut to $70.00/Share From $71.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $70.00/Share From $71.00 by B of A Securities
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Adj EPS 50c,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Adj EPS 50c >APH
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 3Q Sales $4.04B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Sales $4.04B >APH
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,3Q EPS 48c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q EPS 48c >APH
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 4Q Sales $3.95B-$4.05B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Sales $3.95B-$4.05B >APH
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q Adj EPS 48c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Adj EPS 48c-Adj EPS 50c >APH
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q EPS 48c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q EPS 48c-EPS 50c >APH
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Net $604.4M,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Net $604.4M >APH
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY EPS $1.81,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY EPS $1.81-EPS $1.83 >APH
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY Adj EPS $1.82,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Adj EPS $1.82-Adj EPS $1.84 >APH
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.44,revenues,up,"Amphenol Corp.: Record sales of $4.04 billion, up 26%",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP Diluted EPS of $0.48,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.50,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the quarter, the Company purchased 2.7 million shares of its common stock for $176 million",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2024, Amphenol expects sales to be in the range of $14.85 billion to $14.95 billion",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.48 to $0.50,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results -2-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.72,revenues,up,"Amphenol Corp.: expected earnings, revenues, growth",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results -2-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $4,038.8 $3,199.2",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results -2-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,356.9",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results -2-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results -2-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 Results -2-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2024,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -3-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -3-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -3-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -3-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -3-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $ 19,585.6 $ 16,526.4",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -3-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 608.9 $ 518.3 $,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -3-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2024,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -4-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -4-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -4-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2024,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -5-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -5-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2024,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -6-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -6-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.48 - $0.50,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -6-
APH,2024-10-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.48 - $0.50,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2024 -6-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2024 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.44,revenues,up,"Amphenol Corp.: Record sales of $4.04 billion, up 26%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP Diluted EPS of $0.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the quarter, the Company purchased 2.7 million shares of its common stock for $176 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2024, Amphenol expects sales to be in the range of $14.85 billion to $14.95 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.48 to $0.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2024 Results
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.72,revenues,up,"Amphenol Corp.: expected earnings, revenues, growth",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $4,038.8 $3,199.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,356.9",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $ 19,585.6 $ 16,526.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 608.9 $ 518.3 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.48 - $0.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2024-10-23,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.48 - $0.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2024-10-23,12:02:52,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees FY Sales $14.85B-$14.95B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Sales $14.85B-$14.95B >APH
APH,2024-10-23,13:09:20,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Posts Higher 3Q Profit,FULL-ARTICLE,Dow Jones Newswires,"Amphenol Posts Higher 3Q Profit, Sets Full-Year Guidance Ahead of Street"
APH,2024-10-23,13:09:20,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol forecast adjusted earnings of between $1.82 to $1.84 a share for the full year,FULL-ARTICLE,Dow Jones Newswires,"Amphenol Posts Higher 3Q Profit, Sets Full-Year Guidance Ahead of Street"
APH,2024-10-23,13:49:07,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: the Company's financial results for the quarter,RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Operations And Financial Condition >APH
APH,2024-10-24,11:50:10,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2024-10-24,11:50:10,BB07E4,Amphenol Corp.,100,0.72,price-targets,upgrade,Amphenol Price Target Raised to $77.00/Share From $71.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $77.00/Share From $71.00 by Baird
APH,2024-10-24,12:12:20,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Neutral by B of A Securities
APH,2024-10-24,12:12:20,BB07E4,Amphenol Corp.,100,0.6,price-targets,upgrade,Amphenol Price Target Raised to $74.00/Share From $70.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $74.00/Share From $70.00 by B of A Securities
APH,2024-10-24,15:10:30,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Evercore ISI Group
APH,2024-10-24,15:10:30,BB07E4,Amphenol Corp.,100,0.64,price-targets,upgrade,Amphenol Price Target Raised to $80.00/Share From $75.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $80.00/Share From $75.00 by Evercore ISI Group
APH,2024-10-24,15:54:40,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2024-10-24,15:54:40,BB07E4,Amphenol Corp.,100,0.7,price-targets,upgrade,Amphenol Price Target Raised to $82.00/Share From $76.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $82.00/Share From $76.00 by Truist Securities
APH,2024-10-25,19:17:53,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Hold by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Hold by TD Cowen
APH,2024-10-25,19:17:53,BB07E4,Amphenol Corp.,100,0.58,price-targets,upgrade,Amphenol Price Target Raised to $63.00/Share From $60.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $63.00/Share From $60.00 by TD Cowen
APH,2024-10-28,14:36:11,BB07E4,Amphenol Corp.,100,0.06,credit-ratings,set,S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'BBB+,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'BBB+'
APH,2024-10-28,14:36:11,BB07E4,Amphenol Corp.,100,0.06,credit-ratings,set,S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'BBB+'
APH,2024-10-28,14:36:11,BB07E4,Amphenol Corp.,100,0.41,revenues,up,Amphenol Corp.: we now expect reported revenue growth of about 19%,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'BBB+'
APH,2024-10-28,22:11:00,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corporation Announces Pricing of Senior Notes Offering,PRESS-RELEASE,Business Wire,Amphenol Corporation Announces Pricing of Senior Notes Offering
APH,2024-10-28,22:11:00,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corp.: the Company's pending acquisition of CommScope's (NASDAQ: COMM) mobile networks businesses,PRESS-RELEASE,Business Wire,Amphenol Corporation Announces Pricing of Senior Notes Offering
APH,2024-10-28,22:11:01,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corporation Announces Pricing of Senior Notes Offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Announces Pricing of Senior Notes Offering
APH,2024-10-28,22:11:01,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corp.: the Company's pending acquisition of CommScope's (NASDAQ: COMM) mobile networks businesses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Announces Pricing of Senior Notes Offering
APH,2024-10-29,20:12:28,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Silverman Registers 180,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Silverman Registers 180,000 Of Amphenol Corp >APH"
APH,2024-10-29,20:16:20,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 75,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 75,000 Of Amphenol Corp >APH"
APH,2024-10-29,20:45:39,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Cfo Lampo Registers 150,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CFO Lampo Registers 150,000 Of Amphenol Corp >APH"
APH,2024-10-29,21:12:28,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 900,672 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 900,672 Of Amphenol Corp >APH"
APH,2024-10-31,12:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Fourth Quarter 2024 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces Fourth Quarter 2024 Dividend
APH,2024-10-31,12:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Fourth Quarter 2024 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Fourth Quarter 2024 Dividend
APH,2024-10-31,20:02:31,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Ceo Norwitt Sells 1,190,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Norwitt Sells 1,190,000 Of Amphenol Corp >APH"
APH,2024-10-31,20:03:49,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Cfo Lampo Sells 150,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Lampo Sells 150,000 Of Amphenol Corp >APH"
APH,2024-10-31,20:20:30,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 75,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 75,000 Of Amphenol Corp >APH"
APH,2024-10-31,20:20:32,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Silverman Sells 180,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Silverman Sells 180,000 Of Amphenol Corp >APH"
APH,2024-11-06,21:36:40,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Silverman Registers 180,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Silverman Registers 180,000 Of Amphenol Corp >APH"
APH,2024-11-06,22:25:35,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Cfo Lampo Registers 300,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CFO Lampo Registers 300,000 Of Amphenol Corp >APH"
APH,2024-11-07,21:02:19,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Cfo Lampo Sells 300,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Lampo Sells 300,000 Of Amphenol Corp >APH"
APH,2024-11-07,21:31:58,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Silverman Sells 180,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Silverman Sells 180,000 Of Amphenol Corp >APH"
APH,2024-11-08,21:29:36,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Straub Sells 132,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Straub Sells 132,000 Of Amphenol Corp >APH"
APH,2024-11-08,21:30:53,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Straub Registers 132,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Straub Registers 132,000 Of Amphenol Corp >APH"
APH,2024-11-12,13:00:03,BB07E4,Amphenol Corp.,99,0.39,products-services,,Amphenol Corp.: FDH Electronics Signs Value-Added Distribution Agreement with Amphenol Military,PRESS-RELEASE,GlobeNewswire,FDH Electronics Signs Value-Added Distribution Agreement with Amphenol Military High Speed
APH,2024-11-12,13:00:03,BB07E4,Amphenol Corp.,99,0.49,partnerships,,Amphenol Corp.: our strategic relationship with Amphenol.,PRESS-RELEASE,GlobeNewswire,FDH Electronics Signs Value-Added Distribution Agreement with Amphenol Military High Speed
APH,2021-01-05,16:00:00,BB07E4,Amphenol Corp.,99,0.39,products-services,,Amphenol Corp.: This new distribution agreement,PRESS-RELEASE,GlobeNewswire,"Waytek, Inc. and Amphenol Sine Systems Announce New Distribution Partnership"
APH,2021-01-13,15:00:09,BB07E4,Amphenol Corp.,99,0.49,partnerships,,Amphenol Corp.: Our longstanding partnership with Digi-Key allows us to continuously support,PRESS-RELEASE,PR Newswire,"Digi-Key Electronics Launches New Smart Agriculture Video Series, 'Farm Different,' with Supplyframe and Amphenol RF"
APH,2021-01-19,13:00:01,BB07E4,Amphenol Corp.,99,0.62,acquisitions-mergers,,Amphenol's acquisition of MTS is,PRESS-RELEASE,GlobeNewswire,ITW to Acquire MTS Test & Simulation Business From Amphenol
APH,2021-01-19,13:00:01,BB07E4,Amphenol Corp.,99,0.62,acquisitions-mergers,,Amphenol's acquisition of MTS is,PRESS-RELEASE,Dow Jones Newswires,Press Release: ITW to Acquire MTS Test & Simulation Business From Amphenol
APH,2021-01-19,13:00:40,BB07E4,Amphenol Corp.,99,0.62,acquisitions-mergers,,Amphenol's acquisition of MTS is,PRESS-RELEASE,Business Wire,ITW To Acquire MTS Test & Simulation Business From Amphenol
APH,2021-01-19,13:00:40,BB07E4,Amphenol Corp.,99,0.62,acquisitions-mergers,,Amphenol's acquisition of MTS is,PRESS-RELEASE,Dow Jones Newswires,Press Release: ITW To Acquire MTS Test & Simulation Business From Amphenol
APH,2021-01-19,13:00:40,BB07E4,Amphenol Corp.,100,0.58,acquisitions-mergers,,Itw to Acquire MTS Test & Simulation Business From Amphenol,NEWS-FLASH,Dow Jones Newswires,ITW to Acquire MTS Test & Simulation Business From Amphenol
APH,2021-01-27,13:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter 2020 Results,NEWS-FLASH,Dow Jones Newswires,Amphenol Reports Record Fourth Quarter 2020 Results And Announces 2-for-1 Stock Split >APH
APH,2021-01-27,13:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,4Q EPS $1.15 >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q EPS $1.15 >APH
APH,2021-01-27,13:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Net $357M,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Net $357M >APH
APH,2021-01-27,13:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 4Q Sales $2.43B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Sales $2.43B >APH
APH,2021-01-27,13:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Adj EPS $1.13,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Adj EPS $1.13 >APH
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter 2020 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $2.426 billion, up 13%",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP diluted EPS of $1.15,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS of $3.74,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Closed on two acquisitions in January 2021,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corp.: Announced 2-for-1 stock split,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP diluted EPS of $3.91, up",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2020, sales",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,"Amphenol Corp.: the Company purchased 1.5 million shares of its common stock for $182 million, bringing",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The Company also paid dividends of $75 million,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2021 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,-0.56,earnings,suspended,Amphenol is not providing full-year sales and EPS guidance,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.120 billion to $2.180 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter results at 1:00 PM (EST) Wednesday,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter 2020,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -2-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $2,426.0 $2,151.0",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -2-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 765.6,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -2-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter 2020,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -3-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -3-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -3-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income per common share - Basic $ 1.19 $ 1.07 $,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -3-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2019",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -3-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: Dividends,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -3-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2020",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -3-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2019",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -3-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter 2020,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -4-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -4-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -4-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter 2020,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -5-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -5-
APH,2021-01-27,13:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter 2020 -5-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter 2020 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $2.426 billion, up 13%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP diluted EPS of $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS of $3.74,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Closed on two acquisitions in January 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corp.: Announced 2-for-1 stock split,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP diluted EPS of $3.91, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2020, sales",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,"Amphenol Corp.: the Company purchased 1.5 million shares of its common stock for $182 million, bringing",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The Company also paid dividends of $75 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2021 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,-0.56,earnings,suspended,Amphenol is not providing full-year sales and EPS guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.120 billion to $2.180 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter results at 1:00 PM (EST) Wednesday,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter 2020 Results and Announces 2-for-1 Stock Split
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -2-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $2,426.0 $2,151.0",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 765.6,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income per common share - Basic $ 1.19 $ 1.07 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2019",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: Dividends,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2019",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -4-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -4-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -4-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -5-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -5-
APH,2021-01-27,13:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -5-
APH,2021-01-27,13:05:08,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Declares 2-for-1 Stock Split,NEWS-FLASH,Wall Street Journal,Amphenol Declares 2-for-1 Stock Split Effective March 4 >APH
APH,2021-01-27,13:06:38,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 1Q Sales $2.12B-$2.18B >APH,NEWS-FLASH,Wall Street Journal,Amphenol Sees 1Q Sales $2.12B-$2.18B >APH
APH,2021-01-27,13:06:55,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 1Q Adj EPS 90c,NEWS-FLASH,Wall Street Journal,Amphenol Sees 1Q Adj EPS 90c-Adj EPS 94c >APH
APH,2021-01-27,13:07:15,BB07E4,Amphenol Corp.,100,-0.56,earnings,suspended,"Amphenol Not Providing Full-Year Sales, EPS Guidance",NEWS-FLASH,Wall Street Journal,"Amphenol Not Providing Full-Year Sales, EPS Guidance >APH"
APH,2021-01-27,13:16:35,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol's 4Q Profit Rises,FULL-ARTICLE,Dow Jones Newswires,"Amphenol's 4Q Profit Rises on Stronger Mobile-Devices, Industrial Sales"
APH,2021-01-27,13:16:35,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol's operating margin was 20.1%,FULL-ARTICLE,Dow Jones Newswires,"Amphenol's 4Q Profit Rises on Stronger Mobile-Devices, Industrial Sales"
APH,2021-01-27,13:21:46,BB07E4,Amphenol Corp.,100,0.72,revenues,up,Amphenol Sees Higher 1Q Sales,FULL-ARTICLE,Dow Jones Newswires,Amphenol Sees Higher 1Q Sales
APH,2021-01-27,13:21:46,BB07E4,Amphenol Corp.,100,0.72,revenues,up,Amphenol Corp. forecast higher sales year over year,FULL-ARTICLE,Dow Jones Newswires,Amphenol Sees Higher 1Q Sales
APH,2021-01-27,13:21:46,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol said it will implement a two-for-one stock split on,FULL-ARTICLE,Dow Jones Newswires,Amphenol Sees Higher 1Q Sales
APH,2021-01-28,01:31:06,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corporation CEO Adam Norwitt on Q4 2020 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation CEO Adam Norwitt on Q4 2020 Results -- Earnings Call Transcript >APH
APH,2021-02-04,13:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2021 Dividend Payment,PRESS-RELEASE,Business Wire,Amphenol Announces First Quarter 2021 Dividend Payment
APH,2021-02-04,13:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2021 Dividend Payment,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces First Quarter 2021 Dividend Payment
APH,2021-03-04,16:27:17,BB07E4,Amphenol Corp.,100,0.59,acquisitions-mergers,approved,Mts Shareholders Approve Merger with Amphenol,PRESS-RELEASE,PR Newswire,MTS Shareholders Approve Merger with Amphenol
APH,2021-03-04,16:27:17,BB07E4,Amphenol Corp.,100,0.59,acquisitions-mergers,approved,Mts Shareholders Approve Merger With Amphenol,NEWS-FLASH,Dow Jones Newswires,MTS Shareholders Approve Merger With Amphenol >MTSC APH
APH,2021-03-04,16:27:17,BB07E4,Amphenol Corp.,100,0.59,acquisitions-mergers,approved,Mts Shareholders Approve Merger with Amphenol,PRESS-RELEASE,Dow Jones Newswires,Press Release: MTS Shareholders Approve Merger with Amphenol
APH,2021-03-05,13:34:00,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Equal-Weight by Morgan Stanley
APH,2021-03-05,13:34:00,BB07E4,Amphenol Corp.,100,-0.88,price-targets,downgrade,Amphenol Price Target Cut to $65.50/Share From $131.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $65.50/Share From $131.00 by Morgan Stanley
APH,2021-03-08,15:25:27,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Equal-Weight by Morgan Stanley
APH,2021-03-08,15:25:27,BB07E4,Amphenol Corp.,100,0.3,price-targets,upgrade,Amphenol Price Target Raised to $66.00/Share From $65.50 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $66.00/Share From $65.50 by Morgan Stanley
APH,2021-03-23,16:59:10,BB07E4,Amphenol Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amphenol Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amphenol Corporation
APH,2021-04-02,20:45:48,BB07E4,Amphenol Corp.,100,0.58,acquisitions-mergers,completed,Required to Complete Merger With Amphenol,NEWS-FLASH,Dow Jones Newswires,MTS Systems Corporation: Received all Regulatory Approvals Required to Complete Merger With Amphenol >MTSC
APH,2021-04-07,14:31:00,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Completes Acquisition Of MTS Systems >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Completes Acquisition Of MTS Systems >APH
APH,2021-04-07,14:31:00,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Completes Acquisition of MTS Systems,PRESS-RELEASE,Business Wire,Amphenol Completes Acquisition of MTS Systems
APH,2021-04-07,14:31:01,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Completes Acquisition of MTS Systems,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Completes Acquisition of MTS Systems
APH,2021-04-28,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2021 Results,NEWS-FLASH,Dow Jones Newswires,Amphenol Reports First Quarter 2021 Results And Announces New Stock Repurchase Program >APH
APH,2021-04-28,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Adj EPS 52c,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Adj EPS 52c >APH
APH,2021-04-28,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,1Q EPS 53c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q EPS 53c >APH
APH,2021-04-28,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Net $329.6M,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Net $329.6M >APH
APH,2021-04-28,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 1Q Sales $2.38B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Sales $2.38B >APH
APH,2021-04-28,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 2Q Sales $2.42B-$2.48B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Sales $2.42B-$2.48B >APH
APH,2021-04-28,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 2Q EPS 41c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q EPS 41c-EPS 43c >APH
APH,2021-04-28,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 2Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Adj EPS 53c-Adj EPS 55c >APH
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2021 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.46,revenues,up,"Amphenol Corp.: Sales of $2.377 billion, up 28%",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP diluted EPS of $0.53, up",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS1 of $0.52,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Operating margin of 19.6%,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Announces closing of two new acquisitions,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,"Amphenol Corp.: the Company purchased 2.4 million shares of its common stock for $153 million, bringing",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The Company also paid dividends of $87 million,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,Amphenol Corp.: New Stock Repurchase Program,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2021 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.415 billion to $2.475 billion,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corp.: 2-for-1 Stock Split,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.57,equity-actions,listing,Amphenol Corp.: the Company's common stock began trading,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT) Wednesday,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2021 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -2-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $ 2,377.1 $1,862.0",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -2-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 727.5,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -2-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -2-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -2-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2021 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -3-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income per common share - Basic $ 0.55 $ 0.41,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -3-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended March 31, 2020",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -3-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2021 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -4-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -4-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -4-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -4-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2021 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -5-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) $0.53 - $0.55,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -5-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.41 - $0.43,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -5-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2021 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2021 Results and -6-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.46,revenues,up,"Amphenol Corp.: Sales of $2.377 billion, up 28%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP diluted EPS of $0.53, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS1 of $0.52,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Operating margin of 19.6%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Announces closing of two new acquisitions,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,"Amphenol Corp.: the Company purchased 2.4 million shares of its common stock for $153 million, bringing",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The Company also paid dividends of $87 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,Amphenol Corp.: New Stock Repurchase Program,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2021 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.415 billion to $2.475 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol Corp.: 2-for-1 Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.57,equity-actions,listing,Amphenol Corp.: the Company's common stock began trading,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT) Wednesday,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2021 Results and Announces New Stock Repurchase Program
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $ 2,377.1 $1,862.0",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Gross profit 727.5,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,94,0.61,earnings,positive,Amphenol Corp.: Net income per common share - Basic $ 0.55 $ 0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,94,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended March 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -4-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -4-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -4-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) $0.53 - $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2021-04-28,12:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.41 - $0.43,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2021-04-28,12:14:25,BB07E4,Amphenol Corp.,97,0.0,revenues,,Amphenol Corp. Wednesday posted greater revenue and profit figures for its first quarter,FULL-ARTICLE,Dow Jones Newswires,"Amphenol Logs 1Q Rev, Profit Growth; Launches More Buybacks"
APH,2021-04-28,12:23:37,BB07E4,Amphenol Corp.,100,0.7,earnings,above-expectations,"Amphenol 2Q Rev, Profit Outlook Tops Analysts' Forecasts",FULL-ARTICLE,Dow Jones Newswires,"Amphenol 2Q Rev, Profit Outlook Tops Analysts' Forecasts"
APH,2021-04-28,21:44:27,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp CEO Adam Norwitt on Q1 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amphenol Corp CEO Adam Norwitt on Q1 2021 Results -- Earnings Call Transcript >APH
APH,2021-04-29,11:52:10,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Equal-Weight by Morgan Stanley
APH,2021-04-29,11:52:10,BB07E4,Amphenol Corp.,100,0.62,price-targets,upgrade,Amphenol Price Target Raised to $70.00/Share From $66.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $70.00/Share From $66.00 by Morgan Stanley
APH,2021-04-29,14:23:30,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2021-04-29,14:23:30,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $80.00/Share From $70.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $80.00/Share From $70.00 by Citigroup
APH,2021-05-04,21:20:36,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 15,133 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 15,133 Of Amphenol Corp >APH"
APH,2021-05-04,22:23:32,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 150,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 150,000 Of Amphenol Corp >APH"
APH,2021-05-04,22:29:18,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 15,133 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 15,133 Of Amphenol Corp >APH"
APH,2021-05-04,22:30:54,BB07E4,Amphenol Corp.,100,0.52,insider-trading,,"Dir Livingston Buys 20,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Livingston Buys 20,000 Of Amphenol Corp >APH"
APH,2021-05-05,20:26:33,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 400,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 400,000 Of Amphenol Corp >APH"
APH,2021-05-05,21:12:42,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Ceo Norwitt Sells 1,150,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Norwitt Sells 1,150,000 Of Amphenol Corp >APH"
APH,2021-05-06,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2021 Dividend Payment,PRESS-RELEASE,Business Wire,Amphenol Announces Second Quarter 2021 Dividend Payment
APH,2021-05-06,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The second quarter dividend,PRESS-RELEASE,Business Wire,Amphenol Announces Second Quarter 2021 Dividend Payment
APH,2021-05-06,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2021 Dividend Payment,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Second Quarter 2021 Dividend Payment
APH,2021-05-06,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The second quarter dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Second Quarter 2021 Dividend Payment
APH,2021-05-06,18:12:00,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 600,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 600,000 Of Amphenol Corp >APH"
APH,2021-05-10,15:41:53,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Gu Sells 60,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Gu Sells 60,000 Of Amphenol Corp >APH"
APH,2021-05-10,15:53:55,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 14,867 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 14,867 Of Amphenol Corp >APH"
APH,2021-05-10,16:17:58,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Cfo Lampo Sells 144,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Lampo Sells 144,000 Of Amphenol Corp >APH"
APH,2021-05-10,23:08:36,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 14,867 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 14,867 Of Amphenol Corp >APH"
APH,2021-05-10,23:20:43,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Cfo Lampo Registers 144,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CFO Lampo Registers 144,000 Of Amphenol Corp >APH"
APH,2021-05-10,23:27:07,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Gu Registers 60,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Gu Registers 60,000 Of Amphenol Corp >APH"
APH,2021-05-24,13:56:03,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Gavelle Sells 150,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Gavelle Sells 150,000 Of Amphenol Corp >APH"
APH,2021-05-24,19:08:29,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Gavelle Registers 150,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Gavelle Registers 150,000 Of Amphenol Corp >APH"
APH,2021-06-07,10:00:09,BB07E4,Amphenol Corp.,99,0.62,acquisitions-mergers,,Amphenol Corp.: New acquisitions,PRESS-RELEASE,PR Newswire,Amphenol uses ANGA COM Event to showcase expanded Broadband Solution Capabilities
APH,2021-07-27,21:14:00,BB07E4,Amphenol Corp.,100,0.47,labor-issues,,Amphenol Corp.: Nancy Altobello Appointed to Board of Directors,PRESS-RELEASE,Business Wire,Nancy Altobello Appointed to Board of Directors of Amphenol Corporation
APH,2021-07-27,21:14:00,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Mts Systems before it was acquired by Amphenol in April 2021,PRESS-RELEASE,Business Wire,Nancy Altobello Appointed to Board of Directors of Amphenol Corporation
APH,2021-07-27,21:14:01,BB07E4,Amphenol Corp.,100,0.47,labor-issues,,Amphenol Corp.: Press Release: Nancy Altobello Appointed to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Nancy Altobello Appointed to Board of Directors of Amphenol Corporation
APH,2021-07-27,21:14:01,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Mts Systems before it was acquired by Amphenol in April 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Nancy Altobello Appointed to Board of Directors of Amphenol Corporation
APH,2021-07-27,21:14:28,BB07E4,Amphenol Corp.,100,0.47,labor-issues,,Amphenol Says Nancy Altobello Appointed to Board of Directors,NEWS-FLASH,Dow Jones Newswires,Amphenol Says Nancy Altobello Appointed to Board of Directors >APH
APH,2021-07-28,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,2Q EPS 59c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q EPS 59c >APH
APH,2021-07-28,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 2Q Sales $2.65B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Sales $2.65B >APH
APH,2021-07-28,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Adj EPS 61c,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Adj EPS 61c >APH
APH,2021-07-28,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Net $369.8M,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Net $369.8M >APH
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2021 Record Results,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.5,revenues,up,"Amphenol Corp.: Record sales of $2.654 billion, up 34%",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP diluted EPS of $0.59, up",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Record Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.34,products-services,,Amphenol Corp.: Announces acquisition of Unlimited Services,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,Amphenol Corp.: the Company purchased 2.5 million shares of its common stock for $167 million,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The Company also paid dividends of $87 million,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2021 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol expects sales from continuing operations to be in the range of $2.640 billion to $2.700 billion, representing 14% to 16% growth over the third quarter of 2020",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT) Wednesday,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $2,653.9 $1,987.5",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Gross profit 843.2,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Net income per common share,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -3-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -3-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,98,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -4-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,98,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -4-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: Such amount is calculated by subtracting current year net sales,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -5-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales Growth,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -5-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -6-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -6-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2021 Record -6-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2021 Record Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.5,revenues,up,"Amphenol Corp.: Record sales of $2.654 billion, up 34%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP diluted EPS of $0.59, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Record Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.34,products-services,,Amphenol Corp.: Announces acquisition of Unlimited Services,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,Amphenol Corp.: the Company purchased 2.5 million shares of its common stock for $167 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The Company also paid dividends of $87 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2021 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol expects sales from continuing operations to be in the range of $2.640 billion to $2.700 billion, representing 14% to 16% growth over the third quarter of 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT) Wednesday,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2021 Record Results
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $2,653.9 $1,987.5",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Gross profit 843.2,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Net income per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,98,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -4-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,98,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -4-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: Such amount is calculated by subtracting current year net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -5-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -5-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -6-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -6-
APH,2021-07-28,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -6-
APH,2021-07-28,12:02:29,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol to Acquire Unlimited Services >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol to Acquire Unlimited Services >APH
APH,2021-07-28,12:03:12,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 3Q Sales $2.64B-$2.7B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Sales $2.64B-$2.7B >APH
APH,2021-07-28,12:03:30,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 3Q Adj EPS 60c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Adj EPS 60c-Adj EPS 62c >APH
APH,2021-07-29,00:31:18,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corporation's CEO Adam Norwitt on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation's CEO Adam Norwitt on Q2 2021 Results -- Earnings Call Transcript >APH
APH,2021-07-29,00:31:18,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol-corporations-aph-ceo-adam-norwitt-on-q2-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation's CEO Adam Norwitt on Q2 2021 Results -- Earnings Call Transcript >APH
APH,2021-07-29,12:08:08,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Equal-Weight by Morgan Stanley
APH,2021-07-29,12:08:08,BB07E4,Amphenol Corp.,100,0.66,price-targets,upgrade,Amphenol Price Target Raised to $75.00/Share From $70.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $75.00/Share From $70.00 by Morgan Stanley
APH,2021-07-29,15:05:29,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Sector Perform by RBC Capital
APH,2021-07-29,15:05:29,BB07E4,Amphenol Corp.,100,0.5,price-targets,upgrade,Amphenol Price Target Raised to $76.00/Share From $73.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $76.00/Share From $73.00 by RBC Capital
APH,2021-08-03,14:24:31,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 40,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 40,000 Of Amphenol Corp >APH"
APH,2021-08-03,20:17:47,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 40,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 40,000 Of Amphenol Corp >APH"
APH,2021-08-05,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Third Quarter 2021 Dividend Payment,PRESS-RELEASE,Business Wire,Amphenol Announces Third Quarter 2021 Dividend Payment
APH,2021-08-05,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Third Quarter 2021 Dividend Payment,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Third Quarter 2021 Dividend Payment
APH,2021-08-09,17:26:24,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Walter Sells 82,400 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Walter Sells 82,400 Of Amphenol Corp >APH"
APH,2021-08-09,20:29:28,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Walter Registers 82,400 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Walter Registers 82,400 Of Amphenol Corp >APH"
APH,2021-08-16,19:44:48,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Silverman Registers 120,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Silverman Registers 120,000 Of Amphenol Corp >APH"
APH,2021-08-17,08:00:07,BB07E4,Amphenol Corp.,99,0.0,products-services,,Amphenol Corp.: Ardent's development of these products,PRESS-RELEASE,PR Newswire,Amphenol Ardent Concepts and PHY-SI LLC Released QSFP DD 800G and OSFP 800G Form-Factor Host Compliance Test Fixtures Targeting IEEE 802.3ck CEI 112G-VSR Specification
APH,2021-08-30,19:15:22,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Booker Sells 140,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Booker Sells 140,000 Of Amphenol Corp >APH"
APH,2021-08-30,21:48:01,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Booker Registers 140,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Booker Registers 140,000 Of Amphenol Corp >APH"
APH,2021-09-03,13:03:29,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Gavelle Sells 60,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Gavelle Sells 60,000 Of Amphenol Corp >APH"
APH,2021-09-03,18:29:57,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Gavelle Registers 60,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Gavelle Registers 60,000 Of Amphenol Corp >APH"
APH,2021-09-07,18:00:43,BB07E4,Amphenol Corp.,100,0.0,credit-ratings,affirmation,S&PGR Afrms Amphenol Rtgs,NEWS-FLASH,Dow Jones Newswires,S&PGR Afrms Amphenol Rtgs; Sr Unsecured Nts Rated 'BBB+'
APH,2021-09-07,18:00:43,BB07E4,Amphenol Corp.,100,0.0,credit-ratings,affirmation,S&PGR Afrms Amphenol Rtgs,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Afrms Amphenol Rtgs; Sr Unsecured Nts Rated 'BBB+'
APH,2021-09-07,18:00:43,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol will continue to post solid operating performance in 2021-2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Afrms Amphenol Rtgs; Sr Unsecured Nts Rated 'BBB+'
APH,2021-09-07,18:00:43,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol's $1.7 billion acquisition of MTS Systems Corp.,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Afrms Amphenol Rtgs; Sr Unsecured Nts Rated 'BBB+'
APH,2021-09-07,18:00:53,BB07E4,Amphenol Corp.,100,0.0,credit-ratings,affirmation,S&PGR Afrms Amphenol Rtgs,NEWS-FLASH,Dow Jones Newswires,Press Release: S&PGR Afrms Amphenol Rtgs; Sr -2-
APH,2021-09-08,12:00:03,BB07E4,Amphenol Corp.,100,0.0,credit,,"Amphenol Corporation Announces Pricing of $750,000,000 of Senior Notes",PRESS-RELEASE,Business Wire,"Amphenol Corporation Announces Pricing of $750,000,000 of Senior Notes"
APH,2021-09-08,12:00:04,BB07E4,Amphenol Corp.,100,0.0,credit,,"Amphenol Corporation Announces Pricing of $750,000,000 of Senior Notes",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Amphenol Corporation Announces Pricing of $750,000,000 of Senior Notes"
APH,2021-09-08,12:01:04,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Announces Pricing of $750 Million of Senior Notes,NEWS-FLASH,Dow Jones Newswires,Amphenol Announces Pricing of $750 Million of Senior Notes
APH,2021-09-08,13:11:20,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 27,500 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 27,500 Of Amphenol Corp >APH"
APH,2021-09-08,19:47:53,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 27,500 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 27,500 Of Amphenol Corp >APH"
APH,2021-09-22,13:51:13,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Jefferies,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Jefferies
APH,2021-09-22,13:51:13,BB07E4,Amphenol Corp.,100,0.54,price-targets,upgrade,Amphenol Price Target Raised to $88.00/Share From $84.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $88.00/Share From $84.00 by Jefferies
APH,2021-09-23,14:00:33,BB07E4,Amphenol Corp.,99,0.0,products-services,,Amphenol Corp.: Our Diamond Technology Reviews,PRESS-RELEASE,PR Newswire,Amphenol Broadband Solutions (ABS) Products Recognized in 2021 Diamond Technology Reviews
APH,2021-09-27,11:38:16,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Goldman Sachs
APH,2021-09-27,11:38:16,BB07E4,Amphenol Corp.,100,0.64,price-targets,upgrade,Amphenol Price Target Raised to $80.00/Share From $75.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $80.00/Share From $75.00 by Goldman Sachs
APH,2021-10-27,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2021 Results,NEWS-FLASH,Dow Jones Newswires,Amphenol Reports Record Third Quarter 2021 Results And Announces Dividend Increase >APH
APH,2021-10-27,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Adj EPS 65c,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Adj EPS 65c >APH
APH,2021-10-27,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 3Q Sales $2.82B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Sales $2.82B >APH
APH,2021-10-27,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 4Q Sales $2.69B-$2.75B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Sales $2.69B-$2.75B >APH
APH,2021-10-27,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q Adj EPS 61c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Adj EPS 61c-Adj EPS 63c >APH
APH,2021-10-27,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,3Q EPS 68c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q EPS 68c >APH
APH,2021-10-27,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Net $426.5M,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Net $426.5M >APH
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2021 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $2.818 billion, up 21%",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP diluted EPS of $0.67,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Record Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Operating Margin of 20.3%,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.52,dividends,up,Amphenol Corp.: Quarterly dividend increased by 38%,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,Amphenol Corp.: the Company purchased 2.3 million shares of its common stock for $171 million,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2021, we expect sales to be in the range of $10.540 billion to $10.600 billion",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT) Wednesday,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2021,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $2,818.5 $2,323.4",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 889.9,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Net income per common share,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2021,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -3-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -3-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2021,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -4-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -4-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -4-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2021,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -5-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Such amount is calculated by subtracting current year net sales,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -5-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -5-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2021,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -6-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) - $0.61 - $0.63,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -6-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) - continuing operations $0.61 - $0.63,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2021 -6-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $2.818 billion, up 21%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP diluted EPS of $0.67,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Record Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Operating Margin of 20.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.52,dividends,up,Amphenol Corp.: Quarterly dividend increased by 38%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,Amphenol Corp.: the Company purchased 2.3 million shares of its common stock for $171 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2021, we expect sales to be in the range of $10.540 billion to $10.600 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT) Wednesday,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2021 Results and Announces Dividend Increase
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $2,818.5 $2,323.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 889.9,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Net income per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Such amount is calculated by subtracting current year net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) - $0.61 - $0.63,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2021-10-27,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) - continuing operations $0.61 - $0.63,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2021-10-27,12:01:42,BB07E4,Amphenol Corp.,100,0.62,dividends,up,Amphenol Raises Dividend to 20c,NEWS-FLASH,Dow Jones Newswires,Amphenol Raises Dividend to 20c >APH
APH,2021-10-27,12:02:40,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY Adj EPS $2.39,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Adj EPS $2.39-Adj EPS $2.41 >APH
APH,2021-10-27,12:02:40,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees FY Sales $10.54B-$10.6B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Sales $10.54B-$10.6B >APH
APH,2021-10-27,12:11:07,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol 3Q Profit, Sales Rise",FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Profit, Sales Rise"
APH,2021-10-27,12:11:07,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp. said its third-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Profit, Sales Rise"
APH,2021-10-27,12:18:09,BB07E4,Amphenol Corp.,100,0.52,dividends,up,Amphenol Raises Quarterly Dividend by 38%,FULL-ARTICLE,Dow Jones Newswires,Amphenol Raises Quarterly Dividend by 38%
APH,2021-10-27,12:24:11,BB07E4,Amphenol Corp.,100,0.72,revenues,up,Amphenol Corp.: the company said it sees sales of $10.54 billion to $10.6 billion,FULL-ARTICLE,Dow Jones Newswires,"Amphenol Expects Sales Growth as Supply-Chain, Inflationary Challenges Remain"
APH,2021-10-27,12:24:11,BB07E4,Amphenol Corp.,100,0.44,revenues,up,Amphenol Corp. said it expects sales growth for the fourth quarter,FULL-ARTICLE,Dow Jones Newswires,"Amphenol Expects Sales Growth as Supply-Chain, Inflationary Challenges Remain"
APH,2021-10-28,00:17:31,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corporation's CEO Adam Norwitt on Q3 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation's CEO Adam Norwitt on Q3 2021 Results -- Earnings Call Transcript >APH
APH,2021-10-28,00:17:31,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol-corporations-aph-ceo-adam-norwitt-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation's CEO Adam Norwitt on Q3 2021 Results -- Earnings Call Transcript >APH
APH,2021-10-28,13:51:57,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Equal-Weight by Morgan Stanley
APH,2021-10-28,13:51:57,BB07E4,Amphenol Corp.,100,0.64,price-targets,upgrade,Amphenol Price Target Raised to $80.00/Share From $75.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $80.00/Share From $75.00 by Morgan Stanley
APH,2021-11-26,19:04:37,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Gavelle Sells 54,800 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Gavelle Sells 54,800 Of Amphenol Corp >APH"
APH,2021-11-29,18:24:29,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Gavelle Registers 54,800 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Gavelle Registers 54,800 Of Amphenol Corp >APH"
APH,2021-12-01,21:46:00,BB07E4,Amphenol Corp.,100,0.34,products-services,,Amphenol Corporation Announces Acquisition Of Halo Technology,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation Announces Acquisition Of Halo Technology And Closing Of Sale Of MTS Test & Simulation Business >APH
APH,2021-12-01,21:46:00,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corporation (NYSE: APH) today announced that it has acquired Halo Technology Limited for approximately $715 million,PRESS-RELEASE,Business Wire,Amphenol Corporation Announces Acquisition of Halo Technology and Closing of Sale of MTS Test & Simulation Business
APH,2021-12-01,21:46:01,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corporation (NYSE: APH) today announced that it has acquired Halo Technology Limited for approximately $715 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Announces Acquisition of Halo Technology and Closing of Sale of MTS Test & Simulation Business
APH,2021-12-06,19:59:34,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 547,087 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 547,087 Of Amphenol Corp >APH"
APH,2021-12-07,20:14:46,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 217,913 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 217,913 Of Amphenol Corp >APH"
APH,2021-12-07,22:23:23,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Doherty Sells 165,800 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Doherty Sells 165,800 Of Amphenol Corp >APH"
APH,2021-12-07,22:29:15,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Ceo Norwitt Sells 765,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Norwitt Sells 765,000 Of Amphenol Corp >APH"
APH,2021-12-08,20:08:34,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Doherty Registers 165,800 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Doherty Registers 165,800 Of Amphenol Corp >APH"
APH,2021-12-15,13:53:51,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Equal-Weight by Morgan Stanley
APH,2021-12-15,13:53:51,BB07E4,Amphenol Corp.,100,0.48,price-targets,upgrade,Amphenol Price Target Raised to $83.00/Share From $80.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $83.00/Share From $80.00 by Morgan Stanley
APH,2022-01-18,07:00:27,A1C370,Alliance Pharma PLC,99,0.63,revenues,up,Alliance Pharma PLC: Full year revenues grew 3%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2022-01-18,07:00:27,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Nizoral(TM) revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2022-02-03,07:08:56,A1C370,Alliance Pharma PLC,100,-0.47,regulatory,,Alliance Pharma PLC Update on CMA investigation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Update on CMA investigation
APH,2022-02-03,07:08:56,A1C370,Alliance Pharma PLC,100,-0.4,legal,,Alliance will be appealing the CMA's decision,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Update on CMA investigation
APH,2022-02-03,09:09:03,A1C370,Alliance Pharma PLC,100,-0.4,legal,,"Alliance Pharma to Appeal UK Regulator's Collusion Findings, Fine",FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma to Appeal UK Regulator's Collusion Findings, Fine -- Update"
APH,2022-03-21,13:45:29,A1C370,Alliance Pharma PLC,100,0.55,acquisitions-mergers,interest,Alliance Pharma Is in Talks to Buy Two US Products for $20 Mln,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Is in Talks to Buy Two US Products for $20 Mln
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.86,earnings,up,Alliance Pharma PLC: Excellent performance in 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2021
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 109.5,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2021
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2021
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Basic earnings per share 6.39p 1.37p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2021
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.63,revenues,up,Alliance Pharma PLC: Robust Prescription Medicine performance with revenues up 8% to GBP47.8m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2021
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.72,revenues,up,Alliance Pharma PLC: We also anticipate sales growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 December 2021
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.58,revenues,up,Alliance Pharma PLC: Full year revenue growth was up 3%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.72,revenues,up,Alliance Pharma PLC: We expect to see Amberen revenue growth accelerate in 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -2-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Regional revenues in 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.65,revenues,up,Alliance Pharma PLC: The uplift in sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.64,earnings,up,Alliance Pharma PLC: Increased profitability,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.52,earnings,up,Alliance Pharma PLC: Reported profit before tax increased 39% to GBP18.2m (2020: GBP13.0m),PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.46,equity-actions,,Alliance Pharma PLC: our investment in the business,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.62,earnings,up,Alliance Pharma PLC: Reported operating profit increased by GBP5.3m to GBP21.6m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,dividends,,Alliance Pharma PLC: The final dividend for 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.41,assets,open,"Alliance Pharma PLC: During the Year we secured new, larger offices in Cary, North Carolina",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,-0.51,assets,close,"Alliance Pharma PLC: our growing US team , closed our office in Los Angeles",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -3-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 109,450 - 109,450",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Operating expenses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -4-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Profit for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -5-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.39,products-services,,"Alliance Pharma PLC: Transactions with owners 35 1,609 - - - 1,218 (2,837",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -5-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -6-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.57,equity-actions,listing,Alliance Pharma PLC: The Company is listed on the AIM stock exchange,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -6-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -6-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Nizoral statutory revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -6-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross Profit 83,831",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -6-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -6-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -7-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,-0.48,equity-actions,costs,Alliance Pharma PLC: restructuring costs,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -7-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: The taxation charge for the Year Ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -7-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -7-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: The taxation charge for the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -7-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,dividends,,Alliance Pharma PLC: An interim dividend of 0.563p per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2019,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.47,equity-actions,,Alliance Pharma PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -8-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Profit for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -9-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -10-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Adjusted profitability,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -10-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Underlying profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -10-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -10-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -10-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Total taxation charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -10-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Results for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -11-
APH,2022-03-22,07:00:53,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 82,816 - 82,816",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Results for the year ended 31 -11-
APH,2022-03-25,11:11:28,A1C370,Alliance Pharma PLC,100,0.44,products-services,,Alliance Pharma Enters Into US Scar-Treatment Market,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Enters Into US Scar-Treatment Market in $19.4 Mln Deal -- Deal Digest
APH,2022-04-11,12:39:02,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: is to build a trusted partnership with our,PRESS-RELEASE,PR Newswire,Alliance Pharma Appoints Patrick Bennett as Chief Executive Officer
APH,2022-05-17,11:00:06,A1C370,Alliance Pharma PLC,99,0.18,acquisitions-mergers,,Kkr is investing in Alliance,PRESS-RELEASE,PR Newswire,"Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (""DDS"") and welcomes KKR as joint shareholder"
APH,2022-05-17,11:00:06,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: is to build a trusted partnership with our,PRESS-RELEASE,PR Newswire,"Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (""DDS"") and welcomes KKR as joint shareholder"
APH,2022-05-17,11:00:06,A1C370,Alliance Pharma PLC,99,0.18,acquisitions-mergers,,Kkr is investing in Alliance,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (""DDS"") and welcomes KKR as joint shareholder"
APH,2022-05-17,11:00:06,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: is to build a trusted partnership with our,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (""DDS"") and welcomes KKR as joint shareholder"
APH,2022-05-17,11:01:08,A1C370,Alliance Pharma PLC,99,0.18,acquisitions-mergers,,Kkr is investing in Alliance,PRESS-RELEASE,PR Newswire,"Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (""DDS"") and welcomes KKR as joint shareholder"
APH,2022-05-17,11:01:08,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: is to build a trusted partnership with our,PRESS-RELEASE,PR Newswire,"Ampersand-backed Alliance Pharma to acquire LGC's Drug Development Solutions Business (""DDS"") and welcomes KKR as joint shareholder"
APH,2022-05-18,06:05:15,A1C370,Alliance Pharma PLC,99,0.53,labor-issues,,Alliance Pharma PLC: Directorate changes,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Directorate Changes
APH,2022-05-18,06:05:15,A1C370,Alliance Pharma PLC,99,-0.51,labor-issues,,"Alliance's Chair, will be stepping down next year",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Directorate Changes
APH,2022-05-18,08:11:27,A1C370,Alliance Pharma PLC,100,-0.51,labor-issues,,Alliance Pharma Chairman David Cook to Step Down in 2023,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Chairman David Cook to Step Down in 2023; Jo LeCouilliard to Take on Role
APH,2022-05-18,08:11:27,A1C370,Alliance Pharma PLC,100,-0.57,labor-issues,,Alliance Pharma PLC said Wednesday that Chairman David Cook will step down,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Chairman David Cook to Step Down in 2023; Jo LeCouilliard to Take on Role
APH,2022-05-18,14:07:43,A1C370,Alliance Pharma PLC,99,0.53,labor-issues,,Alliance Pharma PLC: Directorate changes,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Directorate Changes
APH,2022-05-18,14:07:43,A1C370,Alliance Pharma PLC,99,-0.51,labor-issues,,"Alliance's Chair, will be stepping down next year",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Directorate Changes
APH,2022-05-18,14:42:39,A1C370,Alliance Pharma PLC,99,0.0,investor-relations,,Alliance Pharma PLC: Result of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Result of AGM
APH,2022-06-15,05:05:50,A1C370,Alliance Pharma PLC,100,0.95,analyst-ratings,positive,Alliance Pharma Started at Buy by Berenberg,NEWS-FLASH,Dow Jones Newswires,Alliance Pharma Started at Buy by Berenberg
APH,2022-06-15,05:05:50,A1C370,Alliance Pharma PLC,100,0.0,price-targets,set,Alliance Pharma Target Started at 145p by Berenberg,NEWS-FLASH,Dow Jones Newswires,Alliance Pharma Target Started at 145p by Berenberg
APH,2022-07-13,10:00:01,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: is to build a trusted partnership with our,PRESS-RELEASE,Business Wire,U.S. Alliance Pharma Acquires U.K.-based LGC's Drug Development Solutions (DDS) Business
APH,2022-07-20,06:00:18,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Full year guidance,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2022-07-20,06:00:18,A1C370,Alliance Pharma PLC,99,0.41,revenues,up,Alliance Pharma PLC: Consumer Healthcare revenues of GBP57.4m were up 1%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2022-07-20,06:00:18,A1C370,Alliance Pharma PLC,99,0.0,products-services,unchanged,Alliance Pharma PLC: In -market demand remains strong,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2022-07-20,06:00:18,A1C370,Alliance Pharma PLC,99,0.61,products-services,increase,Alliance Pharma PLC: We anticipate increased order,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2022-07-20,06:00:18,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Nizoral see-through revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2022-07-20,06:00:18,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: The delayed sales from H1 22,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2022-07-20,06:00:18,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: we now expect 2022 sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2022-07-20,07:17:28,A1C370,Alliance Pharma PLC,100,0.65,revenues,up,Alliance Pharma 1H Revenue Rose,FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma 1H Revenue Rose, 2022 Performance Seen in Line With Views"
APH,2022-07-20,07:17:28,A1C370,Alliance Pharma PLC,100,0.41,revenues,up,Alliance Pharma PLC said Wednesday that first-half revenue rose 1%,FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma 1H Revenue Rose, 2022 Performance Seen in Line With Views"
APH,2022-07-20,07:17:28,A1C370,Alliance Pharma PLC,100,0.54,earnings,meet-expectations,Alliance Pharma PLC: the company's performance for the year to be in line with market expectations,FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma 1H Revenue Rose, 2022 Performance Seen in Line With Views"
APH,2022-08-08,07:18:24,A1C370,Alliance Pharma PLC,100,0.0,regulatory,,Alliance Pharma PLC said Monday that it has appointed Deloitte LLP as its auditor,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Names New Auditor After KPMG Resigns Over Corporate Concerns
APH,2022-08-08,07:33:24,A1C370,Alliance Pharma PLC,100,0.0,regulatory,,Alliance Pharma PLC said Monday that it has appointed Deloitte LLP as its auditor,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Names New Auditor After KPMG Resigns Over Corporate Concerns
APH,2022-08-11,12:00:00,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: is to build a trusted partnership with our,PRESS-RELEASE,Business Wire,U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia
APH,2022-09-02,06:06:03,A1C370,Alliance Pharma PLC,100,-0.47,regulatory,,Alliance Pharma PLC Update on CMA investigation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Update on CMA investigation
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Results for the six months ended 30 June 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 50.6,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.0,dividends,,Alliance Pharma PLC: Interim dividend per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.65,revenues,up,Alliance Pharma PLC: H1 revenue growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.72,revenues,up,Alliance Pharma PLC: We anticipate strong sales growth in H2,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.41,revenues,up,Alliance Pharma PLC: Consumer Healthcare revenues of GBP57.4m were up 1%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.0,products-services,unchanged,Alliance Pharma PLC: In -market demand remains strong,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Nizoral see-through revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.46,equity-actions,,Alliance Pharma PLC: our investment in the business,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.44,products-services,,Alliance Pharma PLC: of our new product expansion in China,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,-0.51,labor-issues,,"Alliance's Chair, will be stepping down next year",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.72,revenues,up,Alliance Pharma PLC: We anticipate strong sales growth in H2,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 50,638 - 50,638",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.0,equity-actions,,Alliance Pharma PLC: Operating expenses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.6,earnings,positive,Alliance Pharma PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,94,0.0,revenues,,Alliance Pharma PLC: Total Revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,94,0.0,revenues,,Alliance Pharma PLC: Nizoral revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,94,0.0,earnings,,Alliance Pharma PLC: Interest income,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -6-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,90,-0.48,equity-actions,costs,Alliance Pharma PLC: restructuring costs,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,90,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,90,0.62,earnings,up,Alliance Pharma PLC: Profit before taxation multiplied,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,90,0.0,dividends,,Alliance Pharma PLC: Interim dividend for the 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,90,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,90,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,90,0.0,earnings,,Alliance Pharma PLC: For diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2022-09-20,06:00:25,A1C370,Alliance Pharma PLC,92,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 50,638 - 50,638",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -10-
APH,2022-09-21,12:00:01,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: is to build a trusted partnership with our,PRESS-RELEASE,Business Wire,"CRO Alliance Pharma's Executive Team Grows by Four, Supporting Bioanalytical and CMC Testing Expansions"
APH,2022-11-23,07:00:19,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Sales have also been,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Update on Q4 Trading
APH,2022-12-07,14:00:02,A1C370,Alliance Pharma PLC,99,0.49,partnerships,,Alliance Pharma PLC: is to build a trusted partnership with our,PRESS-RELEASE,Business Wire,Alliance Pharma Opens State-of-the-Art Bioanalytical Laboratory in Brisbane
APH,2022-12-22,10:31:19,A1C370,Alliance Pharma PLC,99,0.0,assets,,Alliance reported net assets of GBP296.9 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Logistics Development Group PLC Alliance Pharma plc Investment
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,96,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,96,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:15:14,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss/Shr C$0.42,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss/Shr C$0.42 >APHA
APH,2021-01-14,12:15:24,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 2Q Rev C$160.5M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Rev C$160.5M >APHA
APH,2021-01-14,12:19:03,D06CF0,Aphria Inc.,100,0.48,revenues,above-expectations,Aphria Q2 rev. C$160.5 mln vs. C$120.6 mln a year ago; FactSet consensus C$153.9 mln,NEWS-FLASH,MarketWatch,MW Aphria Q2 rev. C$160.5 mln vs. C$120.6 mln a year ago; FactSet consensus C$153.9 mln
APH,2021-01-14,12:20:03,D06CF0,Aphria Inc.,100,-1.0,earnings,down,Aphria Q2 loss C 42 cents vs. loss C 3 cents a year ago,NEWS-FLASH,MarketWatch,MW Aphria Q2 loss C 42 cents vs. loss C 3 cents a year ago
APH,2021-01-14,12:20:47,D06CF0,Aphria Inc.,100,0.82,earnings,above-expectations,Aphria Q2 adj. EPS C 1 cent; FactSet consensus loss 3 cents,NEWS-FLASH,MarketWatch,MW Aphria Q2 adj. EPS C 1 cent; FactSet consensus loss 3 cents
APH,2021-01-14,12:31:00,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 2Q Rev C$160.5M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Rev C$160.5M >APHA
APH,2021-01-14,12:31:07,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss/Shr C$0.42,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss/Shr C$0.42 >APHA
APH,2021-01-14,12:31:14,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss C$120.6M,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss C$120.6M >APHA
APH,2021-01-14,12:31:29,D06CF0,Aphria Inc.,100,-0.67,earnings,down,Aphria 2Q Loss Widens,FULL-ARTICLE,Dow Jones Newswires,"Aphria 2Q Loss Widens, Revenue Rises"
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,0.72,revenues,above-expectations,Aphria Inc.: the company posted better-than-expected revenue for its November quarter,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Ticker: APHA) reported a net loss of 120.6 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria Inc.: the company announced a merger with Canadian peer Tilray (TLRY,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,19:30:32,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript >APHA
APH,2021-01-14,19:30:32,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-apha-ceo-irwin-simon-on-q2-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript >APHA
APH,2021-01-15,14:31:04,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?"
APH,2021-01-15,15:53:54,D06CF0,Aphria Inc.,96,0.41,revenues,up,Aphria on Thursday reported second-quarter net revenue of $160.5 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Tilray and Aphria Shares Continue Gains
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,0.0,price-targets,unchanged,Aphria Inc Price Target Is Maintained at C$20.00,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Is Maintained at C$20.00/Share by Alliance Global Partners
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Hold From Buy by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Hold From Buy by Haywood Securities
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,0.78,price-targets,upgrade,Aphria Inc Price Target Raised to C$14.00/Share From C$12.25 by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$14.00/Share From C$12.25 by Haywood Securities
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.94,analyst-ratings,positive,Aphria Inc Raised to Speculative Buy From Hold by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Raised to Speculative Buy From Hold by Canaccord Genuity
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria Inc Price Target Raised to C$17.50/Share From C$11.00 by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$17.50/Share From C$11.00 by Canaccord Genuity
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria Inc Price Target Raised to C$18.00/Share From C$12.50 by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$18.00/Share From C$12.50 by CIBC World Markets
APH,2021-01-19,12:11:03,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria stock price target raised to C$15.50 from C$9.80 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target raised to C$15.50 from C$9.80 at Stifel Nicolaus
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria stock price target raised to C$15.50 by Stifel,FULL-ARTICLE,MarketWatch,MW Aphria stock price target raised to C$15.50 by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,MarketWatch,MW Aphria stock price target raised to C$15.50 by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria Stock Price Target Raised To C$15.50 By Stifel,FULL-ARTICLE,Dow Jones Newswires,Aphria Stock Price Target Raised To C$15.50 By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,Dow Jones Newswires,Aphria Stock Price Target Raised To C$15.50 By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria stock price target raised by Stifel,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria stock price target raised by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria stock price target raised by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria Stock Price Target Raised By Stifel,FULL-ARTICLE,Dow Jones Newswires,Update: Aphria Stock Price Target Raised By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,Dow Jones Newswires,Update: Aphria Stock Price Target Raised By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,revenues,,Aphria last Thursday reported second-quarter net revenue of $160.5 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,analyst-ratings,neutral,Stifel maintained its Hold rating on Aphria,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria's F2Q21 earnings report,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,17:12:19,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria Inc Price Target Raised to C$15.50/Share From C$9.80 by Stifel Nicolaus,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$15.50/Share From C$9.80 by Stifel Nicolaus
APH,2021-02-03,14:31:03,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Tyme Technologies, Lizhi Inc, Aphria, Sasol Limited, or Artelo Biosciences?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Tyme Technologies, Lizhi Inc, Aphria, Sasol Limited, or Artelo Biosciences?"
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,PR Newswire,Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Canadian News Wire,(CNW) Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-10,14:31:02,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Mesa Air Group, Aphria, Energous Corp, Liminal BioSciences, or Kintara Therapeutics?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Mesa Air Group, Aphria, Energous Corp, Liminal BioSciences, or Kintara Therapeutics?"
APH,2021-02-10,16:22:01,D06CF0,Aphria Inc.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - APHA,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - APHA
APH,2021-02-10,16:22:02,D06CF0,Aphria Inc.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - APHA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - APHA
APH,2021-02-10,16:29:29,D06CF0,Aphria Inc.,100,0.48,equity-actions,resumed,Iiroc Trade Resumption - APHA,PRESS-RELEASE,Canadian News Wire,IIROC Trade Resumption - APHA
APH,2021-02-10,16:29:29,D06CF0,Aphria Inc.,100,0.48,equity-actions,resumed,Iiroc Trade Resumption - APHA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trade Resumption - APHA
APH,2021-02-11,16:05:03,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Aphria, Zomedica, Aurora Cannabis, Iterum Therapeutics, or Globalstar?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Aphria, Zomedica, Aurora Cannabis, Iterum Therapeutics, or Globalstar?"
APH,2021-02-16,13:28:15,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:15,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:22,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:22,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:57:14,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:57:14,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,16:15:46,D06CF0,Aphria Inc.,99,0.34,analyst-ratings,neutral,He has an Overweight rating on Aphria,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Tilray Rises Ahead of Earnings. An Analyst Prefers Aphria. -- Barrons.com
APH,2021-02-16,16:15:46,D06CF0,Aphria Inc.,99,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Tilray Rises Ahead of Earnings. An Analyst Prefers Aphria. -- Barrons.com
APH,2021-02-16,17:00:10,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,17:23:47,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,17:23:47,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,12:12:42,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,12:12:42,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,21:34:01,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:34:24,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:37:57,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:38:49,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:54:23,D06CF0,Aphria Inc.,97,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:54:23,D06CF0,Aphria Inc.,97,0.5,stock-picks,buy,Analyst says to buy Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-18,02:28:35,D06CF0,Aphria Inc.,97,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 8%"
APH,2021-02-18,02:28:35,D06CF0,Aphria Inc.,97,0.5,stock-picks,buy,Analyst says to buy Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 8%"
APH,2021-02-18,16:13:39,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-18,16:13:39,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,15:22:20,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,15:22:20,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,22:29:42,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,22:29:42,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Canadian News Wire,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria to Host Special Meeting of Shareholders,PRESS-RELEASE,Canadian News Wire,Aphria to Host Special Meeting of Shareholders on -2-
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria to Host Special Meeting of Shareholders,PRESS-RELEASE,Canadian News Wire,Aphria to Host Special Meeting of Shareholders on -3-
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,PR Newswire,"(PR) Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-06,11:19:23,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria stock price target raised to C$22.00 from C$15.50 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target raised to C$22.00 from C$15.50 at Stifel Nicolaus
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,-0.64,revenues,downgrade,Aphria revenue estimates lowered by Stifel,FULL-ARTICLE,MarketWatch,MW Aphria revenue estimates lowered by Stifel ahead of Q3 earnings on weak cannabis consumption trends
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria to post revenue of C$163 million,FULL-ARTICLE,MarketWatch,MW Aphria revenue estimates lowered by Stifel ahead of Q3 earnings on weak cannabis consumption trends
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,-0.64,revenues,downgrade,Aphria Revenue Estimates Lowered By Stifel,FULL-ARTICLE,Dow Jones Newswires,Aphria Revenue Estimates Lowered By Stifel Ahead Of Q3 Earnings On Weak Cannabis Consumption Trends -- MarketWatch
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria to post revenue of C$163 million,FULL-ARTICLE,Dow Jones Newswires,Aphria Revenue Estimates Lowered By Stifel Ahead Of Q3 Earnings On Weak Cannabis Consumption Trends -- MarketWatch
APH,2021-04-06,16:23:16,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria Inc Price Target Raised to C$22.00/Share From C$15.50 by Stifel Nicolaus,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$22.00/Share From C$15.50 by Stifel Nicolaus
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:21,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -3-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:02:59,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria Q3 loss C$1.14,NEWS-FLASH,MarketWatch,MW Aphria Q3 loss C$1.14 vs. EPS 2 cents a year ago
APH,2021-04-12,11:04:06,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria Q3 adj. per-share loss C$0.15,NEWS-FLASH,MarketWatch,MW Aphria Q3 adj. per-share loss C$0.15; FactSet loss consensus C$0.05
APH,2021-04-12,11:04:12,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 3Q Loss/Shr C$1.14,NEWS-FLASH,Dow Jones Newswires,Aphria 3Q Loss/Shr C$1.14 >APHA
APH,2021-04-12,11:04:22,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 3Q Rev C$153.6M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 3Q Rev C$153.6M >APHA
APH,2021-04-12,11:04:45,D06CF0,Aphria Inc.,100,-0.27,revenues,below-expectations,Aphria Q3 revenue C$153.6 mln vs. C$144.4 mln a year ago; FactSet consensus C$161.3 mln,NEWS-FLASH,MarketWatch,MW Aphria Q3 revenue C$153.6 mln vs. C$144.4 mln a year ago; FactSet consensus C$161.3 mln
APH,2021-04-12,15:20:49,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria reported a net loss of 361 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Aphria Tanks After Net Loss Widens -- Barrons.com
APH,2021-04-12,18:29:01,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-12,18:29:01,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-apha-ceo-irwin-simon-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-13,10:55:51,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria stock price target cut to C$18 from C$22 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target cut to C$18 from C$22 at Stifel Nicolaus
APH,2021-04-13,11:50:42,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Cut to Hold From Speculative Buy by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Cut to Hold From Speculative Buy by Canaccord Genuity
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Aphria Inc Is Maintained at Outperform by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Is Maintained at Outperform by CIBC World Markets
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$23.00/Share From C$28.00 by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$23.00/Share From C$28.00 by CIBC World Markets
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Hold From Speculative Buy by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Hold From Speculative Buy by Canaccord Genuity
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$20.00/Share From C$26.00 by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$20.00/Share From C$26.00 by Haywood Securities
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Neutral From Buy by PI Financial,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Neutral From Buy by PI Financial
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,0.84,price-targets,upgrade,Aphria Inc Price Target Raised to C$16.00/Share From C$11.00 by PI Financial,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$16.00/Share From C$11.00 by PI Financial
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$18.00/Share From C$22.00 by Standpoint Research,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$18.00/Share From C$22.00 by Standpoint Research
APH,2021-04-13,20:18:45,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-13,20:18:45,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-s-apha-ceo-irwin-simon-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-15,11:01:58,D06CF0,Aphria Inc.,100,-0.59,acquisitions-mergers,delayed,Aphria merger adjourned to April 30 from April 16,NEWS-FLASH,MarketWatch,MW Tilray special shareholder meeting to vote on Aphria merger adjourned to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria merger to April 30,FULL-ARTICLE,MarketWatch,MW Tilray moves shareholder meeting to vote on proposed Aphria merger to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with rival Aphria Inc. (APHA.T),FULL-ARTICLE,MarketWatch,MW Tilray moves shareholder meeting to vote on proposed Aphria merger to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria Merger To April 30,FULL-ARTICLE,Dow Jones Newswires,Tilray Moves Shareholder Meeting To Vote On Proposed Aphria Merger To April 30 From April 16 -- MarketWatch
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with rival Aphria Inc. (APHA.T),FULL-ARTICLE,Dow Jones Newswires,Tilray Moves Shareholder Meeting To Vote On Proposed Aphria Merger To April 30 From April 16 -- MarketWatch
APH,2021-04-15,11:06:56,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Aphria Hldrs Approve Proposed Merger With Tilray,NEWS-FLASH,Dow Jones Newswires,Aphria Hldrs Approve Proposed Merger With Tilray >APHA
APH,2021-04-15,11:08:14,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Aphria shareholders overwhelmingly approve proposed merger with Tilray,NEWS-FLASH,MarketWatch,MW Aphria shareholders overwhelmingly approve proposed merger with Tilray
APH,2021-04-16,17:38:21,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,17:54:32,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,18:56:08,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,19:01:49,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-17,12:20:38,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Tilray shareholders approve Aphria merger,FULL-ARTICLE,MarketWatch,"MW Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with Aphria Inc. (APHA.T),FULL-ARTICLE,MarketWatch,"MW Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Tilray Shareholders Approve Aphria Merger,FULL-ARTICLE,Dow Jones Newswires,"Tilray Shareholders Approve Aphria Merger, Creating World's Biggest Cannabis Company By Revenue -- MarketWatch"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with Aphria Inc. (APHA.T),FULL-ARTICLE,Dow Jones Newswires,"Tilray Shareholders Approve Aphria Merger, Creating World's Biggest Cannabis Company By Revenue -- MarketWatch"
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Business Wire,"Tilray & Aphria Announce Closing of Transaction That Creates the ""New"" Tilray -- a Global Cannabis Leader"
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Business Wire,Tilray & Aphria Announce Closing of Transaction -2-
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Tilray & Aphria Announce Closing of Transaction That Creates the ""New"" Tilray -- a Global Cannabis Leader"
APH,2021-05-03,10:00:37,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,NEWS-FLASH,Dow Jones Newswires,"Tilray & Aphria Announce Closing of Transaction That Creates ""New"" Tilray"
APH,2021-05-03,10:13:13,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,After Aphria merger approved,FULL-ARTICLE,MarketWatch,MW Tilray says shares will start trading on Toronto Stock Exchange from May 5 after Aphria merger approved
APH,2021-05-03,10:13:13,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,After Aphria Merger Approved,FULL-ARTICLE,Dow Jones Newswires,Tilray Says Shares Will Start Trading On Toronto Stock Exchange From May 5 After Aphria Merger Approved -- MarketWatch
APH,2021-05-03,17:59:31,D06CF0,Aphria Inc.,100,0.58,acquisitions-mergers,completed,Tilray and Aphria merger closes,FULL-ARTICLE,MarketWatch,MW Tilray and Aphria merger closes and creates world's biggest weed company by revenue
APH,2021-06-04,11:11:56,D06CF0,Aphria Inc.,92,0.58,acquisitions-mergers,completed,Recently closed its merger with Aphria Inc.,FULL-ARTICLE,Dow Jones Newswires,Tilray Rated Overweight At Cantor After Aphria Merger Closes -- MarketWatch
APH,2021-06-04,11:11:56,D06CF0,Aphria Inc.,92,0.58,acquisitions-mergers,completed,Recently closed its merger with Aphria Inc.,FULL-ARTICLE,MarketWatch,MW Tilray rated overweight at Cantor after Aphria merger closes
APH,2021-08-31,12:00:26,D06CF0,Aphria Inc.,95,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Canadian News Wire,"Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:26,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:27,D06CF0,Aphria Inc.,95,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,PR Newswire,"(PR) Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:27,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:01:52,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,96,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,96,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:15:14,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss/Shr C$0.42,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss/Shr C$0.42 >APHA
APH,2021-01-14,12:15:24,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 2Q Rev C$160.5M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Rev C$160.5M >APHA
APH,2021-01-14,12:19:03,D06CF0,Aphria Inc.,100,0.48,revenues,above-expectations,Aphria Q2 rev. C$160.5 mln vs. C$120.6 mln a year ago; FactSet consensus C$153.9 mln,NEWS-FLASH,MarketWatch,MW Aphria Q2 rev. C$160.5 mln vs. C$120.6 mln a year ago; FactSet consensus C$153.9 mln
APH,2021-01-14,12:20:03,D06CF0,Aphria Inc.,100,-1.0,earnings,down,Aphria Q2 loss C 42 cents vs. loss C 3 cents a year ago,NEWS-FLASH,MarketWatch,MW Aphria Q2 loss C 42 cents vs. loss C 3 cents a year ago
APH,2021-01-14,12:20:47,D06CF0,Aphria Inc.,100,0.82,earnings,above-expectations,Aphria Q2 adj. EPS C 1 cent; FactSet consensus loss 3 cents,NEWS-FLASH,MarketWatch,MW Aphria Q2 adj. EPS C 1 cent; FactSet consensus loss 3 cents
APH,2021-01-14,12:31:00,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 2Q Rev C$160.5M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Rev C$160.5M >APHA
APH,2021-01-14,12:31:07,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss/Shr C$0.42,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss/Shr C$0.42 >APHA
APH,2021-01-14,12:31:14,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss C$120.6M,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss C$120.6M >APHA
APH,2021-01-14,12:31:29,D06CF0,Aphria Inc.,100,-0.67,earnings,down,Aphria 2Q Loss Widens,FULL-ARTICLE,Dow Jones Newswires,"Aphria 2Q Loss Widens, Revenue Rises"
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,0.72,revenues,above-expectations,Aphria Inc.: the company posted better-than-expected revenue for its November quarter,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Ticker: APHA) reported a net loss of 120.6 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria Inc.: the company announced a merger with Canadian peer Tilray (TLRY,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,19:30:32,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript >APHA
APH,2021-01-14,19:30:32,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-apha-ceo-irwin-simon-on-q2-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript >APHA
APH,2021-01-15,14:31:04,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?"
APH,2021-01-15,15:53:54,D06CF0,Aphria Inc.,96,0.41,revenues,up,Aphria on Thursday reported second-quarter net revenue of $160.5 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Tilray and Aphria Shares Continue Gains
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,0.0,price-targets,unchanged,Aphria Inc Price Target Is Maintained at C$20.00,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Is Maintained at C$20.00/Share by Alliance Global Partners
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Hold From Buy by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Hold From Buy by Haywood Securities
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,0.78,price-targets,upgrade,Aphria Inc Price Target Raised to C$14.00/Share From C$12.25 by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$14.00/Share From C$12.25 by Haywood Securities
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.94,analyst-ratings,positive,Aphria Inc Raised to Speculative Buy From Hold by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Raised to Speculative Buy From Hold by Canaccord Genuity
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria Inc Price Target Raised to C$17.50/Share From C$11.00 by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$17.50/Share From C$11.00 by Canaccord Genuity
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria Inc Price Target Raised to C$18.00/Share From C$12.50 by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$18.00/Share From C$12.50 by CIBC World Markets
APH,2021-01-19,12:11:03,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria stock price target raised to C$15.50 from C$9.80 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target raised to C$15.50 from C$9.80 at Stifel Nicolaus
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria stock price target raised to C$15.50 by Stifel,FULL-ARTICLE,MarketWatch,MW Aphria stock price target raised to C$15.50 by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,MarketWatch,MW Aphria stock price target raised to C$15.50 by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria Stock Price Target Raised To C$15.50 By Stifel,FULL-ARTICLE,Dow Jones Newswires,Aphria Stock Price Target Raised To C$15.50 By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,Dow Jones Newswires,Aphria Stock Price Target Raised To C$15.50 By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria stock price target raised by Stifel,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria stock price target raised by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria stock price target raised by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria Stock Price Target Raised By Stifel,FULL-ARTICLE,Dow Jones Newswires,Update: Aphria Stock Price Target Raised By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,Dow Jones Newswires,Update: Aphria Stock Price Target Raised By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,revenues,,Aphria last Thursday reported second-quarter net revenue of $160.5 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,analyst-ratings,neutral,Stifel maintained its Hold rating on Aphria,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria's F2Q21 earnings report,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,17:12:19,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria Inc Price Target Raised to C$15.50/Share From C$9.80 by Stifel Nicolaus,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$15.50/Share From C$9.80 by Stifel Nicolaus
APH,2021-02-03,14:31:03,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Tyme Technologies, Lizhi Inc, Aphria, Sasol Limited, or Artelo Biosciences?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Tyme Technologies, Lizhi Inc, Aphria, Sasol Limited, or Artelo Biosciences?"
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,PR Newswire,Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Canadian News Wire,(CNW) Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-10,14:31:02,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Mesa Air Group, Aphria, Energous Corp, Liminal BioSciences, or Kintara Therapeutics?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Mesa Air Group, Aphria, Energous Corp, Liminal BioSciences, or Kintara Therapeutics?"
APH,2021-02-10,16:22:01,D06CF0,Aphria Inc.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - APHA,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - APHA
APH,2021-02-10,16:22:02,D06CF0,Aphria Inc.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - APHA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - APHA
APH,2021-02-10,16:29:29,D06CF0,Aphria Inc.,100,0.48,equity-actions,resumed,Iiroc Trade Resumption - APHA,PRESS-RELEASE,Canadian News Wire,IIROC Trade Resumption - APHA
APH,2021-02-10,16:29:29,D06CF0,Aphria Inc.,100,0.48,equity-actions,resumed,Iiroc Trade Resumption - APHA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trade Resumption - APHA
APH,2021-02-11,16:05:03,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Aphria, Zomedica, Aurora Cannabis, Iterum Therapeutics, or Globalstar?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Aphria, Zomedica, Aurora Cannabis, Iterum Therapeutics, or Globalstar?"
APH,2021-02-16,13:28:15,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:15,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:22,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:22,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:57:14,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:57:14,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,16:15:46,D06CF0,Aphria Inc.,99,0.34,analyst-ratings,neutral,He has an Overweight rating on Aphria,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Tilray Rises Ahead of Earnings. An Analyst Prefers Aphria. -- Barrons.com
APH,2021-02-16,16:15:46,D06CF0,Aphria Inc.,99,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Tilray Rises Ahead of Earnings. An Analyst Prefers Aphria. -- Barrons.com
APH,2021-02-16,17:00:10,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,17:23:47,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,17:23:47,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,12:12:42,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,12:12:42,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,21:34:01,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:34:24,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:37:57,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:38:49,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:54:23,D06CF0,Aphria Inc.,97,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:54:23,D06CF0,Aphria Inc.,97,0.5,stock-picks,buy,Analyst says to buy Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-18,02:28:35,D06CF0,Aphria Inc.,97,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 8%"
APH,2021-02-18,02:28:35,D06CF0,Aphria Inc.,97,0.5,stock-picks,buy,Analyst says to buy Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 8%"
APH,2021-02-18,16:13:39,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-18,16:13:39,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,15:22:20,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,15:22:20,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,22:29:42,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,22:29:42,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Canadian News Wire,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria to Host Special Meeting of Shareholders,PRESS-RELEASE,Canadian News Wire,Aphria to Host Special Meeting of Shareholders on -2-
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria to Host Special Meeting of Shareholders,PRESS-RELEASE,Canadian News Wire,Aphria to Host Special Meeting of Shareholders on -3-
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,PR Newswire,"(PR) Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-06,11:19:23,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria stock price target raised to C$22.00 from C$15.50 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target raised to C$22.00 from C$15.50 at Stifel Nicolaus
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,-0.64,revenues,downgrade,Aphria revenue estimates lowered by Stifel,FULL-ARTICLE,MarketWatch,MW Aphria revenue estimates lowered by Stifel ahead of Q3 earnings on weak cannabis consumption trends
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria to post revenue of C$163 million,FULL-ARTICLE,MarketWatch,MW Aphria revenue estimates lowered by Stifel ahead of Q3 earnings on weak cannabis consumption trends
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,-0.64,revenues,downgrade,Aphria Revenue Estimates Lowered By Stifel,FULL-ARTICLE,Dow Jones Newswires,Aphria Revenue Estimates Lowered By Stifel Ahead Of Q3 Earnings On Weak Cannabis Consumption Trends -- MarketWatch
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria to post revenue of C$163 million,FULL-ARTICLE,Dow Jones Newswires,Aphria Revenue Estimates Lowered By Stifel Ahead Of Q3 Earnings On Weak Cannabis Consumption Trends -- MarketWatch
APH,2021-04-06,16:23:16,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria Inc Price Target Raised to C$22.00/Share From C$15.50 by Stifel Nicolaus,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$22.00/Share From C$15.50 by Stifel Nicolaus
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:21,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -3-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:02:59,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria Q3 loss C$1.14,NEWS-FLASH,MarketWatch,MW Aphria Q3 loss C$1.14 vs. EPS 2 cents a year ago
APH,2021-04-12,11:04:06,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria Q3 adj. per-share loss C$0.15,NEWS-FLASH,MarketWatch,MW Aphria Q3 adj. per-share loss C$0.15; FactSet loss consensus C$0.05
APH,2021-04-12,11:04:12,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 3Q Loss/Shr C$1.14,NEWS-FLASH,Dow Jones Newswires,Aphria 3Q Loss/Shr C$1.14 >APHA
APH,2021-04-12,11:04:22,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 3Q Rev C$153.6M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 3Q Rev C$153.6M >APHA
APH,2021-04-12,11:04:45,D06CF0,Aphria Inc.,100,-0.27,revenues,below-expectations,Aphria Q3 revenue C$153.6 mln vs. C$144.4 mln a year ago; FactSet consensus C$161.3 mln,NEWS-FLASH,MarketWatch,MW Aphria Q3 revenue C$153.6 mln vs. C$144.4 mln a year ago; FactSet consensus C$161.3 mln
APH,2021-04-12,15:20:49,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria reported a net loss of 361 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Aphria Tanks After Net Loss Widens -- Barrons.com
APH,2021-04-12,18:29:01,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-12,18:29:01,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-apha-ceo-irwin-simon-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-13,10:55:51,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria stock price target cut to C$18 from C$22 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target cut to C$18 from C$22 at Stifel Nicolaus
APH,2021-04-13,11:50:42,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Cut to Hold From Speculative Buy by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Cut to Hold From Speculative Buy by Canaccord Genuity
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Aphria Inc Is Maintained at Outperform by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Is Maintained at Outperform by CIBC World Markets
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$23.00/Share From C$28.00 by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$23.00/Share From C$28.00 by CIBC World Markets
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Hold From Speculative Buy by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Hold From Speculative Buy by Canaccord Genuity
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$20.00/Share From C$26.00 by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$20.00/Share From C$26.00 by Haywood Securities
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Neutral From Buy by PI Financial,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Neutral From Buy by PI Financial
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,0.84,price-targets,upgrade,Aphria Inc Price Target Raised to C$16.00/Share From C$11.00 by PI Financial,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$16.00/Share From C$11.00 by PI Financial
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$18.00/Share From C$22.00 by Standpoint Research,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$18.00/Share From C$22.00 by Standpoint Research
APH,2021-04-13,20:18:45,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-13,20:18:45,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-s-apha-ceo-irwin-simon-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-15,11:01:58,D06CF0,Aphria Inc.,100,-0.59,acquisitions-mergers,delayed,Aphria merger adjourned to April 30 from April 16,NEWS-FLASH,MarketWatch,MW Tilray special shareholder meeting to vote on Aphria merger adjourned to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria merger to April 30,FULL-ARTICLE,MarketWatch,MW Tilray moves shareholder meeting to vote on proposed Aphria merger to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with rival Aphria Inc. (APHA.T),FULL-ARTICLE,MarketWatch,MW Tilray moves shareholder meeting to vote on proposed Aphria merger to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria Merger To April 30,FULL-ARTICLE,Dow Jones Newswires,Tilray Moves Shareholder Meeting To Vote On Proposed Aphria Merger To April 30 From April 16 -- MarketWatch
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with rival Aphria Inc. (APHA.T),FULL-ARTICLE,Dow Jones Newswires,Tilray Moves Shareholder Meeting To Vote On Proposed Aphria Merger To April 30 From April 16 -- MarketWatch
APH,2021-04-15,11:06:56,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Aphria Hldrs Approve Proposed Merger With Tilray,NEWS-FLASH,Dow Jones Newswires,Aphria Hldrs Approve Proposed Merger With Tilray >APHA
APH,2021-04-15,11:08:14,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Aphria shareholders overwhelmingly approve proposed merger with Tilray,NEWS-FLASH,MarketWatch,MW Aphria shareholders overwhelmingly approve proposed merger with Tilray
APH,2021-04-16,17:38:21,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,17:54:32,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,18:56:08,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,19:01:49,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-17,12:20:38,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Tilray shareholders approve Aphria merger,FULL-ARTICLE,MarketWatch,"MW Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with Aphria Inc. (APHA.T),FULL-ARTICLE,MarketWatch,"MW Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Tilray Shareholders Approve Aphria Merger,FULL-ARTICLE,Dow Jones Newswires,"Tilray Shareholders Approve Aphria Merger, Creating World's Biggest Cannabis Company By Revenue -- MarketWatch"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with Aphria Inc. (APHA.T),FULL-ARTICLE,Dow Jones Newswires,"Tilray Shareholders Approve Aphria Merger, Creating World's Biggest Cannabis Company By Revenue -- MarketWatch"
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Business Wire,"Tilray & Aphria Announce Closing of Transaction That Creates the ""New"" Tilray -- a Global Cannabis Leader"
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Business Wire,Tilray & Aphria Announce Closing of Transaction -2-
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Tilray & Aphria Announce Closing of Transaction That Creates the ""New"" Tilray -- a Global Cannabis Leader"
APH,2021-05-03,10:00:37,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,NEWS-FLASH,Dow Jones Newswires,"Tilray & Aphria Announce Closing of Transaction That Creates ""New"" Tilray"
APH,2021-05-03,10:13:13,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,After Aphria merger approved,FULL-ARTICLE,MarketWatch,MW Tilray says shares will start trading on Toronto Stock Exchange from May 5 after Aphria merger approved
APH,2021-05-03,10:13:13,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,After Aphria Merger Approved,FULL-ARTICLE,Dow Jones Newswires,Tilray Says Shares Will Start Trading On Toronto Stock Exchange From May 5 After Aphria Merger Approved -- MarketWatch
APH,2021-05-03,17:59:31,D06CF0,Aphria Inc.,100,0.58,acquisitions-mergers,completed,Tilray and Aphria merger closes,FULL-ARTICLE,MarketWatch,MW Tilray and Aphria merger closes and creates world's biggest weed company by revenue
APH,2021-06-04,11:11:56,D06CF0,Aphria Inc.,92,0.58,acquisitions-mergers,completed,Recently closed its merger with Aphria Inc.,FULL-ARTICLE,Dow Jones Newswires,Tilray Rated Overweight At Cantor After Aphria Merger Closes -- MarketWatch
APH,2021-06-04,11:11:56,D06CF0,Aphria Inc.,92,0.58,acquisitions-mergers,completed,Recently closed its merger with Aphria Inc.,FULL-ARTICLE,MarketWatch,MW Tilray rated overweight at Cantor after Aphria merger closes
APH,2021-08-31,12:00:26,D06CF0,Aphria Inc.,95,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Canadian News Wire,"Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:26,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:27,D06CF0,Aphria Inc.,95,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,PR Newswire,"(PR) Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:27,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:01:52,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,96,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,96,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:15:14,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss/Shr C$0.42,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss/Shr C$0.42 >APHA
APH,2021-01-14,12:15:24,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 2Q Rev C$160.5M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Rev C$160.5M >APHA
APH,2021-01-14,12:19:03,D06CF0,Aphria Inc.,100,0.48,revenues,above-expectations,Aphria Q2 rev. C$160.5 mln vs. C$120.6 mln a year ago; FactSet consensus C$153.9 mln,NEWS-FLASH,MarketWatch,MW Aphria Q2 rev. C$160.5 mln vs. C$120.6 mln a year ago; FactSet consensus C$153.9 mln
APH,2021-01-14,12:20:03,D06CF0,Aphria Inc.,100,-1.0,earnings,down,Aphria Q2 loss C 42 cents vs. loss C 3 cents a year ago,NEWS-FLASH,MarketWatch,MW Aphria Q2 loss C 42 cents vs. loss C 3 cents a year ago
APH,2021-01-14,12:20:47,D06CF0,Aphria Inc.,100,0.82,earnings,above-expectations,Aphria Q2 adj. EPS C 1 cent; FactSet consensus loss 3 cents,NEWS-FLASH,MarketWatch,MW Aphria Q2 adj. EPS C 1 cent; FactSet consensus loss 3 cents
APH,2021-01-14,12:31:00,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 2Q Rev C$160.5M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Rev C$160.5M >APHA
APH,2021-01-14,12:31:07,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss/Shr C$0.42,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss/Shr C$0.42 >APHA
APH,2021-01-14,12:31:14,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss C$120.6M,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss C$120.6M >APHA
APH,2021-01-14,12:31:29,D06CF0,Aphria Inc.,100,-0.67,earnings,down,Aphria 2Q Loss Widens,FULL-ARTICLE,Dow Jones Newswires,"Aphria 2Q Loss Widens, Revenue Rises"
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,0.72,revenues,above-expectations,Aphria Inc.: the company posted better-than-expected revenue for its November quarter,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Ticker: APHA) reported a net loss of 120.6 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria Inc.: the company announced a merger with Canadian peer Tilray (TLRY,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,19:30:32,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript >APHA
APH,2021-01-14,19:30:32,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-apha-ceo-irwin-simon-on-q2-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript >APHA
APH,2021-01-15,14:31:04,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?"
APH,2021-01-15,15:53:54,D06CF0,Aphria Inc.,96,0.41,revenues,up,Aphria on Thursday reported second-quarter net revenue of $160.5 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Tilray and Aphria Shares Continue Gains
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,0.0,price-targets,unchanged,Aphria Inc Price Target Is Maintained at C$20.00,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Is Maintained at C$20.00/Share by Alliance Global Partners
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Hold From Buy by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Hold From Buy by Haywood Securities
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,0.78,price-targets,upgrade,Aphria Inc Price Target Raised to C$14.00/Share From C$12.25 by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$14.00/Share From C$12.25 by Haywood Securities
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.94,analyst-ratings,positive,Aphria Inc Raised to Speculative Buy From Hold by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Raised to Speculative Buy From Hold by Canaccord Genuity
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria Inc Price Target Raised to C$17.50/Share From C$11.00 by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$17.50/Share From C$11.00 by Canaccord Genuity
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria Inc Price Target Raised to C$18.00/Share From C$12.50 by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$18.00/Share From C$12.50 by CIBC World Markets
APH,2021-01-19,12:11:03,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria stock price target raised to C$15.50 from C$9.80 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target raised to C$15.50 from C$9.80 at Stifel Nicolaus
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria stock price target raised to C$15.50 by Stifel,FULL-ARTICLE,MarketWatch,MW Aphria stock price target raised to C$15.50 by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,MarketWatch,MW Aphria stock price target raised to C$15.50 by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria Stock Price Target Raised To C$15.50 By Stifel,FULL-ARTICLE,Dow Jones Newswires,Aphria Stock Price Target Raised To C$15.50 By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,Dow Jones Newswires,Aphria Stock Price Target Raised To C$15.50 By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria stock price target raised by Stifel,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria stock price target raised by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria stock price target raised by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria Stock Price Target Raised By Stifel,FULL-ARTICLE,Dow Jones Newswires,Update: Aphria Stock Price Target Raised By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,Dow Jones Newswires,Update: Aphria Stock Price Target Raised By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,revenues,,Aphria last Thursday reported second-quarter net revenue of $160.5 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,analyst-ratings,neutral,Stifel maintained its Hold rating on Aphria,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria's F2Q21 earnings report,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,17:12:19,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria Inc Price Target Raised to C$15.50/Share From C$9.80 by Stifel Nicolaus,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$15.50/Share From C$9.80 by Stifel Nicolaus
APH,2021-02-03,14:31:03,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Tyme Technologies, Lizhi Inc, Aphria, Sasol Limited, or Artelo Biosciences?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Tyme Technologies, Lizhi Inc, Aphria, Sasol Limited, or Artelo Biosciences?"
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,PR Newswire,Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Canadian News Wire,(CNW) Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-10,14:31:02,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Mesa Air Group, Aphria, Energous Corp, Liminal BioSciences, or Kintara Therapeutics?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Mesa Air Group, Aphria, Energous Corp, Liminal BioSciences, or Kintara Therapeutics?"
APH,2021-02-10,16:22:01,D06CF0,Aphria Inc.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - APHA,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - APHA
APH,2021-02-10,16:22:02,D06CF0,Aphria Inc.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - APHA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - APHA
APH,2021-02-10,16:29:29,D06CF0,Aphria Inc.,100,0.48,equity-actions,resumed,Iiroc Trade Resumption - APHA,PRESS-RELEASE,Canadian News Wire,IIROC Trade Resumption - APHA
APH,2021-02-10,16:29:29,D06CF0,Aphria Inc.,100,0.48,equity-actions,resumed,Iiroc Trade Resumption - APHA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trade Resumption - APHA
APH,2021-02-11,16:05:03,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Aphria, Zomedica, Aurora Cannabis, Iterum Therapeutics, or Globalstar?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Aphria, Zomedica, Aurora Cannabis, Iterum Therapeutics, or Globalstar?"
APH,2021-02-16,13:28:15,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:15,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:22,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:22,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:57:14,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:57:14,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,16:15:46,D06CF0,Aphria Inc.,99,0.34,analyst-ratings,neutral,He has an Overweight rating on Aphria,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Tilray Rises Ahead of Earnings. An Analyst Prefers Aphria. -- Barrons.com
APH,2021-02-16,16:15:46,D06CF0,Aphria Inc.,99,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Tilray Rises Ahead of Earnings. An Analyst Prefers Aphria. -- Barrons.com
APH,2021-02-16,17:00:10,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,17:23:47,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,17:23:47,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,12:12:42,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,12:12:42,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,21:34:01,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:34:24,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:37:57,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:38:49,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:54:23,D06CF0,Aphria Inc.,97,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:54:23,D06CF0,Aphria Inc.,97,0.5,stock-picks,buy,Analyst says to buy Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-18,02:28:35,D06CF0,Aphria Inc.,97,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 8%"
APH,2021-02-18,02:28:35,D06CF0,Aphria Inc.,97,0.5,stock-picks,buy,Analyst says to buy Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 8%"
APH,2021-02-18,16:13:39,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-18,16:13:39,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,15:22:20,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,15:22:20,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,22:29:42,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,22:29:42,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Canadian News Wire,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria to Host Special Meeting of Shareholders,PRESS-RELEASE,Canadian News Wire,Aphria to Host Special Meeting of Shareholders on -2-
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria to Host Special Meeting of Shareholders,PRESS-RELEASE,Canadian News Wire,Aphria to Host Special Meeting of Shareholders on -3-
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,PR Newswire,"(PR) Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-06,11:19:23,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria stock price target raised to C$22.00 from C$15.50 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target raised to C$22.00 from C$15.50 at Stifel Nicolaus
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,-0.64,revenues,downgrade,Aphria revenue estimates lowered by Stifel,FULL-ARTICLE,MarketWatch,MW Aphria revenue estimates lowered by Stifel ahead of Q3 earnings on weak cannabis consumption trends
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria to post revenue of C$163 million,FULL-ARTICLE,MarketWatch,MW Aphria revenue estimates lowered by Stifel ahead of Q3 earnings on weak cannabis consumption trends
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,-0.64,revenues,downgrade,Aphria Revenue Estimates Lowered By Stifel,FULL-ARTICLE,Dow Jones Newswires,Aphria Revenue Estimates Lowered By Stifel Ahead Of Q3 Earnings On Weak Cannabis Consumption Trends -- MarketWatch
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria to post revenue of C$163 million,FULL-ARTICLE,Dow Jones Newswires,Aphria Revenue Estimates Lowered By Stifel Ahead Of Q3 Earnings On Weak Cannabis Consumption Trends -- MarketWatch
APH,2021-04-06,16:23:16,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria Inc Price Target Raised to C$22.00/Share From C$15.50 by Stifel Nicolaus,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$22.00/Share From C$15.50 by Stifel Nicolaus
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:21,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -3-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:02:59,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria Q3 loss C$1.14,NEWS-FLASH,MarketWatch,MW Aphria Q3 loss C$1.14 vs. EPS 2 cents a year ago
APH,2021-04-12,11:04:06,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria Q3 adj. per-share loss C$0.15,NEWS-FLASH,MarketWatch,MW Aphria Q3 adj. per-share loss C$0.15; FactSet loss consensus C$0.05
APH,2021-04-12,11:04:12,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 3Q Loss/Shr C$1.14,NEWS-FLASH,Dow Jones Newswires,Aphria 3Q Loss/Shr C$1.14 >APHA
APH,2021-04-12,11:04:22,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 3Q Rev C$153.6M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 3Q Rev C$153.6M >APHA
APH,2021-04-12,11:04:45,D06CF0,Aphria Inc.,100,-0.27,revenues,below-expectations,Aphria Q3 revenue C$153.6 mln vs. C$144.4 mln a year ago; FactSet consensus C$161.3 mln,NEWS-FLASH,MarketWatch,MW Aphria Q3 revenue C$153.6 mln vs. C$144.4 mln a year ago; FactSet consensus C$161.3 mln
APH,2021-04-12,15:20:49,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria reported a net loss of 361 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Aphria Tanks After Net Loss Widens -- Barrons.com
APH,2021-04-12,18:29:01,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-12,18:29:01,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-apha-ceo-irwin-simon-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-13,10:55:51,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria stock price target cut to C$18 from C$22 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target cut to C$18 from C$22 at Stifel Nicolaus
APH,2021-04-13,11:50:42,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Cut to Hold From Speculative Buy by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Cut to Hold From Speculative Buy by Canaccord Genuity
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Aphria Inc Is Maintained at Outperform by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Is Maintained at Outperform by CIBC World Markets
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$23.00/Share From C$28.00 by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$23.00/Share From C$28.00 by CIBC World Markets
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Hold From Speculative Buy by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Hold From Speculative Buy by Canaccord Genuity
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$20.00/Share From C$26.00 by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$20.00/Share From C$26.00 by Haywood Securities
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Neutral From Buy by PI Financial,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Neutral From Buy by PI Financial
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,0.84,price-targets,upgrade,Aphria Inc Price Target Raised to C$16.00/Share From C$11.00 by PI Financial,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$16.00/Share From C$11.00 by PI Financial
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$18.00/Share From C$22.00 by Standpoint Research,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$18.00/Share From C$22.00 by Standpoint Research
APH,2021-04-13,20:18:45,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-13,20:18:45,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-s-apha-ceo-irwin-simon-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-15,11:01:58,D06CF0,Aphria Inc.,100,-0.59,acquisitions-mergers,delayed,Aphria merger adjourned to April 30 from April 16,NEWS-FLASH,MarketWatch,MW Tilray special shareholder meeting to vote on Aphria merger adjourned to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria merger to April 30,FULL-ARTICLE,MarketWatch,MW Tilray moves shareholder meeting to vote on proposed Aphria merger to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with rival Aphria Inc. (APHA.T),FULL-ARTICLE,MarketWatch,MW Tilray moves shareholder meeting to vote on proposed Aphria merger to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria Merger To April 30,FULL-ARTICLE,Dow Jones Newswires,Tilray Moves Shareholder Meeting To Vote On Proposed Aphria Merger To April 30 From April 16 -- MarketWatch
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with rival Aphria Inc. (APHA.T),FULL-ARTICLE,Dow Jones Newswires,Tilray Moves Shareholder Meeting To Vote On Proposed Aphria Merger To April 30 From April 16 -- MarketWatch
APH,2021-04-15,11:06:56,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Aphria Hldrs Approve Proposed Merger With Tilray,NEWS-FLASH,Dow Jones Newswires,Aphria Hldrs Approve Proposed Merger With Tilray >APHA
APH,2021-04-15,11:08:14,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Aphria shareholders overwhelmingly approve proposed merger with Tilray,NEWS-FLASH,MarketWatch,MW Aphria shareholders overwhelmingly approve proposed merger with Tilray
APH,2021-04-16,17:38:21,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,17:54:32,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,18:56:08,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,19:01:49,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-17,12:20:38,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Tilray shareholders approve Aphria merger,FULL-ARTICLE,MarketWatch,"MW Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with Aphria Inc. (APHA.T),FULL-ARTICLE,MarketWatch,"MW Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Tilray Shareholders Approve Aphria Merger,FULL-ARTICLE,Dow Jones Newswires,"Tilray Shareholders Approve Aphria Merger, Creating World's Biggest Cannabis Company By Revenue -- MarketWatch"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with Aphria Inc. (APHA.T),FULL-ARTICLE,Dow Jones Newswires,"Tilray Shareholders Approve Aphria Merger, Creating World's Biggest Cannabis Company By Revenue -- MarketWatch"
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Business Wire,"Tilray & Aphria Announce Closing of Transaction That Creates the ""New"" Tilray -- a Global Cannabis Leader"
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Business Wire,Tilray & Aphria Announce Closing of Transaction -2-
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Tilray & Aphria Announce Closing of Transaction That Creates the ""New"" Tilray -- a Global Cannabis Leader"
APH,2021-05-03,10:00:37,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,NEWS-FLASH,Dow Jones Newswires,"Tilray & Aphria Announce Closing of Transaction That Creates ""New"" Tilray"
APH,2021-05-03,10:13:13,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,After Aphria merger approved,FULL-ARTICLE,MarketWatch,MW Tilray says shares will start trading on Toronto Stock Exchange from May 5 after Aphria merger approved
APH,2021-05-03,10:13:13,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,After Aphria Merger Approved,FULL-ARTICLE,Dow Jones Newswires,Tilray Says Shares Will Start Trading On Toronto Stock Exchange From May 5 After Aphria Merger Approved -- MarketWatch
APH,2021-05-03,17:59:31,D06CF0,Aphria Inc.,100,0.58,acquisitions-mergers,completed,Tilray and Aphria merger closes,FULL-ARTICLE,MarketWatch,MW Tilray and Aphria merger closes and creates world's biggest weed company by revenue
APH,2021-06-04,11:11:56,D06CF0,Aphria Inc.,92,0.58,acquisitions-mergers,completed,Recently closed its merger with Aphria Inc.,FULL-ARTICLE,Dow Jones Newswires,Tilray Rated Overweight At Cantor After Aphria Merger Closes -- MarketWatch
APH,2021-06-04,11:11:56,D06CF0,Aphria Inc.,92,0.58,acquisitions-mergers,completed,Recently closed its merger with Aphria Inc.,FULL-ARTICLE,MarketWatch,MW Tilray rated overweight at Cantor after Aphria merger closes
APH,2021-08-31,12:00:26,D06CF0,Aphria Inc.,95,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Canadian News Wire,"Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:26,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:27,D06CF0,Aphria Inc.,95,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,PR Newswire,"(PR) Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:27,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:01:52,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-06,13:00:18,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021"
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,96,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,96,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Record Second Quarter -4-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.64,earnings,up,Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.48,revenues,up,"Aphria Inc.: Net revenue of $160.5 million in the second quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA of $12.6 Million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Cash Cost Per Gram Decreases for the Fifth Consecutive Quarter to $0.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.51,products-services,,Aphria Inc.: Executed supply agreement with ODI Pharma AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $67.9 million in the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record Second Quarter Fiscal Year 2021 Results
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.48,revenues,up,"Aphria Inc.: Net revenue for the three months ended November 30, 2020 was $160.5 million, an increase of 33%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.41,revenues,up,Aphria Inc.: Second quarter fiscal year 2021 net revenue increased 10%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the second quarter of fiscal year 2021 was $120.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: The adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: ___________________ (2) Adjusted loss per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -2-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.61,earnings,positive,"Aphria Inc.: Gross profit 39,492",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,99,0.0,assets,,"Aphria Inc.: November 30, May 31, 2020 2020 Assets",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -3-
APH,2021-01-14,12:13:58,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Record -4-
APH,2021-01-14,12:15:14,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss/Shr C$0.42,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss/Shr C$0.42 >APHA
APH,2021-01-14,12:15:24,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 2Q Rev C$160.5M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Rev C$160.5M >APHA
APH,2021-01-14,12:19:03,D06CF0,Aphria Inc.,100,0.48,revenues,above-expectations,Aphria Q2 rev. C$160.5 mln vs. C$120.6 mln a year ago; FactSet consensus C$153.9 mln,NEWS-FLASH,MarketWatch,MW Aphria Q2 rev. C$160.5 mln vs. C$120.6 mln a year ago; FactSet consensus C$153.9 mln
APH,2021-01-14,12:20:03,D06CF0,Aphria Inc.,100,-1.0,earnings,down,Aphria Q2 loss C 42 cents vs. loss C 3 cents a year ago,NEWS-FLASH,MarketWatch,MW Aphria Q2 loss C 42 cents vs. loss C 3 cents a year ago
APH,2021-01-14,12:20:47,D06CF0,Aphria Inc.,100,0.82,earnings,above-expectations,Aphria Q2 adj. EPS C 1 cent; FactSet consensus loss 3 cents,NEWS-FLASH,MarketWatch,MW Aphria Q2 adj. EPS C 1 cent; FactSet consensus loss 3 cents
APH,2021-01-14,12:31:00,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 2Q Rev C$160.5M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Rev C$160.5M >APHA
APH,2021-01-14,12:31:07,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss/Shr C$0.42,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss/Shr C$0.42 >APHA
APH,2021-01-14,12:31:14,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 2Q Loss C$120.6M,NEWS-FLASH,Dow Jones Newswires,Aphria 2Q Loss C$120.6M >APHA
APH,2021-01-14,12:31:29,D06CF0,Aphria Inc.,100,-0.67,earnings,down,Aphria 2Q Loss Widens,FULL-ARTICLE,Dow Jones Newswires,"Aphria 2Q Loss Widens, Revenue Rises"
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,0.72,revenues,above-expectations,Aphria Inc.: the company posted better-than-expected revenue for its November quarter,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Ticker: APHA) reported a net loss of 120.6 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,15:25:54,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria Inc.: the company announced a merger with Canadian peer Tilray (TLRY,FULL-ARTICLE,Dow Jones Newswires,Aphria Shares Are Rallying After Quarterly Sales Beat Wall Street Forecasts -- Barrons.com
APH,2021-01-14,19:30:32,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript >APHA
APH,2021-01-14,19:30:32,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-apha-ceo-irwin-simon-on-q2-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q2 2021 Results -- Earnings Call Transcript >APHA
APH,2021-01-15,14:31:04,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?"
APH,2021-01-15,15:53:54,D06CF0,Aphria Inc.,96,0.41,revenues,up,Aphria on Thursday reported second-quarter net revenue of $160.5 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Tilray and Aphria Shares Continue Gains
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,0.0,price-targets,unchanged,Aphria Inc Price Target Is Maintained at C$20.00,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Is Maintained at C$20.00/Share by Alliance Global Partners
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Hold From Buy by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Hold From Buy by Haywood Securities
APH,2021-01-15,18:03:23,D06CF0,Aphria Inc.,100,0.78,price-targets,upgrade,Aphria Inc Price Target Raised to C$14.00/Share From C$12.25 by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$14.00/Share From C$12.25 by Haywood Securities
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.94,analyst-ratings,positive,Aphria Inc Raised to Speculative Buy From Hold by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Raised to Speculative Buy From Hold by Canaccord Genuity
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria Inc Price Target Raised to C$17.50/Share From C$11.00 by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$17.50/Share From C$11.00 by Canaccord Genuity
APH,2021-01-15,18:03:24,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria Inc Price Target Raised to C$18.00/Share From C$12.50 by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$18.00/Share From C$12.50 by CIBC World Markets
APH,2021-01-19,12:11:03,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria stock price target raised to C$15.50 from C$9.80 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target raised to C$15.50 from C$9.80 at Stifel Nicolaus
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria stock price target raised to C$15.50 by Stifel,FULL-ARTICLE,MarketWatch,MW Aphria stock price target raised to C$15.50 by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,MarketWatch,MW Aphria stock price target raised to C$15.50 by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria Stock Price Target Raised To C$15.50 By Stifel,FULL-ARTICLE,Dow Jones Newswires,Aphria Stock Price Target Raised To C$15.50 By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:22:23,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,Dow Jones Newswires,Aphria Stock Price Target Raised To C$15.50 By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria stock price target raised by Stifel,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria stock price target raised by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria stock price target raised by Stifel but analysts caution on stretched valuation
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.54,price-targets,upgrade,Aphria Stock Price Target Raised By Stifel,FULL-ARTICLE,Dow Jones Newswires,Update: Aphria Stock Price Target Raised By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,12:51:58,D06CF0,Aphria Inc.,100,0.7,earnings,above-expectations,Aphria's earnings beat Stifel's estimates,FULL-ARTICLE,Dow Jones Newswires,Update: Aphria Stock Price Target Raised By Stifel But Analysts Caution On Stretched Valuation -- MarketWatch
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,revenues,,Aphria last Thursday reported second-quarter net revenue of $160.5 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,analyst-ratings,neutral,Stifel maintained its Hold rating on Aphria,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,16:22:29,D06CF0,Aphria Inc.,99,0.0,earnings,,Aphria's F2Q21 earnings report,FULL-ARTICLE,Dow Jones Newswires,Tilray Shares Down; Stock Up Last Week After Aphria Results
APH,2021-01-19,17:12:19,D06CF0,Aphria Inc.,100,0.86,price-targets,upgrade,Aphria Inc Price Target Raised to C$15.50/Share From C$9.80 by Stifel Nicolaus,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$15.50/Share From C$9.80 by Stifel Nicolaus
APH,2021-02-03,14:31:03,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Tyme Technologies, Lizhi Inc, Aphria, Sasol Limited, or Artelo Biosciences?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Tyme Technologies, Lizhi Inc, Aphria, Sasol Limited, or Artelo Biosciences?"
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,PR Newswire,Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Canadian News Wire,(CNW) Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-08,13:00:22,D06CF0,Aphria Inc.,99,0.22,acquisitions-mergers,,Aphria Inc.: we invested in the completion of our,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Strengthens Leadership Position in Germany
APH,2021-02-10,14:31:02,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Mesa Air Group, Aphria, Energous Corp, Liminal BioSciences, or Kintara Therapeutics?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Mesa Air Group, Aphria, Energous Corp, Liminal BioSciences, or Kintara Therapeutics?"
APH,2021-02-10,16:22:01,D06CF0,Aphria Inc.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - APHA,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - APHA
APH,2021-02-10,16:22:02,D06CF0,Aphria Inc.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - APHA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - APHA
APH,2021-02-10,16:29:29,D06CF0,Aphria Inc.,100,0.48,equity-actions,resumed,Iiroc Trade Resumption - APHA,PRESS-RELEASE,Canadian News Wire,IIROC Trade Resumption - APHA
APH,2021-02-10,16:29:29,D06CF0,Aphria Inc.,100,0.48,equity-actions,resumed,Iiroc Trade Resumption - APHA,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trade Resumption - APHA
APH,2021-02-11,16:05:03,D06CF0,Aphria Inc.,100,0.5,stock-picks,buy,"Thinking about buying stock in Aphria, Zomedica, Aurora Cannabis, Iterum Therapeutics, or Globalstar?",PRESS-RELEASE,PR Newswire,"Thinking about buying stock in Aphria, Zomedica, Aurora Cannabis, Iterum Therapeutics, or Globalstar?"
APH,2021-02-16,13:28:15,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:15,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:22,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:28:22,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:57:14,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,13:57:14,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,16:15:46,D06CF0,Aphria Inc.,99,0.34,analyst-ratings,neutral,He has an Overweight rating on Aphria,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Tilray Rises Ahead of Earnings. An Analyst Prefers Aphria. -- Barrons.com
APH,2021-02-16,16:15:46,D06CF0,Aphria Inc.,99,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Tilray Rises Ahead of Earnings. An Analyst Prefers Aphria. -- Barrons.com
APH,2021-02-16,17:00:10,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,17:23:47,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-16,17:23:47,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,12:12:42,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,12:12:42,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-17,21:34:01,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:34:24,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:37:57,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:38:49,D06CF0,Aphria Inc.,93,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:54:23,D06CF0,Aphria Inc.,97,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-17,21:54:23,D06CF0,Aphria Inc.,97,0.5,stock-picks,buy,Analyst says to buy Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%"
APH,2021-02-18,02:28:35,D06CF0,Aphria Inc.,97,0.63,acquisitions-mergers,,Tilray and Aphria (APHA.T)have agreed to merge,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 8%"
APH,2021-02-18,02:28:35,D06CF0,Aphria Inc.,97,0.5,stock-picks,buy,Analyst says to buy Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: Tilray pot sales jump ahead of Aphria merger, stock gains more than 8%"
APH,2021-02-18,16:13:39,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-18,16:13:39,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,15:22:20,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,15:22:20,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,22:29:42,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Merger of Tilray and Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-02-20,22:29:42,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Zuanic reiterated his overweight rating on Aphria,FULL-ARTICLE,MarketWatch,"MW UPDATE: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Canadian News Wire,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria to Host Special Meeting of Shareholders,PRESS-RELEASE,Canadian News Wire,Aphria to Host Special Meeting of Shareholders on -2-
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria to Host Special Meeting of Shareholders,PRESS-RELEASE,Canadian News Wire,Aphria to Host Special Meeting of Shareholders on -3-
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,PR Newswire,"(PR) Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-15,12:00:23,D06CF0,Aphria Inc.,100,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,PR Newswire,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Canadian News Wire,"(CNW) Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,earnings,,"Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-03-31,12:00:13,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria executives will host a conference call to discuss these results at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aphria Inc. to Announce Third Quarter Fiscal 2021 Financial Results on April 12, 2021"
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-05,11:30:03,D06CF0,Aphria Inc.,99,0.62,acquisitions-mergers,,Aphria to effectively acquire Tilray,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders Vote FOR the Proposed Aphria-Tilray Business Combination
APH,2021-04-06,11:19:23,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria stock price target raised to C$22.00 from C$15.50 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target raised to C$22.00 from C$15.50 at Stifel Nicolaus
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,-0.64,revenues,downgrade,Aphria revenue estimates lowered by Stifel,FULL-ARTICLE,MarketWatch,MW Aphria revenue estimates lowered by Stifel ahead of Q3 earnings on weak cannabis consumption trends
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria to post revenue of C$163 million,FULL-ARTICLE,MarketWatch,MW Aphria revenue estimates lowered by Stifel ahead of Q3 earnings on weak cannabis consumption trends
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,-0.64,revenues,downgrade,Aphria Revenue Estimates Lowered By Stifel,FULL-ARTICLE,Dow Jones Newswires,Aphria Revenue Estimates Lowered By Stifel Ahead Of Q3 Earnings On Weak Cannabis Consumption Trends -- MarketWatch
APH,2021-04-06,11:57:45,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria to post revenue of C$163 million,FULL-ARTICLE,Dow Jones Newswires,Aphria Revenue Estimates Lowered By Stifel Ahead Of Q3 Earnings On Weak Cannabis Consumption Trends -- MarketWatch
APH,2021-04-06,16:23:16,D06CF0,Aphria Inc.,100,0.82,price-targets,upgrade,Aphria Inc Price Target Raised to C$22.00/Share From C$15.50 by Stifel Nicolaus,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$22.00/Share From C$15.50 by Stifel Nicolaus
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-09,11:30:21,D06CF0,Aphria Inc.,99,0.0,investor-relations,,"Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Reminds Shareholders to Vote to Approve Proposed Aphria-Tilray Business Combination
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Canadian News Wire,Aphria Inc. Announces Third Quarter Fiscal Year -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,(PR) Aphria Inc. Announces Third Quarter Fiscal -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -3-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,97,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,equity-actions,,Aphria Inc.: Closed a USD $120 million financing,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA2 increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria Inc.: Net cannabis revenue of $51.7 million in the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.44,revenues,up,"Aphria Inc.: Net revenue of $153.6 million in the third quarter, an increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,0.41,revenues,up,"Aphria Inc.: Net revenue for the three months ended February 28, 2021 was $153.6 million, an increase of 6.4%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.24,revenues,down,Aphria Inc.: Third quarter fiscal year 2021 net revenue decreased 4.3%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,100,-0.51,products-services,decrease,Aphria Inc.: the Company experienced what it believes is a transitory reduction in demand,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third Quarter Fiscal Year 2021 Results
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,positive,Aphria Inc.: Adjusted cannabis gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,equity-actions,,Aphria Inc.: Operating expenses in the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria Inc.: Net loss for the third quarter of fiscal year 2021 was $361.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.61,earnings,up,Aphria Inc.: Adjusted EBITDA increased to $12.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.58,earnings,positive,Aphria Inc.: Adjusted EBITDA from cannabis business for the third quarter was $7.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,-0.62,earnings,negative,Aphria Inc.: Adjusted EBITDA loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria will host a conference call to discuss these results today at 9:00 am,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,investor-relations,,Aphria Inc.: Special Shareholders Meeting,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -2-
APH,2021-04-12,11:00:04,D06CF0,Aphria Inc.,99,0.0,revenues,,"Aphria Inc.: Net revenue $ 153,638 $ 144,424 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -3-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.61,earnings,positive,"Aphria Inc.: Gross profit 31,689",PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,-0.63,earnings,negative,Aphria Inc.: Operating loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Loss) income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:00:05,D06CF0,Aphria Inc.,95,0.0,earnings,,Aphria Inc.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Aphria Inc. Announces Third -4-
APH,2021-04-12,11:02:59,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria Q3 loss C$1.14,NEWS-FLASH,MarketWatch,MW Aphria Q3 loss C$1.14 vs. EPS 2 cents a year ago
APH,2021-04-12,11:04:06,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria Q3 adj. per-share loss C$0.15,NEWS-FLASH,MarketWatch,MW Aphria Q3 adj. per-share loss C$0.15; FactSet loss consensus C$0.05
APH,2021-04-12,11:04:12,D06CF0,Aphria Inc.,100,-0.65,earnings,negative,Aphria 3Q Loss/Shr C$1.14,NEWS-FLASH,Dow Jones Newswires,Aphria 3Q Loss/Shr C$1.14 >APHA
APH,2021-04-12,11:04:22,D06CF0,Aphria Inc.,100,0.0,revenues,,Aphria 3Q Rev C$153.6M >APHA,NEWS-FLASH,Dow Jones Newswires,Aphria 3Q Rev C$153.6M >APHA
APH,2021-04-12,11:04:45,D06CF0,Aphria Inc.,100,-0.27,revenues,below-expectations,Aphria Q3 revenue C$153.6 mln vs. C$144.4 mln a year ago; FactSet consensus C$161.3 mln,NEWS-FLASH,MarketWatch,MW Aphria Q3 revenue C$153.6 mln vs. C$144.4 mln a year ago; FactSet consensus C$161.3 mln
APH,2021-04-12,15:20:49,D06CF0,Aphria Inc.,99,-0.65,earnings,negative,Aphria reported a net loss of 361 million Canadian dollars,FULL-ARTICLE,Dow Jones Newswires,Marijuana Stock Aphria Tanks After Net Loss Widens -- Barrons.com
APH,2021-04-12,18:29:01,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-12,18:29:01,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-apha-ceo-irwin-simon-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc. CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-13,10:55:51,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria stock price target cut to C$18 from C$22 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Aphria stock price target cut to C$18 from C$22 at Stifel Nicolaus
APH,2021-04-13,11:50:42,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Cut to Hold From Speculative Buy by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Cut to Hold From Speculative Buy by Canaccord Genuity
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,0.34,analyst-ratings,neutral,Aphria Inc Is Maintained at Outperform by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Is Maintained at Outperform by CIBC World Markets
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$23.00/Share From C$28.00 by CIBC World Markets,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$23.00/Share From C$28.00 by CIBC World Markets
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Hold From Speculative Buy by Canaccord Genuity,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Hold From Speculative Buy by Canaccord Genuity
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$20.00/Share From C$26.00 by Haywood Securities,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$20.00/Share From C$26.00 by Haywood Securities
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.58,analyst-ratings,negative,Aphria Inc Cut to Neutral From Buy by PI Financial,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Cut to Neutral From Buy by PI Financial
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,0.84,price-targets,upgrade,Aphria Inc Price Target Raised to C$16.00/Share From C$11.00 by PI Financial,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Raised to C$16.00/Share From C$11.00 by PI Financial
APH,2021-04-13,16:04:07,D06CF0,Aphria Inc.,100,-0.82,price-targets,downgrade,Aphria Inc Price Target Cut to C$18.00/Share From C$22.00 by Standpoint Research,NEWS-FLASH,Dow Jones Newswires,Aphria Inc Price Target Cut to C$18.00/Share From C$22.00 by Standpoint Research
APH,2021-04-13,20:18:45,D06CF0,Aphria Inc.,100,0.0,investor-relations,,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-13,20:18:45,D06CF0,Aphria Inc.,100,0.0,earnings,,Aphria-inc-s-apha-ceo-irwin-simon-on-q3-2021-results-earnings,NEWS-FLASH,Dow Jones Newswires,Aphria Inc.'s CEO Irwin Simon on Q3 2021 Results -- Earnings Call Transcript >APHA
APH,2021-04-15,11:01:58,D06CF0,Aphria Inc.,100,-0.59,acquisitions-mergers,delayed,Aphria merger adjourned to April 30 from April 16,NEWS-FLASH,MarketWatch,MW Tilray special shareholder meeting to vote on Aphria merger adjourned to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria merger to April 30,FULL-ARTICLE,MarketWatch,MW Tilray moves shareholder meeting to vote on proposed Aphria merger to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with rival Aphria Inc. (APHA.T),FULL-ARTICLE,MarketWatch,MW Tilray moves shareholder meeting to vote on proposed Aphria merger to April 30 from April 16
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.63,acquisitions-mergers,,Aphria Merger To April 30,FULL-ARTICLE,Dow Jones Newswires,Tilray Moves Shareholder Meeting To Vote On Proposed Aphria Merger To April 30 From April 16 -- MarketWatch
APH,2021-04-15,11:05:30,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with rival Aphria Inc. (APHA.T),FULL-ARTICLE,Dow Jones Newswires,Tilray Moves Shareholder Meeting To Vote On Proposed Aphria Merger To April 30 From April 16 -- MarketWatch
APH,2021-04-15,11:06:56,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Aphria Hldrs Approve Proposed Merger With Tilray,NEWS-FLASH,Dow Jones Newswires,Aphria Hldrs Approve Proposed Merger With Tilray >APHA
APH,2021-04-15,11:08:14,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Aphria shareholders overwhelmingly approve proposed merger with Tilray,NEWS-FLASH,MarketWatch,MW Aphria shareholders overwhelmingly approve proposed merger with Tilray
APH,2021-04-16,17:38:21,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,17:54:32,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,18:56:08,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-16,19:01:49,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-04-17,12:20:38,D06CF0,Aphria Inc.,99,0.95,analyst-ratings,positive,Cantor rates Aphria as overweight,FULL-ARTICLE,MarketWatch,MW UPDATE: Aphria and Tilray cannabis merger moves a step closer to approval
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Tilray shareholders approve Aphria merger,FULL-ARTICLE,MarketWatch,"MW Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with Aphria Inc. (APHA.T),FULL-ARTICLE,MarketWatch,"MW Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,Tilray Shareholders Approve Aphria Merger,FULL-ARTICLE,Dow Jones Newswires,"Tilray Shareholders Approve Aphria Merger, Creating World's Biggest Cannabis Company By Revenue -- MarketWatch"
APH,2021-05-02,14:36:50,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Canadian cannabis company's proposed merger with Aphria Inc. (APHA.T),FULL-ARTICLE,Dow Jones Newswires,"Tilray Shareholders Approve Aphria Merger, Creating World's Biggest Cannabis Company By Revenue -- MarketWatch"
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Business Wire,"Tilray & Aphria Announce Closing of Transaction That Creates the ""New"" Tilray -- a Global Cannabis Leader"
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Business Wire,Tilray & Aphria Announce Closing of Transaction -2-
APH,2021-05-03,10:00:01,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Tilray & Aphria Announce Closing of Transaction That Creates the ""New"" Tilray -- a Global Cannabis Leader"
APH,2021-05-03,10:00:37,D06CF0,Aphria Inc.,100,0.39,products-services,,Tilray & Aphria Announce Closing of Transaction,NEWS-FLASH,Dow Jones Newswires,"Tilray & Aphria Announce Closing of Transaction That Creates ""New"" Tilray"
APH,2021-05-03,10:13:13,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,After Aphria merger approved,FULL-ARTICLE,MarketWatch,MW Tilray says shares will start trading on Toronto Stock Exchange from May 5 after Aphria merger approved
APH,2021-05-03,10:13:13,D06CF0,Aphria Inc.,100,0.59,acquisitions-mergers,approved,After Aphria Merger Approved,FULL-ARTICLE,Dow Jones Newswires,Tilray Says Shares Will Start Trading On Toronto Stock Exchange From May 5 After Aphria Merger Approved -- MarketWatch
APH,2021-05-03,17:59:31,D06CF0,Aphria Inc.,100,0.58,acquisitions-mergers,completed,Tilray and Aphria merger closes,FULL-ARTICLE,MarketWatch,MW Tilray and Aphria merger closes and creates world's biggest weed company by revenue
APH,2021-06-04,11:11:56,D06CF0,Aphria Inc.,92,0.58,acquisitions-mergers,completed,Recently closed its merger with Aphria Inc.,FULL-ARTICLE,Dow Jones Newswires,Tilray Rated Overweight At Cantor After Aphria Merger Closes -- MarketWatch
APH,2021-06-04,11:11:56,D06CF0,Aphria Inc.,92,0.58,acquisitions-mergers,completed,Recently closed its merger with Aphria Inc.,FULL-ARTICLE,MarketWatch,MW Tilray rated overweight at Cantor after Aphria merger closes
APH,2021-08-31,12:00:26,D06CF0,Aphria Inc.,95,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Canadian News Wire,"Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:26,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:27,D06CF0,Aphria Inc.,95,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,PR Newswire,"(PR) Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:00:27,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2021-08-31,12:01:52,D06CF0,Aphria Inc.,96,0.65,acquisitions-mergers,,"Aphria""), which was acquired by Tilray, Inc. (NASDAQ: TLRY)",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original ""Shark"" from the NBC hit TV series ""Shark Tank"" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria"
APH,2022-01-07,11:12:31,BB07E4,Amphenol Corp.,100,-0.5,analyst-ratings,negative,Amphenol Cut to Market Perform From Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,Amphenol Cut to Market Perform From Outperform by Cowen & Co.
APH,2022-01-07,11:12:31,BB07E4,Amphenol Corp.,100,0.0,price-targets,set,Amphenol Price Target Announced at $80.00/Share by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Announced at $80.00/Share by Cowen & Co.
APH,2022-01-10,15:29:24,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Goldman Sachs
APH,2022-01-10,15:29:24,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $92.00/Share From $82.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $92.00/Share From $82.00 by Goldman Sachs
APH,2022-01-26,13:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 4Q Sales $3.03B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Sales $3.03B >APH
APH,2022-01-26,13:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,4Q EPS 74c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q EPS 74c >APH
APH,2022-01-26,13:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Adj EPS 70c,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Adj EPS 70c >APH
APH,2022-01-26,13:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Net $465M,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Net $465M >APH
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.44,revenues,up,"Amphenol Corp.: Record sales of $3.027 billion, up 25%",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP diluted EPS of $0.72,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.70,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Completed seven acquisitions,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,"Amphenol Corp.: During the fourth quarter, the Company purchased 2.1 million shares of its common stock for $171 million",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: the Company will report the financial results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2022 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.690 billion to $2.750 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST) Wednesday,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST) Wednesday,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -2-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $3,026.8 $2,426.0",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -2-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 941.2,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -2-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: Dividends,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2020",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2020",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $ 14,678.4 $ 12,327.3",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -4-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -4-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -4-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -5-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: NET SALES ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -5-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -5-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -6-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -6-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -7-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -7-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter and Full Year 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.44,revenues,up,"Amphenol Corp.: Record sales of $3.027 billion, up 25%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP diluted EPS of $0.72,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.70,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Completed seven acquisitions,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,"Amphenol Corp.: During the fourth quarter, the Company purchased 2.1 million shares of its common stock for $171 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: the Company will report the financial results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2022 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.690 billion to $2.750 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST) Wednesday,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST) Wednesday,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2021 Results
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -2-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $3,026.8 $2,426.0",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -2-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 941.2,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -2-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: Dividends,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $ 14,678.4 $ 12,327.3",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -4-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -4-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -4-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -5-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: NET SALES ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -5-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -5-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -6-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -6-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -7-
APH,2022-01-26,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -7-
APH,2022-01-26,13:04:29,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 1Q Rev $2.69B-$2.75B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q Rev $2.69B-$2.75B >APH
APH,2022-01-26,13:04:48,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 1Q Adj EPS 59c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q Adj EPS 59c-Adj EPS 61c >APH
APH,2022-01-26,13:21:36,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Posts Higher 4Q Profit,FULL-ARTICLE,Dow Jones Newswires,"Amphenol Posts Higher 4Q Profit, Sales on Strong Customer Demand"
APH,2022-01-26,13:21:36,BB07E4,Amphenol Corp.,100,0.44,revenues,up,Amphenol Corp. said profit and sales rose in the fourth quarter,FULL-ARTICLE,Dow Jones Newswires,"Amphenol Posts Higher 4Q Profit, Sales on Strong Customer Demand"
APH,2022-01-26,13:40:29,BB07E4,Amphenol Corp.,92,0.0,revenues,,Amphenol Corp. projected first-quarter sales,FULL-ARTICLE,Dow Jones Newswires,Amphenol Projects Better-Than-Expected 1Q Sales
APH,2022-01-27,00:26:35,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corporation CEO Adam Norwitt on Q4 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation CEO Adam Norwitt on Q4 2021 Results -- Earnings Call Transcript >APH
APH,2022-01-27,12:55:39,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Equal-Weight by Morgan Stanley
APH,2022-01-27,12:55:39,BB07E4,Amphenol Corp.,100,0.3,price-targets,upgrade,Amphenol Price Target Raised to $84.00/Share From $83.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $84.00/Share From $83.00 by Morgan Stanley
APH,2022-02-03,13:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2022 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces First Quarter 2022 Dividend
APH,2022-02-03,13:00:04,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2022 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces First Quarter 2022 Dividend
APH,2022-02-05,09:13:05,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corporation CEO Adam Norwitt on Q4 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation CEO Adam Norwitt on Q4 2021 Results -- Earnings Call Transcript >APH
APH,2022-02-22,19:48:21,BB07E4,Amphenol Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amphenol Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amphenol Corporation
APH,2022-02-23,12:55:05,BB07E4,Amphenol Corp.,99,0.0,marketing,,"Amphenol will be exhibiting at MWC in Barcelona, Spain",PRESS-RELEASE,PR Newswire,Amphenol To Exhibit Offerings to Wireless Service Providers
APH,2022-03-29,19:20:00,BB07E4,Amphenol Corp.,99,0.4,products-services,,"Amphenol Industrial, and in 2014, received Amphenol Corporation's Global Excellence Award",PRESS-RELEASE,Business Wire,Mouser Electronics Named Distributor of the Year by Amphenol SV Microwave
APH,2022-04-11,12:40:12,BB07E4,Amphenol Corp.,100,0.56,labor-issues,increase,Amphenol CEO R.A. Norwitt 2021 Total Compensation $13.1M Vs $8M in 2020,NEWS-FLASH,Dow Jones Newswires,Amphenol CEO R.A. Norwitt 2021 Total Compensation $13.1M Vs $8M in 2020
APH,2022-04-25,14:04:58,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Equal-Weight by Morgan Stanley
APH,2022-04-25,14:04:58,BB07E4,Amphenol Corp.,100,-0.64,price-targets,downgrade,Amphenol Price Target Cut to $79.00/Share From $84.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $79.00/Share From $84.00 by Morgan Stanley
APH,2022-04-27,12:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 2Q Sales $2.89B-$2.95B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Sales $2.89B-$2.95B >APH
APH,2022-04-27,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Adj EPS 67c,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Adj EPS 67c >APH
APH,2022-04-27,12:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 1Q Sales $2.95B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Sales $2.95B >APH
APH,2022-04-27,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,1Q EPS 68c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q EPS 68c >APH
APH,2022-04-27,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Net $425.7M,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Net $425.7M >APH
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2022 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.42,revenues,up,"Amphenol Corp.: Sales of $2.952 billion, up 24%",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP diluted EPS of $0.68, up",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.67, up",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Operating Margin of 20.0%,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2022 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.890 billion to $2.950 billion,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.66 to $0.68,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2022 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -2-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $2,951.9 $2,377.1",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -2-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 926.6,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -2-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -2-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -2-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2022 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -3-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $14,873.6 $ 14,678.4",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -3-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 429.2 $ 331.8,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -3-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -3-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -3-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2022 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -4-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -4-
APH,2022-04-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -4-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2022 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -5-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -5-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2022 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -6-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2022 Results -6-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.42,revenues,up,"Amphenol Corp.: Sales of $2.952 billion, up 24%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP diluted EPS of $0.68, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.67, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Operating Margin of 20.0%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2022 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.890 billion to $2.950 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.66 to $0.68,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2022 Results
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $2,951.9 $2,377.1",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Gross profit 926.6,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,94,0.0,assets,,"Amphenol Corp.: Total Assets $14,873.6 $ 14,678.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,94,0.61,earnings,positive,Amphenol Corp.: Net income $ 429.2 $ 331.8,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,94,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,94,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -4-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -4-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2022-04-27,12:00:04,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -6-
APH,2022-04-27,12:04:09,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 2Q Adj EPS 66c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Adj EPS 66c-Adj EPS 68c >APH
APH,2022-04-27,12:32:35,BB07E4,Amphenol Corp.,100,0.42,revenues,up,Amphenol Reports 24% Gain in 1Q Sales,FULL-ARTICLE,Dow Jones Newswires,Amphenol Reports 24% Gain in 1Q Sales
APH,2022-04-27,12:32:35,BB07E4,Amphenol Corp.,100,0.44,revenues,up,Amphenol Corp. said profit and sales rose in its first quarter,FULL-ARTICLE,Dow Jones Newswires,Amphenol Reports 24% Gain in 1Q Sales
APH,2022-04-27,21:24:40,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corporation CEO Adam Norwitt on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation CEO Adam Norwitt on Q1 2022 Results -- Earnings Call Transcript >APH
APH,2022-04-28,13:45:37,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2022-04-28,13:45:37,BB07E4,Amphenol Corp.,100,-0.8,price-targets,downgrade,Amphenol Price Target Cut to $90.00/Share From $100.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $90.00/Share From $100.00 by Citigroup
APH,2022-05-04,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2022 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces Second Quarter 2022 Dividend
APH,2022-05-04,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2022 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Second Quarter 2022 Dividend
APH,2022-05-13,18:50:07,BB07E4,Amphenol Corp.,100,0.49,partnerships,,Amphenol Partners with Melni Technologies to,PRESS-RELEASE,PR Newswire,Amphenol Partners with Melni Technologies to Create Crimpless Solar Connector
APH,2022-06-07,17:08:37,BB07E4,Amphenol Corp.,100,0.49,partnerships,,Amphenol Partners with Eaxtron USA to,PRESS-RELEASE,PR Newswire,Amphenol Partners with Eaxtron USA to take Leadership through Innovation
APH,2022-06-10,12:08:25,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Equal-Weight by Morgan Stanley
APH,2022-06-10,12:08:25,BB07E4,Amphenol Corp.,100,-0.6,price-targets,downgrade,Amphenol Price Target Cut to $75.00/Share From $79.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $75.00/Share From $79.00 by Morgan Stanley
APH,2022-06-21,19:26:28,BB07E4,Amphenol Corp.,100,0.11,credit-ratings,stable,Moody's Upgrades Amphenol To A3; Outlook Stable,NEWS-FLASH,Dow Jones Newswires,Moody's Upgrades Amphenol To A3; Outlook Stable
APH,2022-07-01,14:06:25,BB07E4,Amphenol Corp.,100,0.06,analyst-ratings,neutral,Amphenol Is Maintained at Market Perform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Market Perform by Cowen & Co.
APH,2022-07-01,14:06:25,BB07E4,Amphenol Corp.,100,-0.76,price-targets,downgrade,Amphenol Price Target Cut to $73.00/Share From $80.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $73.00/Share From $80.00 by Cowen & Co.
APH,2022-07-14,09:20:05,BB07E4,Amphenol Corp.,100,0.94,analyst-ratings,positive,Amphenol Raised to Overweight From Neutral by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Raised to Overweight From Neutral by JP Morgan
APH,2022-07-14,10:29:22,BB07E4,Amphenol Corp.,100,0.94,analyst-ratings,positive,Amphenol upgraded to overweight from neutral at J.P. Morgan,NEWS-FLASH,MarketWatch,MW Amphenol upgraded to overweight from neutral at J.P. Morgan
APH,2022-07-27,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,2Q EPS 76c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q EPS 76c >APH
APH,2022-07-27,12:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 2Q Sales $3.14B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Sales $3.14B >APH
APH,2022-07-27,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Adj EPS 75c,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Adj EPS 75c >APH
APH,2022-07-27,12:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 3Q Sales $3.04B-$3.1B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Sales $3.04B-$3.1B >APH
APH,2022-07-27,12:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 3Q Adj EPS 73c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Adj EPS 73c-Adj EPS 75c >APH
APH,2022-07-27,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Net $472.5M,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Net $472.5M >APH
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2022 Record Results,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $3.137 billion, up 18%",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP diluted EPS of $0.76,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.75,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Operating Margin of 20.7%,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corp.: The Company purchased 2.7 million shares of its common stock for $186 million.,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The Company also paid dividends of $119 million,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2022 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.040 billion to $3.100 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.73 to $0.75,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $3,136.8 $2,653.9",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -2-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,004.2",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -2-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -2-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Net income per common share,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -2-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -3-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2022",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -3-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -3-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,95,0.0,assets,,"Amphenol Corp.: Total Assets $14,986.1 $ 14,678.4",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -3-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,98,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -4-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,98,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -4-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -5-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -6-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -6-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2022 Record -6-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2022 Record Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $3.137 billion, up 18%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP diluted EPS of $0.76,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Operating Margin of 20.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corp.: The Company purchased 2.7 million shares of its common stock for $186 million.,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: The Company also paid dividends of $119 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2022 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.040 billion to $3.100 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.73 to $0.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2022 Record Results
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $3,136.8 $2,653.9",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,004.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Net income per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,95,0.0,assets,,"Amphenol Corp.: Total Assets $14,986.1 $ 14,678.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,98,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -4-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,98,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -4-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -5-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -6-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -6-
APH,2022-07-27,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -6-
APH,2022-07-27,12:02:37,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Announces Acquisition of NPI Solutions >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Announces Acquisition of NPI Solutions >APH
APH,2022-07-27,12:18:20,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Posts Higher 2Q Profit,FULL-ARTICLE,Dow Jones Newswires,"Amphenol Posts Higher 2Q Profit, Sales"
APH,2022-07-27,12:29:56,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Expects Third-Quarter Profit, Sales Growth",FULL-ARTICLE,Dow Jones Newswires,"Amphenol Expects Third-Quarter Profit, Sales Growth Despite Costs, Supply Challenges"
APH,2022-07-27,12:29:56,BB07E4,Amphenol Corp.,100,0.0,revenues,unchanged,Amphenol Corp. forecasts continued growth in sales,FULL-ARTICLE,Dow Jones Newswires,"Amphenol Expects Third-Quarter Profit, Sales Growth Despite Costs, Supply Challenges"
APH,2022-07-27,22:54:58,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp CEO Richard Norwitt on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amphenol Corp CEO Richard Norwitt on Q2 2022 Results -- Earnings Call Transcript >APH
APH,2022-07-28,13:13:45,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2022-07-28,13:13:45,BB07E4,Amphenol Corp.,100,0.64,price-targets,upgrade,Amphenol Price Target Raised to $81.00/Share From $76.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $81.00/Share From $76.00 by Baird
APH,2022-07-28,14:22:05,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Sector Perform by RBC Capital
APH,2022-07-28,14:22:05,BB07E4,Amphenol Corp.,100,0.64,price-targets,upgrade,Amphenol Price Target Raised to $81.00/Share From $76.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $81.00/Share From $76.00 by RBC Capital
APH,2022-08-02,11:52:07,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 20,000 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"VP d'Amico Sells 20,000 Of Amphenol Corp >APH"
APH,2022-08-02,15:50:49,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 20,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 20,000 Of Amphenol Corp >APH"
APH,2022-08-03,18:36:13,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 20,000 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"VP d'Amico Sells 20,000 Of Amphenol Corp >APH"
APH,2022-08-04,12:00:03,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Third Quarter 2022 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces Third Quarter 2022 Dividend
APH,2022-08-04,12:03:50,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Third Quarter 2022 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Third Quarter 2022 Dividend
APH,2022-08-05,12:20:54,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Gavelle Sells 122,000 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"Officer Gavelle Sells 122,000 Of Amphenol Corp >APH"
APH,2022-08-05,21:26:53,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Gavelle Registers 122,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Gavelle Registers 122,000 Of Amphenol Corp >APH"
APH,2022-08-10,13:47:44,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 20,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 20,000 Of Amphenol Corp >APH"
APH,2022-08-23,12:48:18,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2022-08-23,12:48:18,BB07E4,Amphenol Corp.,100,0.6,price-targets,upgrade,Amphenol Price Target Raised to $93.00/Share From $88.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $93.00/Share From $88.00 by UBS
APH,2022-10-05,15:58:23,BB07E4,Amphenol Corp.,100,0.0,insider-trading,,"Vp Walter Gifts 7,000 Of Amphenol Corp >APH",FULL-ARTICLE,Dow Jones Newswires,"VP Walter Gifts 7,000 Of Amphenol Corp >APH"
APH,2022-10-10,13:02:10,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2022-10-10,13:02:10,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $97.00/Share From $86.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $97.00/Share From $86.00 by JP Morgan
APH,2022-10-26,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Adj EPS 80c,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Adj EPS 80c >APH
APH,2022-10-26,12:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 3Q Sales $3.3B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Sales $3.3B >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 4Q Sales $3.09B-$3.15B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Sales $3.09B-$3.15B >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,3Q EPS 80c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q EPS 80c >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Net $496.6M,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Net $496.6M >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 4Q Sales $3.09B-$3.15B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Sales $3.09B-$3.15B >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2022 Results,NEWS-FLASH,Dow Jones Newswires,Amphenol Reports Record Third Quarter 2022 Results And Announces Dividend Increase >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q EPS 72c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q EPS 72c-EPS 74c >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q Adj EPS 73c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Adj EPS 73c-Adj EPS 75c >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY Adj EPS $2.95,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Adj EPS $2.95-Adj EPS $2.97 >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q Adj EPS 73c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Adj EPS 73c-Adj EPS 75c >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q EPS 72c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q EPS 72c-EPS 74c >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY EPS $2.96,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY EPS $2.96-EPS $2.98 >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY Adj EPS $2.95,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Adj EPS $2.95-Adj EPS $2.97 >APH
APH,2022-10-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY EPS $2.96,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY EPS $2.96-EPS $2.98 >APH
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2022 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $3.295 billion, up 17%",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.34,products-services,,Amphenol Corp.: Announces acquisition of Integrated Cable,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.38,dividends,up,Amphenol Corp.: Increases quarterly dividend by 5% to $0.21 per share,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,Amphenol Corp.: the Company purchased 2.4 million shares of its common stock for $170 million and,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2022, we expect sales to be in the range of $12.474 billion to $12.534 billion",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.73 to $0.75,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2022,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -2-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $3,295.2 $2,818.5",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -2-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,060.0",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -2-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -2-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2022,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -3-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2022",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -3-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2022",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -3-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -3-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $ 15,097.9 $ 14,678.4",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -3-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2022,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -4-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -4-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -4-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2022,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -5-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: NET SALES ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -5-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2022,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -6-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -6-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.73 - $0.75,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -6-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.72 - $0.74,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -6-
APH,2022-10-26,12:00:04,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third Quarter 2022,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2022 -7-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $3.295 billion, up 17%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.34,products-services,,Amphenol Corp.: Announces acquisition of Integrated Cable,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.38,dividends,up,Amphenol Corp.: Increases quarterly dividend by 5% to $0.21 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.22,acquisitions-mergers,,Amphenol Corp.: the Company purchased 2.4 million shares of its common stock for $170 million and,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2022, we expect sales to be in the range of $12.474 billion to $12.534 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.73 to $0.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2022 Results and Announces Dividend Increase
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $3,295.2 $2,818.5",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,060.0",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $ 15,097.9 $ 14,678.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: NET SALES ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.73 - $0.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.72 - $0.74,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2022-10-26,12:02:51,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Third,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -7-
APH,2022-10-26,12:06:32,BB07E4,Amphenol Corp.,100,0.38,dividends,up,Amphenol Raises Quarterly Dividend to 21c Vs. 20c,NEWS-FLASH,Dow Jones Newswires,Amphenol Raises Quarterly Dividend to 21c Vs. 20c >APH
APH,2022-10-26,12:07:38,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 2022 Sales $12.47B-$12.53B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2022 Sales $12.47B-$12.53B >APH
APH,2022-11-14,13:08:33,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Walter Sells 82,400 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"Officer Walter Sells 82,400 Of Amphenol Corp >APH"
APH,2022-11-14,13:10:56,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Doherty Sells 127,000 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"Officer Doherty Sells 127,000 Of Amphenol Corp >APH"
APH,2022-11-14,13:14:02,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 40,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 40,000 Of Amphenol Corp >APH"
APH,2022-11-15,17:12:34,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 40,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 40,000 Of Amphenol Corp >APH"
APH,2022-11-15,20:33:51,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Walter Registers 82,400 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Walter Registers 82,400 Of Amphenol Corp >APH"
APH,2022-11-15,20:34:01,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 127,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 127,000 Of Amphenol Corp >APH"
APH,2022-11-22,10:10:54,BB07E4,Amphenol Corp.,100,-0.58,analyst-ratings,negative,Amphenol Cut to Hold From Buy by Jefferies,NEWS-FLASH,Dow Jones Newswires,Amphenol Cut to Hold From Buy by Jefferies
APH,2022-11-22,10:10:54,BB07E4,Amphenol Corp.,100,0.3,price-targets,upgrade,Amphenol Price Target Raised to $88.00/Share From $87.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $88.00/Share From $87.00 by Jefferies
APH,2022-11-23,13:24:52,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Silverman Sells 75,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Silverman Sells 75,000 Of Amphenol Corp >APH"
APH,2022-11-23,17:31:09,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Silverman Registers 75,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Silverman Registers 75,000 Of Amphenol Corp >APH"
APH,2022-12-13,10:29:59,BB07E4,Amphenol Corp.,100,0.95,analyst-ratings,positive,Amphenol Initiated at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Amphenol Initiated at Outperform by Credit Suisse
APH,2022-12-13,10:29:59,BB07E4,Amphenol Corp.,100,0.0,price-targets,set,Amphenol Price Target Announced at $93.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Announced at $93.00/Share by Credit Suisse
APH,2022-01-06,21:06:40,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Rite Aid and Attempt to Acquire Aphria,NEWS-FLASH,Dow Jones Newswires,"SEC: Three Charged With Insider Trading Related to Announcements Involving DSW Inc., Rite Aid and Attempt to Acquire Aphria"
APH,2022-02-08,12:50:05,D06CF0,Aphria Inc.,93,0.65,acquisitions-mergers,,"Tilray acquired Aphria in May, 2021",FULL-ARTICLE,MarketWatch,MW Tilray combines Aphria medical business under new unit
APH,2022-02-08,12:50:05,D06CF0,Aphria Inc.,93,0.65,acquisitions-mergers,,"Tilray acquired Aphria in May, 2021",FULL-ARTICLE,Dow Jones Newswires,Tilray Combines Aphria Medical Business Under New Unit -- MarketWatch
APH,2022-01-06,21:06:40,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Rite Aid and Attempt to Acquire Aphria,NEWS-FLASH,Dow Jones Newswires,"SEC: Three Charged With Insider Trading Related to Announcements Involving DSW Inc., Rite Aid and Attempt to Acquire Aphria"
APH,2022-02-08,12:50:05,D06CF0,Aphria Inc.,93,0.65,acquisitions-mergers,,"Tilray acquired Aphria in May, 2021",FULL-ARTICLE,MarketWatch,MW Tilray combines Aphria medical business under new unit
APH,2022-02-08,12:50:05,D06CF0,Aphria Inc.,93,0.65,acquisitions-mergers,,"Tilray acquired Aphria in May, 2021",FULL-ARTICLE,Dow Jones Newswires,Tilray Combines Aphria Medical Business Under New Unit -- MarketWatch
APH,2022-01-06,21:06:40,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Rite Aid and Attempt to Acquire Aphria,NEWS-FLASH,Dow Jones Newswires,"SEC: Three Charged With Insider Trading Related to Announcements Involving DSW Inc., Rite Aid and Attempt to Acquire Aphria"
APH,2022-02-08,12:50:05,D06CF0,Aphria Inc.,93,0.65,acquisitions-mergers,,"Tilray acquired Aphria in May, 2021",FULL-ARTICLE,MarketWatch,MW Tilray combines Aphria medical business under new unit
APH,2022-02-08,12:50:05,D06CF0,Aphria Inc.,93,0.65,acquisitions-mergers,,"Tilray acquired Aphria in May, 2021",FULL-ARTICLE,Dow Jones Newswires,Tilray Combines Aphria Medical Business Under New Unit -- MarketWatch
APH,2022-01-06,21:06:40,D06CF0,Aphria Inc.,100,0.57,acquisitions-mergers,interest,Rite Aid and Attempt to Acquire Aphria,NEWS-FLASH,Dow Jones Newswires,"SEC: Three Charged With Insider Trading Related to Announcements Involving DSW Inc., Rite Aid and Attempt to Acquire Aphria"
APH,2022-02-08,12:50:05,D06CF0,Aphria Inc.,93,0.65,acquisitions-mergers,,"Tilray acquired Aphria in May, 2021",FULL-ARTICLE,MarketWatch,MW Tilray combines Aphria medical business under new unit
APH,2022-02-08,12:50:05,D06CF0,Aphria Inc.,93,0.65,acquisitions-mergers,,"Tilray acquired Aphria in May, 2021",FULL-ARTICLE,Dow Jones Newswires,Tilray Combines Aphria Medical Business Under New Unit -- MarketWatch
APH,2023-01-12,07:00:12,A1C370,Alliance Pharma PLC,99,0.53,labor-issues,,Will join Alliance as COO,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Senior Management and Board Update
APH,2023-01-12,10:39:41,A1C370,Alliance Pharma PLC,100,0.49,labor-issues,,Alliance Pharma Seeks New Interim CEO,FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma Seeks New Interim CEO, Names COO"
APH,2023-01-17,07:00:11,A1C370,Alliance Pharma PLC,99,-0.04,revenues,,Alliance Pharma PLC: Total Consumer Healthcare revenues for the Year were GBP125.2m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2023-01-17,07:00:11,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Nizoral(TM) revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2023-01-17,07:00:11,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Underlying profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2023-01-17,09:03:30,A1C370,Alliance Pharma PLC,100,0.0,earnings,unchanged,Alliance Pharma Backs 2022 Guidance,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Backs 2022 Guidance for Profit Slip; Signals Slight Revenue Rise
APH,2023-02-01,07:00:17,A1C370,Alliance Pharma PLC,99,0.47,labor-issues,,"Alliance Pharma PLC: Martin, who will join the Board",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Appointment of NED and SID
APH,2023-02-01,07:00:17,A1C370,Alliance Pharma PLC,99,-0.57,labor-issues,,Alliance Pharma PLC: Martin stepped down as CEO,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Appointment of NED and SID
APH,2023-02-23,13:28:36,A1C370,Alliance Pharma PLC,99,0.0,assets,,"At 30 June 2022, Alliance reported net assets of GBP296.9 million",PRESS-RELEASE,LSE Regulatory News Service (RNS),Logistics Development Group PLC Further Alliance Pharma plc Investment
APH,2023-02-23,18:19:58,A1C370,Alliance Pharma PLC,99,0.0,assets,,"At 30 June 2022, Alliance reported net assets of GBP296.9 million",PRESS-RELEASE,LSE Regulatory News Service (RNS),Logistics Development Group PLC Replacement Further Alliance Pharma plc Investment
APH,2023-03-21,07:00:13,A1C370,Alliance Pharma PLC,99,0.0,assets,,"At 30 June 2022, Alliance reported net assets of GBP296.9 million",PRESS-RELEASE,LSE Regulatory News Service (RNS),Logistics Development Group PLC Further Alliance Pharma plc Investment
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Preliminary Results for the year ended 31 December 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 101.7,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Basic earnings per share 4.28p 0.17p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.65,revenues,up,Alliance Pharma PLC: Revenue growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.72,revenues,up,Alliance Pharma PLC: we expect total revenue growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,-0.04,revenues,,Alliance Pharma PLC: Total Consumer Healthcare revenues for the Year were GBP125.2m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Nizoral revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: we now anticipate 2025 sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.41,revenues,up,Alliance Pharma PLC: Whilst revenues increased 1% in the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,-0.49,equity-actions,up,Alliance Pharma PLC: Finance costs increased by GBP2.0m to GBP5.4m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Profit for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -5-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,-0.66,earnings,down,Alliance Pharma PLC: Reported operating profit decreased by GBP11m to GBP10.6m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,-0.7,earnings,down,Alliance Pharma PLC: Reported profit before tax decreased 71% to GBP5.2m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,-0.67,earnings,down,Alliance Pharma PLC: Reported basic earnings per share decreased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.5,assets,up,Alliance Pharma PLC: Intangible assets increased by GBP7.9m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,dividends,,Alliance Pharma PLC: The final dividend for 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.52,products-services,,Alliance Pharma PLC: we launched the first product from,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.46,equity-actions,,Alliance Pharma PLC: With investment of GBP1m-GBP2m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.53,labor-issues,,Alliance Pharma PLC: Board and executive changes,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 101,683 - 101,683",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Operating expenses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -5-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross Profit 77,603",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.57,equity-actions,listing,Alliance Pharma PLC: The Company is listed on the AIM stock exchange,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Nizoral statutory revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,-0.48,equity-actions,costs,Alliance Pharma PLC: restructuring costs,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,-0.48,equity-actions,costs,Alliance Pharma PLC: Restructuring costs,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.62,earnings,up,Alliance Pharma PLC: Profit before taxation multiplied,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: The taxation charge for the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,dividends,,Alliance Pharma PLC: An interim dividend of 0.592p per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.47,equity-actions,,Alliance Pharma PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Adjusted profitability,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 101,683 - 101,683",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Underlying taxation charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.59,earnings,positive,Alliance Pharma PLC: Underlying profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2023-03-21,07:00:17,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -11-
APH,2023-05-25,06:00:17,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: Sales for the first four months of the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC AGM Statement
APH,2023-05-25,06:00:17,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: our preliminary results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC AGM Statement
APH,2023-05-25,07:48:09,A1C370,Alliance Pharma PLC,100,0.65,revenues,up,Alliance Pharma Four-Month Sales Rose on Year,FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma Four-Month Sales Rose on Year, But Sees Full-Year FX Hit"
APH,2023-05-25,08:03:09,A1C370,Alliance Pharma PLC,100,0.65,revenues,up,Alliance Pharma Four-Month Sales Rose on Year,FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma Four-Month Sales Rose on Year, But Sees Full-Year FX Hit"
APH,2023-05-25,11:44:49,A1C370,Alliance Pharma PLC,99,0.0,investor-relations,,Alliance Pharma PLC: Result of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Result of AGM
APH,2023-05-25,12:11:57,A1C370,Alliance Pharma PLC,92,0.0,dividends,,Alliance Pharma said Thursday that resolutions related to its final dividend,FULL-ARTICLE,Dow Jones Newswires,"Alliance Pharma Dividend, Directors' Re-Election Get Low Support at AGM"
APH,2023-07-18,06:00:11,A1C370,Alliance Pharma PLC,99,-0.06,revenues,,Alliance Pharma PLC: Strong growth in Kelo-Cote in-market sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2023-07-18,06:00:11,A1C370,Alliance Pharma PLC,99,0.65,revenues,up,Alliance Pharma PLC: Nizoral revenues grew,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Half Year Trading Update
APH,2023-07-18,08:21:36,A1C370,Alliance Pharma PLC,100,0.65,revenues,up,Alliance Pharma 1H Revenue Rose,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma 1H Revenue Rose; Expects Further Growth in 2H
APH,2023-07-18,08:21:36,A1C370,Alliance Pharma PLC,100,0.41,revenues,up,Alliance Pharma said Tuesday that first-half revenue rose 1.1%,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma 1H Revenue Rose; Expects Further Growth in 2H
APH,2023-07-19,06:00:13,A1C370,Alliance Pharma PLC,99,0.22,acquisitions-mergers,,"Alliance Pharma PLC: the Company, purchased 50,988 ordinary shares of 1.0p each in the Company (""Ordinary",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Director Dealings
APH,2023-07-20,08:54:37,A1C370,Alliance Pharma PLC,99,0.22,acquisitions-mergers,,"Alliance Pharma PLC: the Company, purchased 40,957 ordinary shares of 1.0p each in the Company (""Ordinary",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Director Dealing
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Results for the six months ended 30 June 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.65,revenues,up,Alliance Pharma PLC: H1 23 revenue growth,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.39,products-services,,Alliance Pharma PLC: we have extended our distribution agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: our FY revenue expectations,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 46.9,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.0,dividends,,Alliance Pharma PLC: Interim dividend per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,-0.24,revenues,down,"Alliance Pharma PLC: Prescription Medicine revenues of GBP22.7m, down 7%",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: our expectations for full year revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.72,revenues,up,Alliance Pharma PLC: We anticipate strong Group sales growth in H2,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.52,products-services,,Alliance Pharma PLC: we launch several new products,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.41,revenues,up,Alliance Pharma PLC: Like-for-like ScarAway sales increased 17% in Q2,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.39,products-services,,Alliance Pharma PLC: we have extended our distribution agreement,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: our full year revenue expectations,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.26,products-services,unchanged,Alliance Pharma PLC: Domestic China demand continues to be strong,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,-0.24,revenues,down,Alliance Pharma PLC: Amberen revenues declined 3%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.65,revenues,up,Alliance Pharma PLC: Nizoral revenues grew,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -2-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.65,revenues,up,Alliance Pharma PLC: Revenues in our larger,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.0,revenues,,Alliance Pharma PLC: We anticipate annual net sales,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.52,products-services,,"Alliance Pharma PLC: 2022, we launched this product in",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -3-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.33,assets,buy,Alliance Pharma PLC: we have purchased carbon credits to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,-0.51,labor-issues,,Cook stepped down as Alliance's Chair,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.72,revenues,up,Alliance Pharma PLC: We anticipate strong growth in H2 as Kelo-Cote revenues,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 46,862 - 46,862",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.0,equity-actions,,Alliance Pharma PLC: Operating expenses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,99,0.0,earnings,,Alliance Pharma PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -4-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,90,0.0,revenues,,Alliance Pharma PLC: Total Revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,90,0.0,revenues,,Alliance Pharma PLC: Nizoral revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,90,0.0,earnings,,Alliance Pharma PLC: Interest income,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,90,-0.48,equity-actions,costs,Alliance Pharma PLC: restructuring costs,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,90,0.59,earnings,positive,Alliance Pharma PLC: Profit before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,90,0.62,earnings,up,Alliance Pharma PLC: Profit before taxation multiplied,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -7-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,91,0.0,dividends,,Alliance Pharma PLC: Interim dividend for the 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,91,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,91,0.0,dividends,,Alliance Pharma PLC: The interim dividend for 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,91,0.0,earnings,,Alliance Pharma PLC: Underlying diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,91,0.0,equity-actions,,Alliance Pharma PLC: Cost At 1 January 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -8-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,95,0.47,equity-actions,,Alliance Pharma PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,95,0.0,equity-actions,,Alliance Pharma PLC: Cost At 1 January 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,95,0.61,earnings,positive,Alliance Pharma PLC: Adjusted profitability,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -9-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,92,0.59,earnings,positive,Alliance Pharma PLC: Underlying profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -10-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,92,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -10-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,92,0.0,equity-actions,,Alliance Pharma PLC: Total taxation charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -10-
APH,2023-09-26,06:00:28,A1C370,Alliance Pharma PLC,92,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 46,862 - 46,862",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Interim Results -10-
APH,2023-11-07,07:00:29,A1C370,Alliance Pharma PLC,100,0.47,labor-issues,,Alliance Pharma PLC Appointment of Non-Executive Directors,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Appointment of Non-Executive Directors
APH,2023-01-12,21:00:00,BB07E4,Amphenol Corp.,100,0.47,labor-issues,,Amphenol Corp.: Prahlad Singh Appointed to Board of Directors,PRESS-RELEASE,Business Wire,Prahlad Singh Appointed to Board of Directors of Amphenol Corporation
APH,2023-01-12,21:00:00,BB07E4,Amphenol Corp.,100,0.49,labor-issues,,Amphenol Corp.: We conducted an exhaustive search for a director,PRESS-RELEASE,Business Wire,Prahlad Singh Appointed to Board of Directors of Amphenol Corporation
APH,2023-01-12,21:00:00,BB07E4,Amphenol Corp.,100,0.47,labor-issues,,Prahlad Singh Appointed to Board of Directors of Amphenol Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Prahlad Singh Appointed to Board of Directors of Amphenol Corporation
APH,2023-01-12,21:00:00,BB07E4,Amphenol Corp.,100,0.49,labor-issues,,Amphenol Corp.: We conducted an exhaustive search for a director,PRESS-RELEASE,Dow Jones Newswires,Press Release: Prahlad Singh Appointed to Board of Directors of Amphenol Corporation
APH,2023-01-23,15:19:49,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2023-01-23,15:19:49,BB07E4,Amphenol Corp.,100,0.66,price-targets,upgrade,Amphenol Price Target Raised to $90.00/Share From $84.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $90.00/Share From $84.00 by Truist Securities
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 1Q Sales $2.84B-$2.9B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q Sales $2.84B-$2.9B >APH
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 1Q Adj EPS 65c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q Adj EPS 65c-Adj EPS 67c >APH
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Adj EPS 78c,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Adj EPS 78c >APH
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 1Q EPS 64c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q EPS 64c-EPS 66c >APH
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,4Q EPS 82c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q EPS 82c >APH
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Fourth Quarter and Full Year 2022 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Fourth Quarter and Full Year 2022 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $12.623 billion, up 16%",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.82, up",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.78, up",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP Diluted EPS of $3.06,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $3.00,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,"Amphenol Corp.: During the fourth quarter, the Company purchased 2.3 million shares of its common stock for $170 million",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.39,products-services,,Amphenol Corp.: we signed an agreement to,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2023 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.840 billion to $2.900 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.65 to $0.67,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $3,239.2 $3,026.8",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -2-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,037.5",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -2-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -2-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2022",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,dividends,,Amphenol Corp.: Dividends declared per common share,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2022",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2021",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,assets,,"Amphenol Corp.: Total Assets $ 15,326.2 $ 14,678.4",PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -3-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -4-
APH,2023-01-25,13:00:00,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -4-
APH,2023-01-25,13:00:01,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: NET SALES,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -5-
APH,2023-01-25,13:00:01,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -6-
APH,2023-01-25,13:00:01,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -6-
APH,2023-01-25,13:00:01,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.65 - $0.67,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -6-
APH,2023-01-25,13:00:01,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.64 - $0.66,PRESS-RELEASE,Business Wire,Amphenol Reports Fourth Quarter and Full Year -6-
APH,2023-01-25,13:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 4Q Sales $3.24B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Sales $3.24B >APH
APH,2023-01-25,13:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Net $507.5M,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Net $507.5M >APH
APH,2023-01-25,13:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 4Q Sales $3.24B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Sales $3.24B >APH
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Fourth Quarter and Full Year 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Fourth Quarter and Full Year 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Record sales of $12.623 billion, up 16%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.82, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.78, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record GAAP Diluted EPS of $3.06,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $3.00,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,"Amphenol Corp.: During the fourth quarter, the Company purchased 2.3 million shares of its common stock for $170 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.39,products-services,,Amphenol Corp.: we signed an agreement to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2023 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.840 billion to $2.900 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.65 to $0.67,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter and Full Year 2022 Results
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $3,239.2 $3,026.8",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -2-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,037.5",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -2-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -2-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,dividends,,Amphenol Corp.: Dividends declared per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,assets,,"Amphenol Corp.: Total Assets $ 15,326.2 $ 14,678.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -3-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -4-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -4-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: NET SALES,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -5-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -6-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -6-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.65 - $0.67,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -6-
APH,2023-01-25,13:00:50,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.64 - $0.66,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Fourth Quarter -6-
APH,2023-01-25,13:27:14,BB07E4,Amphenol Corp.,100,-0.75,revenues,down,"Amphenol Expects Sales, Earnings to Drop in 1Q",FULL-ARTICLE,Dow Jones Newswires,"Amphenol Expects Sales, Earnings to Drop in 1Q"
APH,2023-02-03,13:00:01,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2023 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces First Quarter 2023 Dividend
APH,2023-02-03,13:00:10,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2023 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces First Quarter 2023 Dividend
APH,2023-02-06,19:46:00,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 25,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 25,000 Of Amphenol Corp >APH"
APH,2023-02-06,19:48:31,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 650,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 650,000 Of Amphenol Corp >APH"
APH,2023-02-07,13:48:22,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Ceo Norwitt Sells 650,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Norwitt Sells 650,000 Of Amphenol Corp >APH"
APH,2023-02-07,13:50:00,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 25,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 25,000 Of Amphenol Corp >APH"
APH,2023-02-10,19:03:23,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Gavelle Sells 129,800 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Gavelle Sells 129,800 Of Amphenol Corp >APH"
APH,2023-02-10,19:30:41,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Gavelle Registers 129,800 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Gavelle Registers 129,800 Of Amphenol Corp >APH"
APH,2023-03-14,14:00:15,BB07E4,Amphenol Corp.,100,0.41,assets,open,"Charles Industries Opens its Second Manufacturing Facility in Nogales, Mexico",PRESS-RELEASE,PR Newswire,"Charles Industries Opens its Second Manufacturing Facility in Nogales, Mexico"
APH,2023-03-27,13:51:57,BB07E4,Amphenol Corp.,100,0.06,credit-ratings,set,S&PGR Rates Amphenol Corp.'s Senior Unsecd Nts Due 2026 'BBB+,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Amphenol Corp.'s Senior Unsecd Nts Due 2026 'BBB+'
APH,2023-03-27,13:51:57,BB07E4,Amphenol Corp.,100,0.06,credit-ratings,set,S&PGR Rates Amphenol Corp.'s Senior Unsecd Nts Due 2026 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Amphenol Corp.'s Senior Unsecd Nts Due 2026 'BBB+'
APH,2023-03-28,12:00:03,BB07E4,Amphenol Corp.,100,0.0,credit,,"Amphenol Corporation Announces Pricing of $350,000,000 of Senior Notes",PRESS-RELEASE,Business Wire,"Amphenol Corporation Announces Pricing of $350,000,000 of Senior Notes"
APH,2023-03-28,12:01:03,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corp Announces Pricing of $350 Million of Senior Notes,NEWS-FLASH,Dow Jones Newswires,Amphenol Corp Announces Pricing of $350 Million of Senior Notes
APH,2023-03-28,12:01:30,BB07E4,Amphenol Corp.,100,0.0,credit,,"Amphenol Corporation Announces Pricing of $350,000,000 of Senior Notes",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Amphenol Corporation Announces Pricing of $350,000,000 of Senior Notes"
APH,2023-04-04,14:00:34,BB07E4,Amphenol Corp.,100,0.0,insider-trading,,"Officer Walter Gifts 6,450 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Gifts 6,450 Of Amphenol Corp >APH"
APH,2023-04-26,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,1Q EPS 71c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q EPS 71c >APH
APH,2023-04-26,12:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 1Q Sales $2.97B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Sales $2.97B >APH
APH,2023-04-26,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Adj EPS 69c,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Adj EPS 69c >APH
APH,2023-04-26,12:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 2Q Adj EPS 66c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Adj EPS 66c-Adj EPS 68c >APH
APH,2023-04-26,12:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 2Q Sales $2.89B-$2.95B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Sales $2.89B-$2.95B >APH
APH,2023-04-26,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Net $439.2M,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Net $439.2M >APH
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Sales of $2.974 billion, up 1%",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.71, up",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.69, up",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,"Amphenol Corp.: During the first quarter, the Company purchased 2.1 million shares of its common stock for $167 million",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2023 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.890 billion to $2.950 billion,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.66 to $0.68,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -2-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $ 2,974.0 $2,951.9",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -2-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 943.4,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -2-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -2-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -2-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended March 31, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -2-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -3-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $15,381.5 $ 15,326.2",PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -3-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 442.7 $ 429.2,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -3-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -3-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -3-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -4-
APH,2023-04-26,12:00:01,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: NET SALES,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -4-
APH,2023-04-26,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -5-
APH,2023-04-26,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -5-
APH,2023-04-26,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports First Quarter 2023 Results -5-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports First Quarter 2023 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,100,0.41,revenues,up,"Amphenol Corp.: Sales of $2.974 billion, up 1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.71, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.69, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,"Amphenol Corp.: During the first quarter, the Company purchased 2.1 million shares of its common stock for $167 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2023 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $2.890 billion to $2.950 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.66 to $0.68,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter 2023 Results
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $ 2,974.0 $2,951.9",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Gross profit 943.4,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended March 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -2-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,94,0.0,assets,,"Amphenol Corp.: Total Assets $15,381.5 $ 15,326.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,94,0.61,earnings,positive,Amphenol Corp.: Net income $ 442.7 $ 429.2,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,94,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,94,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -3-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: NET SALES,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -4-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2023-04-26,12:01:31,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports First Quarter -5-
APH,2023-04-27,11:18:24,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2023-04-27,11:18:24,BB07E4,Amphenol Corp.,100,-0.54,price-targets,downgrade,Amphenol Price Target Cut to $87.00/Share From $91.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $87.00/Share From $91.00 by Baird
APH,2023-05-02,13:40:03,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by TD,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by TD Cowen
APH,2023-05-02,13:40:03,BB07E4,Amphenol Corp.,100,-0.66,price-targets,downgrade,Amphenol Price Target Cut to $70.00/Share From $75.00 by TD,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $70.00/Share From $75.00 by TD Cowen
APH,2023-05-05,12:00:01,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2023 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces Second Quarter 2023 Dividend
APH,2023-05-05,12:00:20,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2023 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Second Quarter 2023 Dividend
APH,2023-05-12,20:33:28,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Gavelle Registers 184,100 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Gavelle Registers 184,100 Of Amphenol Corp >APH"
APH,2023-05-15,15:05:47,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Gavelle Sells 184,100 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"Officer Gavelle Sells 184,100 Of Amphenol Corp >APH"
APH,2023-05-19,08:32:25,BB07E4,Amphenol Corp.,100,-0.58,analyst-ratings,negative,Amphenol Cut to Neutral From Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Amphenol Cut to Neutral From Outperform by Credit Suisse
APH,2023-05-19,08:32:25,BB07E4,Amphenol Corp.,100,-0.82,price-targets,downgrade,Amphenol Price Target Cut to $77.00/Share From $91.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $77.00/Share From $91.00 by Credit Suisse
APH,2023-07-18,15:30:06,BB07E4,Amphenol Corp.,99,0.4,products-services,,Amphenol Corp.: We are honored to receive the Product of the Year award,PRESS-RELEASE,PR Newswire,Waytek Presents New Product of the Year Award to Amphenol Sine Systems for its A Series(TM) Family of Connectors
APH,2023-07-26,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,2Q EPS 74c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q EPS 74c >APH
APH,2023-07-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 3Q Sales $3.04B-$3.1B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Sales $3.04B-$3.1B >APH
APH,2023-07-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 3Q Adj EPS 72c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Adj EPS 72c-Adj EPS 74c >APH
APH,2023-07-26,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Adj EPS 72c,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Adj EPS 72c >APH
APH,2023-07-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 3Q EPS 71c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q EPS 71c-EPS 73c >APH
APH,2023-07-26,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 2Q Sales $3.05B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Sales $3.05B >APH
APH,2023-07-26,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Net $460.5M,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Net $460.5M >APH
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,-0.24,revenues,down,"Amphenol Corp.: Sales of $3.054 billion, down 3%",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: GAAP Diluted EPS of $0.74,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS of $0.72,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2023 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.040 billion to $3.100 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.72 to $0.74,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -2-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $3,053.9 $3,136.8",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -2-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Gross profit 991.7,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -2-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -2-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -2-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -3-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -3-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -3-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $15,237.9 $ 15,326.2",PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -3-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 465.3 $ 476.1 $,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -3-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -4-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -4-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -4-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -5-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -5-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -5-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -6-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.72 - $0.74,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -6-
APH,2023-07-26,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.71 - $0.73,PRESS-RELEASE,Business Wire,Amphenol Reports Second Quarter 2023 Results -6-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Second Quarter 2023 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,100,-0.24,revenues,down,"Amphenol Corp.: Sales of $3.054 billion, down 3%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: GAAP Diluted EPS of $0.74,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS of $0.72,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2023 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $3.040 billion to $3.100 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.72 to $0.74,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter 2023 Results
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: 2023 sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Gross profit 991.7,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -2-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,94,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,94,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,94,0.0,assets,,"Amphenol Corp.: Total Assets $15,237.9 $ 15,326.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,94,0.61,earnings,positive,Amphenol Corp.: Net income $ 465.3 $ 476.1 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -3-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -4-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -4-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -5-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -5-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -5-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.72 - $0.74,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -6-
APH,2023-07-26,12:01:20,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.71 - $0.73,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Second Quarter -6-
APH,2023-07-26,12:38:04,BB07E4,Amphenol Corp.,94,0.72,revenues,above-expectations,Amphenol Corp.'s revenue beat expectations in the second quarter,FULL-ARTICLE,Dow Jones Newswires,Amphenol Revenue Beats With Acquisitions
APH,2023-07-26,12:38:04,BB07E4,Amphenol Corp.,94,-0.04,revenues,,Amphenol's sales fell 3% to $3.054 billion,FULL-ARTICLE,Dow Jones Newswires,Amphenol Revenue Beats With Acquisitions
APH,2023-07-26,12:41:05,BB07E4,Amphenol Corp.,100,-0.27,revenues,down,Amphenol Corp. expects sales to decline 6% to 8% in the third quarter,FULL-ARTICLE,Dow Jones Newswires,Amphenol Expects 6%-8% Sales Decline in 3Q
APH,2023-07-27,19:50:37,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2023-07-27,19:50:37,BB07E4,Amphenol Corp.,100,0.72,price-targets,upgrade,Amphenol Price Target Raised to $101.00/Share From $93.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $101.00/Share From $93.00 by Truist Securities
APH,2023-07-28,20:12:29,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 75,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 75,000 Of Amphenol Corp >APH"
APH,2023-07-28,20:33:41,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Cfo Lampo Registers 300,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CFO Lampo Registers 300,000 Of Amphenol Corp >APH"
APH,2023-07-28,20:42:40,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 650,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 650,000 Of Amphenol Corp >APH"
APH,2023-07-28,21:03:31,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Walter Registers 264,962 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Walter Registers 264,962 Of Amphenol Corp >APH"
APH,2023-07-31,15:36:56,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 75,000 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"VP d'Amico Sells 75,000 Of Amphenol Corp >APH"
APH,2023-07-31,16:53:27,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Cfo Lampo Sells 300,000 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"CFO Lampo Sells 300,000 Of Amphenol Corp >APH"
APH,2023-07-31,19:36:57,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Walter Sells 264,962 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Sells 264,962 Of Amphenol Corp >APH"
APH,2023-08-01,12:45:16,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Ceo Norwitt Sells 650,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Norwitt Sells 650,000 Of Amphenol Corp >APH"
APH,2023-08-03,20:51:14,BB07E4,Amphenol Corp.,100,0.58,products-services,,Amphenol Reaches Agreement With U.S. Government,RNS-SEC8K,Dow Jones Newswires,Amphenol Reaches Agreement With U.S. Government to Settle False Claims Act Investigation
APH,2023-08-03,20:52:06,BB07E4,Amphenol Corp.,100,0.46,legal,,Amphenol to Settle Probe,RNS-SEC8K,Dow Jones Newswires,Amphenol to Settle Probe Involving Allegations Related to 'Stop Shipment' Orders for Certain Military Connector Products
APH,2023-08-04,12:00:01,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Third Quarter 2023 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces Third Quarter 2023 Dividend
APH,2023-08-04,12:00:10,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Third Quarter 2023 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Third Quarter 2023 Dividend
APH,2023-08-07,13:48:26,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2023-08-07,13:48:26,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $103.00/Share From $88.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $103.00/Share From $88.00 by UBS
APH,2023-08-31,20:18:38,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Gavelle Registers 176,186 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Gavelle Registers 176,186 Of Amphenol Corp >APH"
APH,2023-08-31,20:42:28,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 50,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 50,000 Of Amphenol Corp >APH"
APH,2023-08-31,21:31:41,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Doherty Sells 50,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Doherty Sells 50,000 Of Amphenol Corp >APH"
APH,2023-09-01,13:24:46,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Gavelle Sells 176,186 Of Amphenol Corp",FULL-ARTICLE,Dow Jones Newswires,"Officer Gavelle Sells 176,186 Of Amphenol Corp >APH"
APH,2023-09-11,15:38:18,BB07E4,Amphenol Corp.,99,0.41,assets,open,Amphenol Corp.: New solar product facility,PRESS-RELEASE,PR Newswire,Amphenol Industrial Operations to Expand in Q4 2023
APH,2023-09-11,15:38:38,BB07E4,Amphenol Corp.,99,0.41,assets,open,Amphenol Corp.: New solar product facility,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Industrial Operations to Expand in Q4 2023
APH,2023-09-27,14:38:54,BB07E4,Amphenol Corp.,99,0.41,assets,open,Amphenol Corp.: New solar product facility,PRESS-RELEASE,PR Newswire,Amphenol Industrial Operations to Expand in Q4 2023
APH,2023-10-14,00:01:00,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Pctel Announces Definitive Agreement To Be Acquired By Amphenol Corporation,NEWS-FLASH,Dow Jones Newswires,PCTEL Announces Definitive Agreement To Be Acquired By Amphenol Corporation >PCTI
APH,2023-10-14,00:01:00,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Pctel Announces Definitive Agreement to be Acquired by Amphenol Corporation,PRESS-RELEASE,Business Wire,PCTEL Announces Definitive Agreement to be Acquired by Amphenol Corporation
APH,2023-10-14,00:01:00,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Pctel Announces Definitive Agreement to be Acquired by Amphenol Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: PCTEL Announces Definitive Agreement to be Acquired by Amphenol Corporation
APH,2023-10-16,11:39:42,BB07E4,Amphenol Corp.,92,0.62,acquisitions-mergers,,Wireless equipment agreed to be bought by network-equipment supplier Amphenol for about $139.7 million,FULL-ARTICLE,Dow Jones Newswires,PCTEL Shares Jump 47% on $140 Million Deal to be Bought by Amphenol
APH,2023-10-16,11:39:42,BB07E4,Amphenol Corp.,92,0.62,acquisitions-mergers,,Amphenol has agreed to buy PCTEL for $7 a share,FULL-ARTICLE,Dow Jones Newswires,PCTEL Shares Jump 47% on $140 Million Deal to be Bought by Amphenol
APH,2023-10-25,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,3Q EPS 83c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q EPS 83c >APH
APH,2023-10-25,12:00:00,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Adj EPS 78c,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Adj EPS 78c >APH
APH,2023-10-25,12:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 3Q Sales $3.2B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Sales $3.2B >APH
APH,2023-10-25,12:00:00,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 4Q Sales $3.09B-$3.15B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Sales $3.09B-$3.15B >APH
APH,2023-10-25,12:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q Adj EPS 75c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Adj EPS 75c-Adj EPS 77c >APH
APH,2023-10-25,12:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Third Quarter 2023 Results,NEWS-FLASH,Dow Jones Newswires,Amphenol Reports Third Quarter 2023 Results And Announces Dividend Increase >APH
APH,2023-10-25,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q EPS 74c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q EPS 74c-EPS 76c >APH
APH,2023-10-25,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY EPS $3.02,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY EPS $3.02-EPS $3.04 >APH
APH,2023-10-25,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Net $513.9M,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Net $513.9M >APH
APH,2023-10-25,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY Adj EPS $2.94,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Adj EPS $2.94-Adj EPS $2.96 >APH
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Third Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,-0.24,revenues,down,"Amphenol Corp.: Sales of $3.199 billion, down 3%",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.83, up",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS of $0.78,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Closed three acquisitions since July,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corp.: and signed an agreement to acquire PCTEL,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.38,dividends,up,Amphenol Corp.: Increased quarterly dividend by 5% to $0.22 per share,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: our July earnings call,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2023, Amphenol expects sales to be in the range of $12.317 billion to $12.377 billion",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.75 to $0.77,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Third Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -2-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $3,199.2 $3,295.2",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -2-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,048.5",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -2-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -2-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -2-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Third Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -3-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -3-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2022",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -3-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -3-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2022",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -3-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $ 15,759.0 $ 15,326.2",PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -3-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 518.3 $ 500.5 $,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -3-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Third Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -4-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -4-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -4-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Third Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -5-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -5-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Third Quarter 2023 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -6-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.75 - $0.77,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -6-
APH,2023-10-25,12:00:03,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.74 - $0.76,PRESS-RELEASE,Business Wire,Amphenol Reports Third Quarter 2023 Results and -6-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Third Quarter 2023 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,-0.24,revenues,down,"Amphenol Corp.: Sales of $3.199 billion, down 3%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.83, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS of $0.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Closed three acquisitions since July,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corp.: and signed an agreement to acquire PCTEL,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.38,dividends,up,Amphenol Corp.: Increased quarterly dividend by 5% to $0.22 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: our July earnings call,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2023, Amphenol expects sales to be in the range of $12.317 billion to $12.377 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.75 to $0.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $3,199.2 $3,295.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -2-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,048.5",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -2-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -2-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -2-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -3-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -3-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -3-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -3-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,95,0.0,assets,,"Amphenol Corp.: Total Assets $ 15,759.0 $ 15,326.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -3-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,95,0.61,earnings,positive,Amphenol Corp.: Net income $ 518.3 $ 500.5 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -3-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -4-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -4-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -5-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -6-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.75 - $0.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -6-
APH,2023-10-25,12:00:50,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.74 - $0.76,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Third Quarter -6-
APH,2023-10-25,12:05:19,BB07E4,Amphenol Corp.,100,0.38,dividends,up,Raises Quarterly Dividend to 22c From 21c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Raises Quarterly Dividend to 22c From 21c >APH
APH,2023-10-25,12:29:24,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol's profit increased in the third quarter,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Profit Rises on Lower Costs, Provisions"
APH,2023-10-25,12:29:24,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: The company posted revenue of $3.2 billion in the quarter,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Profit Rises on Lower Costs, Provisions"
APH,2023-10-25,12:29:24,BB07E4,Amphenol Corp.,100,-0.68,revenues,down,Amphenol's cost of sales declined,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Profit Rises on Lower Costs, Provisions"
APH,2023-10-26,18:11:48,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2023-10-26,18:11:48,BB07E4,Amphenol Corp.,100,-0.52,price-targets,downgrade,Amphenol Price Target Cut to $97.00/Share From $101.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $97.00/Share From $101.00 by Truist Securities
APH,2023-11-07,17:05:37,BB07E4,Amphenol Corp.,100,0.0,insider-trading,,"Officer Walter Gifts 11,797 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Gifts 11,797 Of Amphenol Corp >APH"
APH,2023-11-09,14:15:20,BB07E4,Amphenol Corp.,100,0.52,insider-trading,,"Dir Livingston Buys 11,839 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Livingston Buys 11,839 Of Amphenol Corp >APH"
APH,2023-11-16,21:12:59,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Silverman Registers 75,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Silverman Registers 75,000 Of Amphenol Corp >APH"
APH,2023-11-17,19:45:21,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Silverman Sells 75,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Silverman Sells 75,000 Of Amphenol Corp >APH"
APH,2023-11-20,09:00:10,BB07E4,Amphenol Corp.,99,0.66,products-services,,Amphenol Corp.: Enhanced Product Showcase: streamlined,PRESS-RELEASE,PR Newswire,"Amphenol Ardent Concepts Launches Upgraded Website, Spotlighting Cutting-Edge Connectivity Solutions for Engineers"
APH,2023-12-15,14:01:55,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2023-12-15,14:01:55,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $109.00/Share From $97.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $109.00/Share From $97.00 by Truist Securities
APH,2023-12-15,21:56:01,BB07E4,Amphenol Corp.,98,0.57,acquisitions-mergers,completed,Pctel Announces Closing of its Acquisition by Amphenol Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: PCTEL Announces Closing of its Acquisition by Amphenol Corporation
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.52,revenues,up,"Avricore Health Inc.: In the year ended December 31, 2024 revenue increased by 37%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,revenues,up,"Avricore Health Inc.: In the three months ended December 31, 2024 revenue increased by 5%",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.46,equity-actions,,Avricore Health Inc.: CAD $1.144 billion) investment in,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-05-01,11:30:02,5A06E6,Avricore Health Inc.,99,0.41,assets,open,Avricore Health Inc.: Added new locations,PRESS-RELEASE,GlobeNewswire,"AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track"
APH,2025-06-02,11:20:00,5A06E6,Avricore Health Inc.,99,0.0,revenues,,"Avricore Health Inc.: Total revenue $ 4,785,711 $3,485,147",PRESS-RELEASE,GlobeNewswire,AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
APH,2025-06-05,11:00:01,5A06E6,Avricore Health Inc.,100,0.53,labor-issues,,Avricore Appoints Rodger Seccombe as CEO,PRESS-RELEASE,GlobeNewswire,Avricore Appoints Rodger Seccombe as CEO
APH,2025-01-10,07:29:46,A1C370,Alliance Pharma PLC,99,0.39,products-services,,"Alliance Pharma plc (""Alliance"") have reached an agreement on",PRESS-RELEASE,LSE Regulatory News Service (RNS),Logistics Development Group PLC Alliance Pharma Investment - Update
APH,2025-01-10,07:29:46,A1C370,Alliance Pharma PLC,99,0.58,earnings,positive,"For the year ended 31 December 2023, Alliance reported Adjusted EBITDA of GBP45.0 million",PRESS-RELEASE,LSE Regulatory News Service (RNS),Logistics Development Group PLC Alliance Pharma Investment - Update
APH,2025-01-30,10:09:58,A1C370,Alliance Pharma PLC,100,-0.58,analyst-ratings,negative,Alliance Pharma Cut to Hold From Buy by Berenberg,NEWS-FLASH,Dow Jones Newswires,Alliance Pharma Cut to Hold From Buy by Berenberg
APH,2025-01-30,10:09:58,A1C370,Alliance Pharma PLC,100,-0.8,price-targets,downgrade,Alliance Pharma Target Cut to 62.5p From 70.0p by Berenberg,NEWS-FLASH,Dow Jones Newswires,Alliance Pharma Target Cut to 62.5p From 70.0p by Berenberg
APH,2025-01-31,07:00:12,A1C370,Alliance Pharma PLC,99,-0.28,revenues,,Alliance Pharma PLC: Kelo-Cote franchise revenues grew 6%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2025-01-31,07:00:12,A1C370,Alliance Pharma PLC,99,0.41,revenues,up,Alliance Pharma PLC: Prescription Medicine revenues increased 8%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Full Year Trading Update
APH,2025-01-31,08:14:43,A1C370,Alliance Pharma PLC,100,-0.75,revenues,down,Alliance Pharma Expected Revenue Falls,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Expected Revenue Falls on Consumer Healthcare Decline
APH,2025-01-31,08:14:43,A1C370,Alliance Pharma PLC,100,-0.68,revenues,down,Alliance Pharma said that expected revenue fell,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Expected Revenue Falls on Consumer Healthcare Decline
APH,2025-02-26,14:00:28,A1C370,Alliance Pharma PLC,99,0.57,acquisitions-mergers,completed,Alliance Pharma PLC: Completion of the Acquisition,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Adjournment of Court Meeting -2-
APH,2025-03-10,07:27:10,A1C370,Alliance Pharma PLC,97,0.0,dividends,,Alliance Pharma shareholder receiving 64.75 pence per share,FULL-ARTICLE,Dow Jones Newswires,Alliance Pharma Valued at $468 Million Under Increased Offer From Aegros Bidco
APH,2025-03-20,14:36:06,A1C370,Alliance Pharma PLC,99,0.57,acquisitions-mergers,completed,Alliance Pharma PLC: Completion of the Acquisition,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Satisfaction of Regulatory Conditions
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Preliminary Results for the year ended 31 December 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Gross profit 109.3,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,-0.24,revenues,down,Alliance Pharma PLC: Prescription Medicine revenues of GBP49.6m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.44,credit,reduction,Alliance Pharma PLC: Net debt reduced to GBP60.1m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,-0.4,revenues,down,Alliance Pharma PLC: Nizoral see-through revenues declined 21%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,-0.24,revenues,down,"Alliance Pharma PLC: Total Consumer Healthcare see-through revenues for the Year were GBP130.7m (2023: GBP136.4m), down 4%",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.41,revenues,up,Alliance Pharma PLC: Kelo-Cote franchise revenues grew 6%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.41,revenues,up,Alliance Pharma PLC: Prescription Medicine revenues increased 8%,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,-0.63,earnings,negative,Alliance Pharma PLC: Reported operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.62,earnings,up,Alliance Pharma PLC: Reported profit before tax increased,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Reported basic earnings per share was a loss of 1.99p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,-0.52,assets,down,Alliance Pharma PLC: Intangible assets decreased by GBP46.4m in the year to GBP253.6m,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -2-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.47,equity-actions,,Alliance Pharma PLC: Throughout 2024 we restructured,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,revenues,,"Alliance Pharma PLC: In 2024, revenues",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.52,products-services,,Alliance Pharma PLC: We launched three significant new products during 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.49,partnerships,,Alliance Pharma PLC: We have partnered with Walmart to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.52,products-services,,Alliance Pharma PLC: We expect to launch in China in 2025,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.72,revenues,up,Alliance Pharma PLC: we anticipate an acceleration in organic revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -3-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 109,286 - 109,286",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Operating expenses,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.6,earnings,positive,Alliance Pharma PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,-0.65,earnings,negative,Alliance Pharma PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -4-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Underlying gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,revenues,,Alliance Pharma PLC: Nizoral revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -6-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,-0.48,equity-actions,costs,Alliance Pharma PLC: restructuring costs,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -7-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,-0.62,earnings,negative,Alliance Pharma PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying diluted EPS,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Cost At 1 January 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -8-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,Alliance Pharma PLC: Adjusted profitability,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.47,equity-actions,,Alliance Pharma PLC: Onerous Provision Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,-0.65,earnings,negative,Alliance Pharma PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -9-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.61,earnings,positive,"Alliance Pharma PLC: Gross profit 109,286 - 109,286",PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,equity-actions,,Alliance Pharma PLC: Underlying taxation charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying profit before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBIT,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC: Underlying EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -10-
APH,2025-04-08,06:00:28,A1C370,Alliance Pharma PLC,100,0.0,earnings,,Alliance Pharma PLC Preliminary Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Preliminary Results -11-
APH,2025-04-23,08:23:26,A1C370,Alliance Pharma PLC,100,0.52,insider-trading,,Alliance Pharma PLC Director's intention to acquire shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Director's intention to acquire shares
APH,2025-05-14,06:30:01,A1C370,Alliance Pharma PLC,100,-0.65,equity-actions,halt,Aim Suspension - Alliance Pharma plc,PRESS-RELEASE,LSE Regulatory News Service (RNS),AIM Suspension - Alliance Pharma plc
APH,2025-05-14,06:30:01,A1C370,Alliance Pharma PLC,99,-0.57,labor-issues,,Alliance Pharma PLC: Director resignations,PRESS-RELEASE,LSE Regulatory News Service (RNS),Alliance Pharma PLC Scheme of Arrangement Becomes Effective
APH,2025-01-17,19:21:27,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2025-01-17,19:21:27,BB07E4,Amphenol Corp.,100,0.3,price-targets,upgrade,Amphenol Price Target Raised to $82.00/Share From $81.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $82.00/Share From $81.00 by Citigroup
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Adj EPS 55c,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Adj EPS 55c >APH
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 4Q Sales $4.3B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Sales $4.3B >APH
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,4Q EPS 59c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q EPS 59c >APH
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 1Q Sales $4B-$4.1B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q Sales $4B-$4.1B >APH
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 4Q Net $746.2M,NEWS-FLASH,Dow Jones Newswires,Amphenol 4Q Net $746.2M >APH
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 1Q Adj EPS 49c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 1Q Adj EPS 49c-Adj EPS 51c >APH
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.46,revenues,up,"Amphenol Corp.: Sales of $4.3 billion, up 30%",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.59, up",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.55, up",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Completed two acquisitions,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the fourth quarter, the Company purchased 2.4 million shares of its common stock for $169 million",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2025 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $4.00 billion to $4.10 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.49 to $0.51,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $4,317.9 $3,327.5",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,480.7",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: Dividends declared per common share,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2023",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $ 21,440.2 $ 16,526.4",PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 752.0 $ 519.2 $,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -4-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -4-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -4-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -5-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -5-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth Quarter,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -6-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -6-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports Record Fourth Quarter and Full -6-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Fourth Quarter and Full Year 2024 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.46,revenues,up,"Amphenol Corp.: Sales of $4.3 billion, up 30%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.59, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.55, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Completed two acquisitions,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the fourth quarter, the Company purchased 2.4 million shares of its common stock for $169 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: First Quarter 2025 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $4.00 billion to $4.10 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.49 to $0.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its fourth quarter and full year results at 1:00 PM (EST),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth Quarter and Full Year 2024 Results
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $4,317.9 $3,327.5",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,480.7",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -2-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Corp.: Dividends declared per common share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,"Amphenol Corp.: Net income per share for the twelve months ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,assets,,"Amphenol Corp.: Total Assets $ 21,440.2 $ 16,526.4",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Net income $ 752.0 $ 519.2 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -3-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -4-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -4-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -4-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -5-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.65,revenues,up,Amphenol Corp.: Organic Net Sales Growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -5-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Reports Record Fourth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -6-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -6-
APH,2025-01-22,13:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Fourth -6-
APH,2025-01-22,13:29:59,BB07E4,Amphenol Corp.,100,0.7,earnings,above-expectations,Amphenol 4Q Results Beat Expectations,FULL-ARTICLE,Dow Jones Newswires,Amphenol 4Q Results Beat Expectations on Growth Across Businesses
APH,2025-01-22,13:29:59,BB07E4,Amphenol Corp.,100,0.72,revenues,above-expectations,Amphenol sales beat market expectations in the fourth quarter,FULL-ARTICLE,Dow Jones Newswires,Amphenol 4Q Results Beat Expectations on Growth Across Businesses
APH,2025-01-22,13:29:59,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol earnings came in at 55 cents a share,FULL-ARTICLE,Dow Jones Newswires,Amphenol 4Q Results Beat Expectations on Growth Across Businesses
APH,2025-01-22,15:00:49,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: the Company's financial results for the quarter,RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Operations And Financial Condition >APH
APH,2025-01-23,12:00:50,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2025-01-23,12:00:50,BB07E4,Amphenol Corp.,100,0.62,price-targets,upgrade,Amphenol Price Target Raised to $90.00/Share From $85.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $90.00/Share From $85.00 by JP Morgan
APH,2025-01-23,12:39:00,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2025-01-23,12:39:00,BB07E4,Amphenol Corp.,100,0.54,price-targets,upgrade,Amphenol Price Target Raised to $89.00/Share From $85.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $89.00/Share From $85.00 by Baird
APH,2025-01-23,13:36:20,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $85.00/Share From $75.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $85.00/Share From $75.00 by B of A Securities
APH,2025-01-23,16:16:50,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $89.00/Share From $79.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $89.00/Share From $79.00 by Goldman Sachs
APH,2025-01-23,17:14:10,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2025-01-23,17:14:10,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $102.00/Share From $90.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $102.00/Share From $90.00 by Truist Securities
APH,2025-01-30,13:00:01,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2025 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces First Quarter 2025 Dividend
APH,2025-01-30,13:00:01,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces First Quarter 2025 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces First Quarter 2025 Dividend
APH,2025-02-03,13:00:00,BB07E4,Amphenol Corp.,100,0.5,acquisitions-mergers,completed,Amphenol Corporation (NYSE: APH) today announced it had completed the acquisition of CommScope's (NASDAQ: COMM),PRESS-RELEASE,Business Wire,Amphenol Corporation Completes Acquisition of OWN and DAS Businesses From CommScope
APH,2025-02-03,13:00:00,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol's 2025 earnings per share,PRESS-RELEASE,Business Wire,Amphenol Corporation Completes Acquisition of OWN and DAS Businesses From CommScope
APH,2025-02-03,13:00:00,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corporation Completes Acquisition of OWN -2,PRESS-RELEASE,Business Wire,Amphenol Corporation Completes Acquisition of OWN -2-
APH,2025-02-03,13:00:01,BB07E4,Amphenol Corp.,100,0.5,acquisitions-mergers,completed,Amphenol Corporation (NYSE: APH) today announced it had completed the acquisition of CommScope's (NASDAQ: COMM),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Completes Acquisition of OWN and DAS Businesses From CommScope
APH,2025-02-03,13:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol's 2025 earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Completes Acquisition of OWN and DAS Businesses From CommScope
APH,2025-02-03,13:01:25,BB07E4,Amphenol Corp.,100,0.5,acquisitions-mergers,completed,Amphenol Corp Completes Acquisition of OWN and DAS Businesses From CommScope,NEWS-FLASH,Dow Jones Newswires,Amphenol Corp Completes Acquisition of OWN and DAS Businesses From CommScope
APH,2025-02-03,13:01:53,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Closes Acquisition of Lifesync Corp >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Closes Acquisition of Lifesync Corp >APH
APH,2025-02-10,15:50:25,BB07E4,Amphenol Corp.,100,0.11,credit-ratings,stable,S&PGR Upgrades Amphenol Corp. To 'A-'; Outlook Stable,NEWS-FLASH,Dow Jones Newswires,S&PGR Upgrades Amphenol Corp. To 'A-'; Outlook Stable
APH,2025-02-10,15:50:25,BB07E4,Amphenol Corp.,100,0.11,credit-ratings,stable,S&PGR Upgrades Amphenol Corp. To 'A-'; Outlook Stable,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Upgrades Amphenol Corp. To 'A-'; Outlook Stable
APH,2025-02-10,15:54:08,BB07E4,Amphenol Corp.,100,0.17,credit-ratings,affirmation,S&P Affirms Amphenol 'A-2,NEWS-FLASH,Dow Jones Newswires,S&P Affirms Amphenol 'A-2' Short-Term Issuer and Comml Paper Ratings >APH
APH,2025-02-10,15:55:13,BB07E4,Amphenol Corp.,100,0.0,credit-ratings,stable,S&P: Stable Outlook Reflects View Amphenol,NEWS-FLASH,Dow Jones Newswires,S&P: Stable Outlook Reflects View Amphenol Acquisitions and Strong Demand in IT Datacom Will Lead to FY25 Rev Growth in at Least Midteens Percentage
APH,2025-03-13,13:00:02,BB07E4,Amphenol Corp.,100,-0.56,legal,,Credo Files AEC Patent Infringement Complaint Against Amphenol,PRESS-RELEASE,Business Wire,"Credo Files AEC Patent Infringement Complaint Against Amphenol, Molex, TE Connectivity, and Volex with United States International Trade Commission"
APH,2025-03-13,13:00:02,BB07E4,Amphenol Corp.,100,-0.47,regulatory,,The United States International Trade Commission to initiate an investigation against Amphenol Corporation,PRESS-RELEASE,Business Wire,"Credo Files AEC Patent Infringement Complaint Against Amphenol, Molex, TE Connectivity, and Volex with United States International Trade Commission"
APH,2025-03-13,13:01:45,BB07E4,Amphenol Corp.,100,-0.56,legal,,Credo Files AEC Patent Infringement Complaint Against Amphenol,NEWS-FLASH,Dow Jones Newswires,"Credo Files AEC Patent Infringement Complaint Against Amphenol, Molex, TE Connectivity, and Volex With United States Intl Trade Commission"
APH,2025-03-13,13:06:31,BB07E4,Amphenol Corp.,100,-0.56,legal,,Credo Files AEC Patent Infringement Complaint Against Amphenol,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Credo Files AEC Patent Infringement Complaint Against Amphenol, Molex, TE Connectivity, and Volex with United States International Trade Commission"
APH,2025-03-13,13:06:31,BB07E4,Amphenol Corp.,100,-0.47,regulatory,,The United States International Trade Commission to initiate an investigation against Amphenol Corporation,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Credo Files AEC Patent Infringement Complaint Against Amphenol, Molex, TE Connectivity, and Volex with United States International Trade Commission"
APH,2025-03-20,15:18:00,BB07E4,Amphenol Corp.,99,0.52,products-services,,Amphenol Corp.: our ability to introduce their new products,PRESS-RELEASE,Business Wire,Mouser Electronics Named 2024 Global Distributor of the Year by Amphenol SV Microwave
APH,2025-03-20,15:18:00,BB07E4,Amphenol Corp.,99,0.49,partnerships,,Amphenol Corp.: our partnership with Amphenol SV Microwave,PRESS-RELEASE,Business Wire,Mouser Electronics Named 2024 Global Distributor of the Year by Amphenol SV Microwave
APH,2025-03-20,15:18:00,BB07E4,Amphenol Corp.,99,0.4,products-services,,"Amphenol Industrial, and in 2014, received Amphenol Corporation's Global Excellence Award",PRESS-RELEASE,Business Wire,Mouser Electronics Named 2024 Global Distributor of the Year by Amphenol SV Microwave
APH,2025-04-10,18:01:21,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Goldman Sachs
APH,2025-04-10,18:01:21,BB07E4,Amphenol Corp.,100,-0.82,price-targets,downgrade,Amphenol Price Target Cut to $72.00/Share From $89.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $72.00/Share From $89.00 by Goldman Sachs
APH,2025-04-10,18:26:41,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2025-04-10,18:26:41,BB07E4,Amphenol Corp.,100,-0.8,price-targets,downgrade,Amphenol Price Target Cut to $78.00/Share From $90.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $78.00/Share From $90.00 by UBS
APH,2025-04-14,20:13:55,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2025-04-14,20:13:55,BB07E4,Amphenol Corp.,100,-0.82,price-targets,downgrade,Amphenol Price Target Cut to $75.00/Share From $89.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $75.00/Share From $89.00 by Citigroup
APH,2025-04-17,12:57:31,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2025-04-17,12:57:31,BB07E4,Amphenol Corp.,100,-0.62,price-targets,downgrade,Amphenol Price Target Cut to $85.00/Share From $90.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Cut to $85.00/Share From $90.00 by JP Morgan
APH,2025-04-23,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Adj EPS 63c,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Adj EPS 63c >APH
APH,2025-04-23,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,1Q EPS 58c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q EPS 58c >APH
APH,2025-04-23,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 1Q Sales $4.8B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Sales $4.8B >APH
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 2Q Sales $4.9B-$5B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Sales $4.9B-$5B >APH
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 2Q Adj EPS 64c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q Adj EPS 64c-Adj EPS 66c >APH
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 2Q EPS 63c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 2Q EPS 63c-EPS 65c >APH
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 1Q Net $737.8M,NEWS-FLASH,Dow Jones Newswires,Amphenol 1Q Net $737.8M >APH
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record First Quarter 2025 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.58,revenues,up,"Amphenol Corp.: Record Sales of $4.8 billion, up 48%",PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.58, up",PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.63,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Completed two acquisitions,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the first quarter, the Company purchased 2.7 million shares of its common stock for $180.9 million",PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2025 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $4.90 billion to $5.00 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.64 to $0.66,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record First Quarter 2025 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: Net sales $4,811.0 $3,256.3",PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,644.0",PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Net income per share,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 Results -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended March 31, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.0,assets,,"Amphenol Corp.: Total Assets $22,902.1 $ 21,440.2",PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.61,earnings,positive,Amphenol Corp.: Net income $ 744.2 $ 552.0,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -4-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: NET SALES,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -4-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -5-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -5-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.64 - $0.66,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -5-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.63 - $0.65,PRESS-RELEASE,Business Wire,Amphenol Reports Record First Quarter 2025 -5-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record First Quarter 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.58,revenues,up,"Amphenol Corp.: Record Sales of $4.8 billion, up 48%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.58, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol Corp.: Record Adjusted Diluted EPS of $0.63,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.57,acquisitions-mergers,completed,Amphenol Corp.: Completed two acquisitions,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the first quarter, the Company purchased 2.7 million shares of its common stock for $180.9 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Second Quarter 2025 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $4.90 billion to $5.00 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.64 to $0.66,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its first quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First Quarter 2025 Results
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $4,811.0 $3,256.3",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 1,644.0",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -2-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended March 31, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.0,assets,,"Amphenol Corp.: Total Assets $22,902.1 $ 21,440.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.61,earnings,positive,Amphenol Corp.: Net income $ 744.2 $ 552.0,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,94,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -3-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -4-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: NET SALES,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -4-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -5-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -5-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.64 - $0.66,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -5-
APH,2025-04-23,12:00:02,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.63 - $0.65,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record First -5-
APH,2025-04-23,13:21:52,BB07E4,Amphenol Corp.,99,0.0,earnings,,"Amphenol Corp.: the Company's financial results for the quarter ended March 31, 2025.",RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Operations And Financial Condition >APH
APH,2025-04-24,12:37:27,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2025-04-24,12:37:27,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $85.00/Share From $73.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $85.00/Share From $73.00 by Baird
APH,2025-04-24,15:12:17,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2025-04-24,15:12:17,BB07E4,Amphenol Corp.,100,0.66,price-targets,upgrade,Amphenol Price Target Raised to $91.00/Share From $85.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $91.00/Share From $85.00 by JP Morgan
APH,2025-04-24,17:02:17,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2025-04-24,17:02:17,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $85.00/Share From $75.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $85.00/Share From $75.00 by Citigroup
APH,2025-04-24,17:23:07,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2025-04-24,17:23:07,BB07E4,Amphenol Corp.,100,0.74,price-targets,upgrade,Amphenol Price Target Raised to $85.00/Share From $78.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $85.00/Share From $78.00 by UBS
APH,2025-04-24,17:51:57,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Goldman Sachs
APH,2025-04-24,17:51:57,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $80.00/Share From $72.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $80.00/Share From $72.00 by Goldman Sachs
APH,2025-04-25,20:15:53,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 100,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 100,000 Of Amphenol Corp >APH"
APH,2025-04-25,20:18:25,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Ceo Norwitt Registers 2,000,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CEO Norwitt Registers 2,000,000 Of Amphenol Corp >APH"
APH,2025-04-25,20:30:30,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 175,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 175,000 Of Amphenol Corp >APH"
APH,2025-04-25,20:45:35,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Cfo Lampo Registers 400,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CFO Lampo Registers 400,000 Of Amphenol Corp >APH"
APH,2025-04-25,20:49:08,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Silverman Registers 100,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Silverman Registers 100,000 Of Amphenol Corp >APH"
APH,2025-04-25,20:57:27,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Walter Registers 390,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Walter Registers 390,000 Of Amphenol Corp >APH"
APH,2025-04-29,20:02:29,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Cfo Lampo Sells 400,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Lampo Sells 400,000 Of Amphenol Corp >APH"
APH,2025-04-29,20:03:05,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Ceo Norwitt Sells 2,000,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Norwitt Sells 2,000,000 Of Amphenol Corp >APH"
APH,2025-04-29,20:04:18,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Silverman Sells 100,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Silverman Sells 100,000 Of Amphenol Corp >APH"
APH,2025-04-29,20:04:30,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Doherty Sells 100,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Doherty Sells 100,000 Of Amphenol Corp >APH"
APH,2025-04-29,20:05:41,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Walter Sells 390,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Sells 390,000 Of Amphenol Corp >APH"
APH,2025-04-29,20:45:33,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 205,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 205,000 Of Amphenol Corp >APH"
APH,2025-05-01,12:00:04,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2025 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces Second Quarter 2025 Dividend
APH,2025-05-01,12:00:04,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Second Quarter 2025 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Second Quarter 2025 Dividend
APH,2025-05-01,15:24:53,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Hold by TD Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Hold by TD Securities
APH,2025-05-01,15:24:53,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $70.00/Share From $63.00 by TD Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $70.00/Share From $63.00 by TD Securities
APH,2025-05-02,20:24:37,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Silverman Registers 87,500 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Silverman Registers 87,500 Of Amphenol Corp >APH"
APH,2025-05-02,20:24:57,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 126,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 126,000 Of Amphenol Corp >APH"
APH,2025-05-06,20:01:57,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Silverman Sells 87,500 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Silverman Sells 87,500 Of Amphenol Corp >APH"
APH,2025-05-06,20:06:26,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Doherty Sells 126,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Doherty Sells 126,000 Of Amphenol Corp >APH"
APH,2025-05-12,21:13:29,BB07E4,Amphenol Corp.,100,0.11,credit-ratings,stable,Moody's Ratings Affirms Amphenol Corporation's A3 Issuer Rating; Outlook Stable,NEWS-FLASH,Dow Jones Newswires,Moody's Ratings Affirms Amphenol Corporation's A3 Issuer Rating; Outlook Stable
APH,2025-05-13,20:39:30,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 100,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 100,000 Of Amphenol Corp >APH"
APH,2025-05-13,21:14:05,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 100,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 100,000 Of Amphenol Corp >APH"
APH,2025-05-27,16:58:18,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2025-05-27,16:58:18,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $100.00/Share From $85.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $100.00/Share From $85.00 by Citigroup
APH,2025-05-29,20:06:33,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Ivas Registers 40,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Ivas Registers 40,000 Of Amphenol Corp >APH"
APH,2025-05-30,13:59:55,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2025-05-30,13:59:55,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $106.00/Share From $85.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $106.00/Share From $85.00 by UBS
APH,2025-05-30,20:02:06,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Ivas Sells 40,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Ivas Sells 40,000 Of Amphenol Corp >APH"
APH,2025-05-30,20:12:55,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 160,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 160,000 Of Amphenol Corp >APH"
APH,2025-05-30,20:15:28,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Silverman Registers 100,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Silverman Registers 100,000 Of Amphenol Corp >APH"
APH,2025-06-02,20:02:48,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Silverman Sells 100,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Silverman Sells 100,000 Of Amphenol Corp >APH"
APH,2025-06-02,20:03:03,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Doherty Sells 160,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Doherty Sells 160,000 Of Amphenol Corp >APH"
APH,2025-06-03,20:36:41,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Walter Registers 286,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Walter Registers 286,000 Of Amphenol Corp >APH"
APH,2025-06-03,20:55:10,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Walter Sells 286,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Sells 286,000 Of Amphenol Corp >APH"
APH,2025-06-05,14:45:32,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Evercore ISI Group
APH,2025-06-05,14:45:32,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $105.00/Share From $88.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $105.00/Share From $88.00 by Evercore ISI Group
APH,2025-06-09,16:04:19,BB07E4,Amphenol Corp.,100,0.16,credit-ratings,set,S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'A-,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'A-'
APH,2025-06-09,16:04:19,BB07E4,Amphenol Corp.,100,0.16,credit-ratings,set,S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'A-'
APH,2025-06-09,16:04:19,BB07E4,Amphenol Corp.,100,0.7,earnings,above-expectations,Amphenol's performance was stronger than we expected,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Amphenol's Proposed Senior Unsecured Notes 'A-'
APH,2025-06-09,20:44:00,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corporation Announces Pricing of USD-Denominated Senior Notes,PRESS-RELEASE,Business Wire,Amphenol Corporation Announces Pricing of USD-Denominated Senior Notes Offering
APH,2025-06-09,20:44:01,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corporation Announces Pricing of USD-Denominated Senior Notes,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Announces Pricing of USD-Denominated Senior Notes Offering
APH,2025-06-10,16:53:44,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Goldman Sachs
APH,2025-06-10,16:53:44,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $102.00/Share From $90.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $102.00/Share From $90.00 by Goldman Sachs
APH,2025-06-11,20:32:00,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol CORPORATION ANNOUNCES PRICING OF EURO-DENOMINATED SENIOR NOTES,PRESS-RELEASE,Business Wire,AMPHENOL CORPORATION ANNOUNCES PRICING OF EURO-DENOMINATED SENIOR NOTES OFFERING
APH,2025-06-11,20:32:00,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol CORPORATION ANNOUNCES PRICING OF EURO-DENOMINATED SENIOR NOTES,PRESS-RELEASE,Dow Jones Newswires,Press Release: AMPHENOL CORPORATION ANNOUNCES PRICING OF EURO-DENOMINATED SENIOR NOTES OFFERING
APH,2025-06-11,20:32:05,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corp ANNOUNCES PRICING of EURO-DENOMINATED SENIOR NOTES,NEWS-FLASH,Dow Jones Newswires,AMPHENOL Corp ANNOUNCES PRICING of EURO-DENOMINATED SENIOR NOTES OFFERING
APH,2025-06-16,20:04:14,BB07E4,Amphenol Corp.,99,0.0,credit,,"Amphenol Corp.: the Company closed its offering of $750,000,000 aggregate principal amount of 4.375% Senior Notes",RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Entry Into Definitive Agreement >APH
APH,2025-07-11,18:39:25,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2025-07-11,18:39:25,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $115.00/Share From $100.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $115.00/Share From $100.00 by Citigroup
APH,2025-07-14,13:26:21,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2025-07-14,13:26:21,BB07E4,Amphenol Corp.,100,0.72,price-targets,upgrade,Amphenol Price Target Raised to $115.00/Share From $106.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $115.00/Share From $106.00 by UBS
APH,2025-07-17,19:21:09,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2025-07-17,19:21:09,BB07E4,Amphenol Corp.,100,0.8,price-targets,upgrade,Amphenol Price Target Raised to $120.00/Share From $91.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $120.00/Share From $91.00 by JP Morgan
APH,2025-07-18,11:29:20,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Evercore ISI Group
APH,2025-07-18,11:29:20,BB07E4,Amphenol Corp.,100,0.54,price-targets,upgrade,Amphenol Price Target Raised to $110.00/Share From $105.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $110.00/Share From $105.00 by Evercore ISI Group
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Adj EPS 81c,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Adj EPS 81c >APH
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 2Q Sales $5.7B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Sales $5.7B >APH
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,2Q EPS 86c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q EPS 86c >APH
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 3Q Sales $5.4B-$5.5B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Sales $5.4B-$5.5B >APH
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 2Q Net $1.09B,NEWS-FLASH,Dow Jones Newswires,Amphenol 2Q Net $1.09B >APH
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 3Q Adj EPS 77c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 3Q Adj EPS 77c-Adj EPS 79c >APH
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Second Quarter 2025 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.64,revenues,up,"Amphenol Corp.: Sales of $5.7 billion, up 57%",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.86, up",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.81, up",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corp.: Acquired Narda-MITEQ in May,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the second quarter, the Company purchased 2.0 million shares of its common stock for $160 million",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2025 Outlook,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $5.4 billion to $5.5 billion,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.77 to $0.79,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $5,650.3 $3,609.7",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -2-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 2,053.3",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -2-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -2-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -2-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2025",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -3-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -3-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2025",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -3-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -3-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,93,0.0,assets,,"Amphenol Corp.: Total Assets $25,668.4 $ 21,440.2",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -3-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,93,0.61,earnings,positive,"Amphenol Corp.: Net income $1,100.8 $ 528.7 $",PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -3-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -4-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -4-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -5-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: OPERATING RESULTS,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -5-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -6-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -6-
APH,2025-07-23,12:00:01,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,Amphenol Reports Record Second Quarter 2025 -6-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Second Quarter 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,revenues,up,"Amphenol Corp.: Sales of $5.7 billion, up 57%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.86, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.81, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corp.: Acquired Narda-MITEQ in May,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the second quarter, the Company purchased 2.0 million shares of its common stock for $160 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Third Quarter 2025 Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $5.4 billion to $5.5 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.77 to $0.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its second quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second Quarter 2025 Results
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $5,650.3 $3,609.7",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -2-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 2,053.3",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -2-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -2-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -2-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended June 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,93,0.0,earnings,,"Amphenol Corp.: Net income per share for the six months ended June 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,93,0.0,assets,,"Amphenol Corp.: Total Assets $25,668.4 $ 21,440.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,93,0.61,earnings,positive,"Amphenol Corp.: Net income $1,100.8 $ 528.7 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -3-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -4-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -4-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -5-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: OPERATING RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -5-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -6-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -6-
APH,2025-07-23,12:00:02,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Second -6-
APH,2025-07-23,12:37:55,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 2Q Sales $5.65B >APH,NEWS-FLASH,Dow Jones Newswires,Correct: Amphenol 2Q Sales $5.65B >APH
APH,2025-07-23,12:39:11,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol 2Q Profit Nearly Doubles,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 2Q Profit Nearly Doubles, Revenue Beats Views"
APH,2025-07-23,12:39:11,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol expects sales to be in the range of $5.4 billion to $5.5 billion,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 2Q Profit Nearly Doubles, Revenue Beats Views"
APH,2025-07-23,14:58:38,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: the Company's financial results for the quarter,RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Operations And Financial Condition >APH
APH,2025-07-24,12:06:05,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2025-07-24,12:06:05,BB07E4,Amphenol Corp.,100,0.52,price-targets,upgrade,Amphenol Price Target Raised to $118.00/Share From $113.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $118.00/Share From $113.00 by Baird
APH,2025-07-24,13:16:45,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2025-07-24,13:16:45,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $126.00/Share From $102.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $126.00/Share From $102.00 by Truist Securities
APH,2025-07-24,14:22:45,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2025-07-24,14:22:45,BB07E4,Amphenol Corp.,100,0.5,price-targets,upgrade,Amphenol Price Target Raised to $125.00/Share From $120.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $125.00/Share From $120.00 by JP Morgan
APH,2025-07-24,15:26:15,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2025-07-24,15:26:15,BB07E4,Amphenol Corp.,100,0.72,price-targets,upgrade,Amphenol Price Target Raised to $125.00/Share From $115.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $125.00/Share From $115.00 by Citigroup
APH,2025-07-24,18:39:05,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2025-07-24,18:39:05,BB07E4,Amphenol Corp.,100,0.52,price-targets,upgrade,Amphenol Price Target Raised to $120.00/Share From $115.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $120.00/Share From $115.00 by UBS
APH,2025-07-31,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Third Quarter 2025 Dividend,PRESS-RELEASE,Business Wire,Amphenol Announces Third Quarter 2025 Dividend
APH,2025-07-31,12:00:02,BB07E4,Amphenol Corp.,100,0.0,dividends,,Amphenol Announces Third Quarter 2025 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Announces Third Quarter 2025 Dividend
APH,2025-08-03,21:04:54,BB07E4,Amphenol Corp.,100,0.48,acquisitions-mergers,interest,Amphenol Nears Deal for CommScope's Broadband Arm,NEWS-FLASH,Dow Jones Newswires,"Amphenol Nears Deal for CommScope's Broadband Arm, Sources Say -- WSJ"
APH,2025-08-03,21:04:54,BB07E4,Amphenol Corp.,98,0.55,acquisitions-mergers,interest,Amphenol is nearing a deal to buy CommScope Holding,FULL-ARTICLE,Dow Jones Newswires,Amphenol Nears Big Broadband Deal in AI Boom -- WSJ
APH,2025-08-03,21:04:54,BB07E4,Amphenol Corp.,98,0.55,acquisitions-mergers,,Amphenol bought the Carlisle Interconnect Technologies division of Carlisle Companies,FULL-ARTICLE,Dow Jones Newswires,Amphenol Nears Big Broadband Deal in AI Boom -- WSJ
APH,2025-08-04,06:33:08,BB07E4,Amphenol Corp.,98,0.55,acquisitions-mergers,interest,Amphenol is nearing a deal to buy CommScope Holding,FULL-ARTICLE,Wall Street Journal,Amphenol Nears Broadband Deal -- WSJ
APH,2025-08-04,06:33:08,BB07E4,Amphenol Corp.,98,0.55,acquisitions-mergers,,Amphenol bought the Carlisle Interconnect Technologies division of Carlisle Cos.,FULL-ARTICLE,Wall Street Journal,Amphenol Nears Broadband Deal -- WSJ
APH,2025-08-04,11:00:01,BB07E4,Amphenol Corp.,95,0.55,acquisitions-mergers,,"CommScope Holding Company Inc.: the ""Company"") is selling its CCS business to Amphenol",PRESS-RELEASE,Business Wire,CommScope to Sell its Connectivity and Cable Solutions Segment to Amphenol Corporation for $10.5 billion
APH,2025-08-04,11:00:01,BB07E4,Amphenol Corp.,95,0.55,acquisitions-mergers,,"CommScope Holding Company Inc.: the ""Company"") is selling its CCS business to Amphenol",PRESS-RELEASE,Dow Jones Newswires,Press Release: CommScope to Sell its Connectivity and Cable Solutions Segment to Amphenol Corporation for $10.5 billion
APH,2025-08-04,11:00:03,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corporation to Acquire Connectivity and Cable Solutions Business From CommScope,PRESS-RELEASE,Business Wire,Amphenol Corporation to Acquire Connectivity and Cable Solutions Business From CommScope
APH,2025-08-04,11:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol intends to finance,PRESS-RELEASE,Business Wire,Amphenol Corporation to Acquire Connectivity and Cable Solutions Business From CommScope
APH,2025-08-04,11:00:03,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Corporation to Acquire Connectivity and Cable Solutions Business From CommScope,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation to Acquire Connectivity and Cable Solutions Business From CommScope
APH,2025-08-04,11:00:03,BB07E4,Amphenol Corp.,100,0.0,equity-actions,,Amphenol intends to finance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation to Acquire Connectivity and Cable Solutions Business From CommScope
APH,2025-08-04,11:05:56,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol to Acquire Connectivity and Cable Solutions Business From CommScope for $10.5B,NEWS-FLASH,Dow Jones Newswires,Amphenol to Acquire Connectivity and Cable Solutions Business From CommScope for $10.5B
APH,2025-08-04,12:04:36,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol Buys CommScope Broadband Unit In $10.5 Billion Deal,FULL-ARTICLE,Dow Jones Newswires,Amphenol Buys CommScope Broadband Unit In $10.5 Billion Deal -- IBD
APH,2025-08-05,14:12:12,BB07E4,Amphenol Corp.,100,0.0,analyst-ratings,neutral,Amphenol Is Maintained at Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Neutral by B of A Securities
APH,2025-08-05,14:12:12,BB07E4,Amphenol Corp.,100,0.74,price-targets,upgrade,Amphenol Price Target Raised to $120.00/Share From $110.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $120.00/Share From $110.00 by B of A Securities
APH,2025-08-06,17:16:12,BB07E4,Amphenol Corp.,100,0.11,credit-ratings,stable,Moody's Ratings Affirms Amphenol Corporation's A3 Issuer Rating; Outlook Stable,NEWS-FLASH,Dow Jones Newswires,Moody's Ratings Affirms Amphenol Corporation's A3 Issuer Rating; Outlook Stable
APH,2025-08-08,20:42:27,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 113,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 113,000 Of Amphenol Corp >APH"
APH,2025-08-11,20:30:43,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 113,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 113,000 Of Amphenol Corp >APH"
APH,2025-08-12,20:01:57,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Ivas Sells 50,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Ivas Sells 50,000 Of Amphenol Corp >APH"
APH,2025-08-12,20:04:05,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Doherty Sells 226,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Doherty Sells 226,000 Of Amphenol Corp >APH"
APH,2025-08-14,20:05:03,BB07E4,Amphenol Corp.,100,0.46,legal,,Credo and Amphenol Reach Settlement,PRESS-RELEASE,Business Wire,Credo and Amphenol Reach Settlement in Active Electrical Cable Patent Infringement Disputes
APH,2025-08-14,20:09:23,BB07E4,Amphenol Corp.,100,0.46,legal,,Credo and Amphenol Reach Settlement,NEWS-FLASH,Dow Jones Newswires,Credo and Amphenol Reach Settlement in Electrical Cable Patent Infringement Disputes
APH,2025-08-14,21:23:26,BB07E4,Amphenol Corp.,100,0.46,legal,,Credo and Amphenol Reach Settlement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Credo and Amphenol Reach Settlement in Active Electrical Cable Patent Infringement Disputes
APH,2025-08-14,21:32:19,BB07E4,Amphenol Corp.,100,0.46,legal,,"Credo Technology, Amphenol Reach Settlement",FULL-ARTICLE,Dow Jones Newswires,"Credo Technology, Amphenol Reach Settlement in Active Electrical Cable Patent Disputes"
APH,2025-08-18,12:00:01,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corporation To Acquire Trexon >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Corporation To Acquire Trexon >APH
APH,2025-08-18,12:00:01,BB07E4,Amphenol Corp.,99,0.65,acquisitions-mergers,,Amphenol Corporation to Acquire Trexon,PRESS-RELEASE,Business Wire,Amphenol Corporation to Acquire Trexon
APH,2025-08-18,12:00:01,BB07E4,Amphenol Corp.,99,0.65,acquisitions-mergers,,Agreement to acquire Trexon for approximately $1 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation to Acquire Trexon
APH,2025-08-18,12:06:48,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol to Acquire Trexon for About $1 B in Cash,NEWS-FLASH,Dow Jones Newswires,Amphenol to Acquire Trexon for About $1 B in Cash >APH
APH,2025-08-18,12:56:48,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,Amphenol to Buy Trexon From Audax Private Equity for $1 Billion,FULL-ARTICLE,Dow Jones Newswires,Amphenol to Buy Trexon From Audax Private Equity for $1 Billion
APH,2025-08-18,20:09:34,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 100,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 100,000 Of Amphenol Corp >APH"
APH,2025-08-19,06:32:09,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Buys Trexon for $1 Billion -- WSJ,FULL-ARTICLE,Wall Street Journal,Amphenol Buys Trexon for $1 Billion -- WSJ
APH,2025-08-19,13:55:09,BB07E4,Amphenol Corp.,99,0.62,acquisitions-mergers,,Amphenol announced an agreement to acquire Trexon for $1 billion,FULL-ARTICLE,Dow Jones Newswires,Amphenol Shows Investors How to Score With Earnings From AI -- Barrons.com
APH,2025-08-19,16:23:14,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2025-08-19,16:23:14,BB07E4,Amphenol Corp.,100,0.68,price-targets,upgrade,Amphenol Price Target Raised to $127.00/Share From $118.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $127.00/Share From $118.00 by Baird
APH,2025-08-19,20:02:11,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 130,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 130,000 Of Amphenol Corp >APH"
APH,2025-08-19,20:27:48,BB07E4,Amphenol Corp.,99,0.62,acquisitions-mergers,,Amphenol announced an agreement to acquire Trexon for $1 billion,FULL-ARTICLE,Dow Jones Newswires,Amphenol Shows Investors How to Score With Earnings From AI -- Barrons.com
APH,2025-08-22,20:27:33,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Cfo Lampo Registers 199,848 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"CFO Lampo Registers 199,848 Of Amphenol Corp >APH"
APH,2025-08-25,20:01:56,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Cfo Lampo Sells 199,848 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Lampo Sells 199,848 Of Amphenol Corp >APH"
APH,2025-08-25,20:12:27,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Silverman Registers 100,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Silverman Registers 100,000 Of Amphenol Corp >APH"
APH,2025-08-25,20:16:28,BB07E4,Amphenol Corp.,99,0.39,products-services,,"Amphenol Corp.: the Company's acquisition of CommScope Holding Company, Inc.'s (NASDAQ: COMM) Connectivity and Cable Solutions",RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Entry Into Definitive Agreement >APH
APH,2025-08-26,20:02:52,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Cfo Lampo Sells 40,076 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Lampo Sells 40,076 Of Amphenol Corp >APH"
APH,2025-08-26,20:03:38,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp Silverman Sells 100,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Silverman Sells 100,000 Of Amphenol Corp >APH"
APH,2025-09-02,21:19:34,BB07E4,Amphenol Corp.,100,0.0,insider-trading,,"Officer Walter Gifts 18,048 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Gifts 18,048 Of Amphenol Corp >APH"
APH,2025-09-08,20:25:02,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Straub Registers 88,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Straub Registers 88,000 Of Amphenol Corp >APH"
APH,2025-09-09,20:10:25,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Straub Sells 88,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Straub Sells 88,000 Of Amphenol Corp >APH"
APH,2025-09-24,14:20:26,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2025-09-24,14:20:26,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $145.00/Share From $125.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $145.00/Share From $125.00 by Citigroup
APH,2025-09-29,18:19:38,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Goldman Sachs
APH,2025-09-29,18:19:38,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $139.00/Share From $124.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $139.00/Share From $124.00 by Goldman Sachs
APH,2025-10-06,16:30:23,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2025-10-06,16:30:23,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $145.00/Share From $120.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $145.00/Share From $120.00 by UBS
APH,2025-10-07,16:20:58,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Evercore ISI Group
APH,2025-10-07,16:20:58,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $150.00/Share From $120.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $150.00/Share From $120.00 by Evercore ISI Group
APH,2025-10-08,12:29:20,BB07E4,Amphenol Corp.,100,0.01,analyst-ratings,neutral,Amphenol Initiated at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,Amphenol Initiated at Equal-Weight by Barclays
APH,2025-10-08,12:29:20,BB07E4,Amphenol Corp.,100,0.0,price-targets,set,Amphenol Price Target Announced at $120.00/Share by Barclays,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Announced at $120.00/Share by Barclays
APH,2025-10-10,11:30:54,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Outperform by Baird
APH,2025-10-10,11:30:54,BB07E4,Amphenol Corp.,100,0.76,price-targets,upgrade,Amphenol Price Target Raised to $139.00/Share From $127.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $139.00/Share From $127.00 by Baird
APH,2025-10-15,10:56:45,BB07E4,Amphenol Corp.,100,0.94,analyst-ratings,positive,Amphenol Raised to Buy From Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Raised to Buy From Neutral by B of A Securities
APH,2025-10-15,10:56:45,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $150.00/Share From $120.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $150.00/Share From $120.00 by B of A Securities
APH,2025-10-15,20:21:32,BB07E4,Amphenol Corp.,99,0.94,analyst-ratings,positive,Bofa Securities upgraded Amphenol to Buy from Neutral,FULL-ARTICLE,Dow Jones Newswires,Amphenol Gets an Upgrade. There's More to the Story Than AI Data Centers. -- Barrons.com
APH,2025-10-16,11:59:58,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2025-10-16,11:59:58,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $145.00/Share From $125.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $145.00/Share From $125.00 by JP Morgan
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2025 Results,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.64,revenues,up,"Amphenol Corp.: Sales of $6.2 billion, up 53%",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.97, up",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.93, up",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corp.: Acquired Rochester Sensors in August,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.62,dividends,up,"Amphenol Corp.: the Company's quarterly dividend, to $0.25",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the third quarter, the Company purchased 1.4 million shares of its common stock for $153 million",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2025, Amphenol expects sales to be in the range of $22.66 billion to $22.76 billion",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.89 to $0.91,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT),PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $6,194.4 $4,038.8",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -2-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 2,359.3",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -2-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -2-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -2-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -3-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2025",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -3-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2024",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -3-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,95,0.0,assets,,"Amphenol Corp.: Total Assets $ 27,143.0 $ 21,440.2",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -3-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,98,0.61,earnings,positive,"Amphenol Corp.: Net income $1,255.1 $ 608.9 $",PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -4-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,98,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -4-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,98,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -4-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: NET SALES,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -5-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -5-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: OPERATING RESULTS,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -5-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -6-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -6-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.89 - $0.91,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -6-
APH,2025-10-22,12:00:03,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.89 - $0.91,PRESS-RELEASE,Business Wire,Amphenol Reports Record Third Quarter 2025 -6-
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2025 Results,NEWS-FLASH,Dow Jones Newswires,Amphenol Reports Record Third Quarter 2025 Results And Announces Dividend Increase >APH
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,3Q EPS 97c >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q EPS 97c >APH
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol 3Q Sales $6.19B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Sales $6.19B >APH
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees 4Q Sales $6B-$6.1B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Sales $6B-$6.1B >APH
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Adj EPS 93c,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Adj EPS 93c >APH
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q Adj EPS 89c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q Adj EPS 89c-Adj EPS 91c >APH
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.61,earnings,positive,Amphenol 3Q Net $1.25B,NEWS-FLASH,Dow Jones Newswires,Amphenol 3Q Net $1.25B >APH
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees 4Q EPS 89c,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees 4Q EPS 89c-EPS 91c >APH
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY EPS $3.31,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY EPS $3.31-EPS $3.33 >APH
APH,2025-10-22,12:00:06,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Sees FY Adj EPS $3.26,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Adj EPS $3.26-Adj EPS $3.28 >APH
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.64,earnings,up,Amphenol Reports Record Third Quarter 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.64,revenues,up,"Amphenol Corp.: Sales of $6.2 billion, up 53%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: GAAP Diluted EPS of $0.97, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.64,earnings,up,"Amphenol Corp.: Adjusted Diluted EPS of $0.93, up",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.62,acquisitions-mergers,,Amphenol Corp.: Acquired Rochester Sensors in August,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.62,dividends,up,"Amphenol Corp.: the Company's quarterly dividend, to $0.25",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.59,equity-actions,,"Amphenol Corp.: During the third quarter, the Company purchased 1.4 million shares of its common stock for $153 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.0,revenues,,"Amphenol Corp.: For the full year 2025, Amphenol expects sales to be in the range of $22.66 billion to $22.76 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.0,earnings,,Amphenol Corp.: Adjusted Diluted EPS is expected to be in the range of $0.89 to $0.91,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,100,0.0,investor-relations,,Amphenol Corp.: The Company will host a conference call to discuss its third quarter results at 1:00 PM (EDT),PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third Quarter 2025 Results and Announces Dividend Increase
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.0,revenues,,"Amphenol Corp.: Net sales $6,194.4 $4,038.8",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,"Amphenol Corp.: Gross profit 2,359.3",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.0,equity-actions,,"Amphenol Corp.: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -2-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the three months ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,95,0.0,earnings,,"Amphenol Corp.: Net income per share for the nine months ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,95,0.0,assets,,"Amphenol Corp.: Total Assets $ 27,143.0 $ 21,440.2",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -3-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,98,0.61,earnings,positive,"Amphenol Corp.: Net income $1,255.1 $ 608.9 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,98,0.0,revenues,,Amphenol Corp.: Net sales: ------,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,98,0.0,earnings,,Amphenol Corp.: Consolidated Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -4-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.0,revenues,,Amphenol Corp.: NET SALES,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.65,revenues,up,Amphenol Corp.: Constant Currency Net Sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: OPERATING RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -5-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: Adjusted Net Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Adjusted Diluted EPS (non-GAAP) (2) $0.89 - $0.91,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2025-10-22,12:00:10,BB07E4,Amphenol Corp.,99,0.61,earnings,positive,Amphenol Corp.: Diluted EPS (GAAP) $0.89 - $0.91,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Reports Record Third -6-
APH,2025-10-22,12:05:29,BB07E4,Amphenol Corp.,100,0.0,revenues,,Amphenol Sees FY Sales $22.66B-$22.76B >APH,NEWS-FLASH,Dow Jones Newswires,Amphenol Sees FY Sales $22.66B-$22.76B >APH
APH,2025-10-22,12:06:55,BB07E4,Amphenol Corp.,100,0.62,dividends,up,Amphenol Raises Dividend to 25c,NEWS-FLASH,Dow Jones Newswires,Amphenol Raises Dividend to 25c >APH
APH,2025-10-22,12:18:30,BB07E4,Amphenol Corp.,100,0.62,dividends,up,Amphenol Raises Quarterly Dividend by 52%,FULL-ARTICLE,Dow Jones Newswires,Amphenol Raises Quarterly Dividend by 52%
APH,2025-10-22,12:24:05,BB07E4,Amphenol Corp.,95,0.65,revenues,up,Amphenol reported higher third-quarter sales,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Sales, Profit Jump on Data Center Demand"
APH,2025-10-22,12:24:05,BB07E4,Amphenol Corp.,95,0.62,acquisitions-mergers,,Amphenol recently agreed to acquire CommScope's connectivity,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Sales, Profit Jump on Data Center Demand"
APH,2025-10-22,12:24:05,BB07E4,Amphenol Corp.,95,0.0,revenues,,Amphenol guided for fourth-quarter sales of $6 billion to $6.1 billion,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Sales, Profit Jump on Data Center Demand"
APH,2025-10-22,12:33:30,BB07E4,Amphenol Corp.,100,0.62,dividends,up,Amphenol Raises Quarterly Dividend by 52%,FULL-ARTICLE,Dow Jones Newswires,Amphenol Raises Quarterly Dividend by 52%
APH,2025-10-22,12:39:05,BB07E4,Amphenol Corp.,95,0.65,revenues,up,Amphenol reported higher third-quarter sales,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Sales, Profit Jump on Data Center Demand"
APH,2025-10-22,12:39:05,BB07E4,Amphenol Corp.,95,0.62,acquisitions-mergers,,Amphenol recently agreed to acquire CommScope's connectivity,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Sales, Profit Jump on Data Center Demand"
APH,2025-10-22,12:39:05,BB07E4,Amphenol Corp.,95,0.0,revenues,,Amphenol guided for fourth-quarter sales of $6 billion to $6.1 billion,FULL-ARTICLE,Dow Jones Newswires,"Amphenol 3Q Sales, Profit Jump on Data Center Demand"
APH,2025-10-22,13:28:51,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol Corp.: the Company's financial results for the quarter,RNS-SEC8K,Dow Jones Newswires,Amphenol Files 8K - Operations And Financial Condition >APH
APH,2025-10-22,14:57:35,BB07E4,Amphenol Corp.,99,0.76,earnings,up,Amphenol earnings jumped 86%,FULL-ARTICLE,Dow Jones Newswires,Amphenol Earnings Growth Accelerates Again. But The AI Play Slashes Early Gain. -- IBD
APH,2025-10-22,14:57:35,BB07E4,Amphenol Corp.,99,0.0,earnings,,Amphenol also guided to Q4 EPS of 89-91 cents,FULL-ARTICLE,Dow Jones Newswires,Amphenol Earnings Growth Accelerates Again. But The AI Play Slashes Early Gain. -- IBD
APH,2025-10-23,11:18:05,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Citigroup
APH,2025-10-23,11:18:05,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $160.00/Share From $145.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $160.00/Share From $145.00 by Citigroup
APH,2025-10-23,14:39:44,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Truist Securities
APH,2025-10-23,14:39:44,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $147.00/Share From $126.00 by Truist Securities,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $147.00/Share From $126.00 by Truist Securities
APH,2025-10-23,15:57:14,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Overweight by JP Morgan
APH,2025-10-23,15:57:14,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $160.00/Share From $145.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $160.00/Share From $145.00 by JP Morgan
APH,2025-10-23,17:36:14,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by Goldman Sachs
APH,2025-10-23,17:36:15,BB07E4,Amphenol Corp.,100,0.78,price-targets,upgrade,Amphenol Price Target Raised to $154.00/Share From $139.00 by Goldman Sachs,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $154.00/Share From $139.00 by Goldman Sachs
APH,2025-10-23,21:28:45,BB07E4,Amphenol Corp.,100,0.34,analyst-ratings,neutral,Amphenol Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Is Maintained at Buy by UBS
APH,2025-10-23,21:28:45,BB07E4,Amphenol Corp.,100,0.56,price-targets,upgrade,Amphenol Price Target Raised to $152.00/Share From $145.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Amphenol Price Target Raised to $152.00/Share From $145.00 by UBS
APH,2025-10-24,20:12:26,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Walter Registers 365,118 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Walter Registers 365,118 Of Amphenol Corp >APH"
APH,2025-10-27,15:08:01,BB07E4,Amphenol Corp.,100,0.16,credit-ratings,set,S&PGR Assigns 'A-' Rtg To Amphenol's Prop Sr Unsecured Notes,NEWS-FLASH,Dow Jones Newswires,S&PGR Assigns 'A-' Rtg To Amphenol's Prop Sr Unsecured Notes
APH,2025-10-27,15:08:01,BB07E4,Amphenol Corp.,100,0.16,credit-ratings,set,S&PGR Assigns 'A-' Rtg To Amphenol's Prop Sr Unsecured Notes,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Assigns 'A-' Rtg To Amphenol's Prop Sr Unsecured Notes
APH,2025-10-27,20:02:31,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Walter Sells 365,118 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Walter Sells 365,118 Of Amphenol Corp >APH"
APH,2025-10-27,22:48:00,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corporation Announces Pricing of Senior Notes Offerings,PRESS-RELEASE,Business Wire,Amphenol Corporation Announces Pricing of Senior Notes Offerings
APH,2025-10-27,22:48:00,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,"Amphenol Corp.: the Company's pending acquisition of CommScope Holding Company, Inc.'s Connectivity and Cable Solutions businesses",PRESS-RELEASE,Business Wire,Amphenol Corporation Announces Pricing of Senior Notes Offerings
APH,2025-10-27,22:48:03,BB07E4,Amphenol Corp.,100,0.0,credit,,Amphenol Corporation Announces Pricing of Senior Notes Offerings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Announces Pricing of Senior Notes Offerings
APH,2025-10-27,22:48:03,BB07E4,Amphenol Corp.,100,0.55,acquisitions-mergers,,"Amphenol Corp.: the Company's pending acquisition of CommScope Holding Company, Inc.'s Connectivity and Cable Solutions businesses",PRESS-RELEASE,Dow Jones Newswires,Press Release: Amphenol Corporation Announces Pricing of Senior Notes Offerings
APH,2025-10-29,20:06:43,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Officer Doherty Registers 80,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"Officer Doherty Registers 80,000 Of Amphenol Corp >APH"
APH,2025-10-29,20:15:30,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp d'Amico Registers 120,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP d'Amico Registers 120,000 Of Amphenol Corp >APH"
APH,2025-10-30,20:02:38,BB07E4,Amphenol Corp.,100,0.52,insider-trading,,"Ceo Norwitt Acquires 75,000 Of Amphenol Corp >APH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Norwitt Acquires 75,000 Of Amphenol Corp >APH"
APH,2025-10-30,20:03:00,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Vp d'Amico Sells 120,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP d'Amico Sells 120,000 Of Amphenol Corp >APH"
APH,2025-10-30,20:03:28,BB07E4,Amphenol Corp.,100,-0.49,insider-trading,,"Officer Doherty Sells 80,000 Of Amphenol Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Doherty Sells 80,000 Of Amphenol Corp >APH"
APH,2025-10-31,21:30:34,BB07E4,Amphenol Corp.,100,-0.48,insider-trading,,"Vp Ivas Registers 120,000 Of Amphenol Corp >APH",RNS-SEC144,Dow Jones Newswires,"VP Ivas Registers 120,000 Of Amphenol Corp >APH"
